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The aim of this thesis is to explore and compare methods that can be used
for the purposes of nding possible genetic eects in the context of ne-scale
genotype-phenotype association studies. Fine-scale genetic association studies
present unique challenges for attempts at nding genetic eects, due to the strong
linkage that can exist between dierent variants and issues that exist as a result
of multiple testing. However, unlike Genome-Wide Association Studies (GWAS),
there is potential to use the information from haplotypes arising from areas of
low genetic recombination.
In order to test the eectiveness of approaches involved in ne-scale studies,
the PheGe-Sim (Phenotype Genotype Simulation) application has been developed
in order to simulate ne-scale phenotype-genotype data sets under a variety of
scenarios. The simulations are based upon the coalescent model with extensions
of population expansion, recombination, and nite sites mutations, that allow
for real data sets to be more closely mirrored. The simulated data sets are
subsequently used to assess the eectiveness of each of the methods that are used
in this thesis, in attempting to nd the known simulated causal variants.
One of the methods suitable for use in ne-scale genetic association studies for
testing associations is Treescan (Templeton et al., 2005). Treescan is a method
that attempts to use relationships between closely related haplotypes in an at-
tempt to increase the power of nding genetic determinants of a phenotype. A
haplotype tree is constructed, and each branch can be sequentially tested for any
evidence of association from the resultant groups. To provide comparisons with
the Treescan method, similar methods to the Treescan approach using each SNP
(single nucleotide polymorphism) and haplotype have been implemented.
iAs a result of the issues of multiple testing in the context of GWAS, Bald-
ing (2006) advocated the use of Bayes factors as an alternative to the standard
use of p-values for categorical data sets. In this thesis Bayes factors have been
formulated that are suitable for continuous phenotype data, and for the context
of ne-scale association studies. Bayes factors are used in a method that utilizes
the Treescan approach of assessing various groupings from a haplotype tree, with
the method being adapted to take advantage of the exibility oered by Bayes
factors. Single SNP and haplotype approaches have also been programmed using
the same implementation of Bayes factors.
The PheGe-Find (Phenotype Genotype-Find) application has been developed
that implements the association methods when supplied with the appropriate
genotype and phenotype input les. In addition to testing the methods on simu-
lated data, the approaches are also tested on two real data sets. The rst of these
concerns genotypes and phenotypes of the Drosophila Melanogaster fruit y, that
has previously been assessed using the original Treescan approach of Templeton
et al. (2005). This allows for comparisons to be made between the dierent ap-
proaches upon a data set where there is strong evidence of a causal link between
the genotype and phenotypes concerned. A second data set of genetic variants
surrounding the human ADRA1A gene is also assessed for any potential causative
genetic eects on blood pressure and heart rate phenotype measurements.
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xivChapter 1
Introduction
Fine-scale genetic association studies are an important component in nding ge-
netic variants that increase an individual's risk of common complex diseases,
such as type 2 diabetes and Alzheimer's disease. Once a genome-wide associa-
tion study (GWAS) has identied an area of the genome that is likely to contain
a causative genetic component, ne-scale mapping studies are required in order
to locate the specic mutation that is responsible for the increased risk, or the
cause of a change in some measurable component such as blood pressure or heart
rate. If a genetic variant is found that is associated with a condition, then this
could provide valuable information as to what biological features are involved in
its aetiology. This information could then be used in order to direct eorts at
attempting to develop treatments that could target the biological and genetic
component of common complex diseases (WTCCC, 2007).
1.1 Mendelian and Complex Diseases
The association of inherited genetic variants with an observable phenotypic trait
has been a key component in understanding the processes involved in genetics
since the late 19th century. As the understanding behind the processes involved
in inheritable diseases improved, the genetic variants that caused diseases were
1CHAPTER 1. INTRODUCTION 2
discovered. Initial experiments on fruit ies by Thomas Hunt Morgan led to
the discovery of the primary patterns of inheritance; namely dominant, recessive
and additive conditions of such traits as eye colour and wing length (Morgan
et al., 1915). Mendelian traits, those that are entirely controlled by the action
of a single gene, are now generally well characterized in many species through
use of methods such as linkage analysis within families of disease carriers. In
humans the genetic variants responsible for heritable Mendelian diseases have
been determined for several severe conditions, such as cystic brosis (Rommens
et al., 1989; Kerem et al., 1989) and Huntington's Chorea (Huntington's Disease
Collaborative Research Group, 1993).
The successful discovery of disease-causing genes in Mendelian disorders has
led to eorts to determine genetic factors involved in more complex diseases,
which are a result of both multiple genetic and environmental components and
hence have a more complicated inheritance pattern than Mendelian diseases. The
common disease-common variant (CDCV) hypothesis (Lander, 1996; Pritchard
and Cox, 2002) proposes that there will be multiple common genetic variants that
each confer a small increase in risk for common diseases, such as type 2 diabetes
or Alzheimer's disease. Strong inuences of environmental factors, and the late
onset of such conditions resulting in limited selection pressures, can make eorts
at nding the relatively small eects of contributing genetic factors dicult. This
can be illustrated in the case of type 2 diabetes where there are well-characterized
genetic eects (Sladek et al., 2007), however, there are also strong associations
between an individual's diet and their risk of contracting the condition. There
are further diculties in detecting genetic associations with complex diseases due
to the possibility of multiple variants in the genome interacting with each other
to contribute to a change in the risk of contracting the disease.
1.2 Genome-wide Association Studies
Genome-wide association studies for complex diseases have become increasingly
feasible, and as a result more popular, due to the accumulation of evidence aboutCHAPTER 1. INTRODUCTION 3
genetic variation that has been documented in the HapMap Database (Inter-
national HapMap Consortium, 2005) and the 1000 Genomes Project (The 1000
Genomes Project Consortium, 2010). A further practical consideration that has
facilitated more widespread use of GWAS is the substantial advancements that
have been made in genotyping technology. In particular, the development of DNA
microarrays that can accurately type single nucleotide polymorphisms (SNPs) at
previously discovered locations in the genome, has enabled the genotyping of
hundreds of thousands of genetic variants quickly, cheaply and with relative ease
compared to previously used technology.
The potential usage of one such microarray, the Aymetrix 500k, was illus-
trated in the inuential genome-wide association study paper from the Wellcome
Trust Case Control Consortium (WTCCC, 2007). In this study genotypes of in-
dividuals with one of seven complex diseases were compared to a common control
group, to detect any associations between the genotypes and the disease under
consideration. The study reports successful discovery of highly signicant asso-
ciations with six of the conditions, with signicance for genome-wide association
being dened as a p-value of less than 5  10 7. As noted by the WTCCC,
the associations that have been found require validation in further studies before
there can be condence in their association with the diseases. GWAS by Bar-
rett et al. (2009) for associations with type 1 diabetes and by Tr egou et,D.A and
others (2009) for coronary artery disease, represent just two of the many such
studies that have attempted to follow up or replicate the results obtained by the
WTCCC.
For genome-wide association studies, it is unlikely that a true causative mu-
tation will be typed in a study, due to there being many more SNPs present in
the genome that will not have been typed. It is though hoped that a SNP will be
found that is highly correlated to a SNP that is indeed causative, due to linkage
disequilibrium between closely-spaced nucleotides. Fine-scale association stud-
ies are then used in an attempt to validate signals of association detected in a
GWAS, which can be achieved by typing additional SNPs in identied regions of
interest. Selected recent examples of the many such validation studies are Rung
et al. (2009) and Lowe et al. (2007), assessing variants for association with type
1 and type 2 diabetes respectively.CHAPTER 1. INTRODUCTION 4
Methods involved in ne-scale studies can be dierent to those used in GWAS,
for both biological and practical reasons. Unlike GWAS, in ne-scale studies there
is information that can be used advantageously about the haplotypes and the re-
lationships in their inheritance over short genetic distances. In practical terms,
simply due to there being fewer SNPs being considered, it is more feasible to con-
sider gene-gene and gene-environment interactions in a ne-scale study. There is,
however, the additional consideration of strong linkage existing between densely
typed SNPs, that will generally not be the case for SNPs in a GWAS. This infor-
mation can be useful in determining potential causative associations, although
this can also lead to diculties in identifying which of the linked variants are in
fact causative for a phenotype. A further practical consideration with ne-scale
studies, is that it is time consuming and expensive to obtain customized genotyp-
ing at a ne-scale level, whereas a GWAS will tend to use a DNA microarray with
pre-determined SNPs to be typed. Irrespective of the approach used, if a SNP is
found to be causatively associated with a condition, then this can potentially be
used in eorts to develop more eective treatments for the condition.
The methods explored in this thesis are aimed at short gene segments in
strong linkage disequilibrium, which have been covered with a dense panel of
SNPs so as to capture a high percentage of the potential variants within a region
being considered. This data can arise through resequencing studies of candidate
genes identied in a GWAS, and will be referred to as ne-mapping approach. As
commented previously, a GWAS will often have been designed so as to genotype
at SNPs that can be used to capture the data represented at the variant itself, and
nearby SNPs that are correlated with it. Imputation of the untyped SNPs using
HapMap or 1000 Genomes data sets can then be used to obtain the likely alleles
at the untyped variants, using programs such as IMPUTE (Howie et al., 2009),
MACH (Li et al., 2010) or BIMBAM (Servin and Stephens, 2007). Although
these approaches can be accurate at imputing untyped variants, there will be
less accuracy at rare variants and SNPs that are separated by recombination
from those that have been typed. As the genotyping technology improves, it is
plausible that almost all genetic variation can be captured using genotyping chips
and the need for imputation will diminish. However, in such situations of dense
SNP coverage, multiple linked variants can all be apparently associated with aCHAPTER 1. INTRODUCTION 5
phenotype being considered. Although the variant with the strongest signal is the
most plausible candidate for true association, it is relevant to rene this further
into determining if other nearby low frequency variants are in fact worthwhile
candidates, and if there is the potential eect of one or more distinct signals
that can be masked by considering each SNP independently. In such situations,
there may be advantages of approaches that can test multiple variants together,
or methods that can take advantage of the specic linkage patterns within a
region of low recombination that can potentially be modelled using the ancestral
relationships between individuals.
The methods that can be used for ne-scale studies are discussed further in
section 1.5. However, rst the theory of the coalescent is introduced, as this
can be used to simulate genetic data upon which the ne-scale methods can be
compared.
1.3 The Coalescent
In order to describe the genetic ancestry of individuals sampled from the present
day the coalescent theory has been developed. Originally suggested in a series of
papers by Kingman (1982a,b), the theory is a development of ideas about neutral
evolution in population genetics attributable to Wright (1931) and Fisher (1930)
in the Wright-Fisher model. A brief summary of the features of the coalescent
model follows. However, further details of the Wright-Fisher and coalescent mod-
els can be found in Hein et al. (2005) and Wakeley (2008).
The coalescent aims to describe relationships between subjects' haplotypes
that exist at the present time, by hypothesizing that at some time in history
there is an ancestor common for a pair of individuals' haplotypes. This con-
cept is extended for all individuals' haplotypes, and subsequently for groups of
individuals, until a single most recent common ancestor to the entire sample of
haplotypes is obtained. Formulation of the coalescent theory provides statistical
distributions and properties of genetic data, that can subsequently be used for
simulating realistic data sets.CHAPTER 1. INTRODUCTION 6
Coalescent theory provides a mathematical framework for describing the ge-
netic ancestry of a set of individuals and relies upon a set of fundamental as-
sumptions (Hein et al., 2005). The rst of these assumptions is that individuals
are haploid in nature. Although not literally true for humans, the pairs of N
individuals can be considered as 2N chromosomes or 2N haploid individuals to
a very good approximation.
A second assumption made in the coalescent process is that of discrete and
non-overlapping generations. This assumption is highly unrealistic, as for exam-
ple it is never going to be the case that all individuals in a human generation are
born and die at exactly the same time with a lifespan of approximately 25 years
per generation. The coalescent is however a method of generalizing to a large pop-
ulation over a considerable period of time, and it turns out that this assumption
is of minor relevance when these two factors are taken into consideration.
Arguably the most important of the assumptions of the coalescent process,
and one that can provoke much discussion, is that mutations that occur are selec-
tively neutral. This assumption is a key feature in the construction of methods
to simulate the coalescent, as it allows the coalescent structure and the mutation
pattern to eectively be treated as two independent processes. A justication
for this neutrality assumption is that most inheritable complex diseases, such
as Type 2 diabetes, are late onset and as such causative mutations are highly
unlikely to have strong selection pressures acting upon them.
The initial formulation of coalescent theory required the assumption of a con-
stant and nite population size, however subsequent developments in theory par-
ticularly by Donnelly and Tavar e (1995) have relaxed this assumption. Complex
arrangements of population expansion and sudden bottlenecks in population size
can be formulated, depending on the population ancestry that is required to be
modelled. The PheGe-Sim program that has been developed in chapter 2 incor-
porates the possibilities of the simplest scenarios of a constant population size,
or of a population that is exponentially increasing in size forward in time. More
complex models of population change over time can be accomplished using other
coalescent simulators. However, exploring the specics of demographic history is
not of primary importance in this thesis.
It is also assumed in the coalescent that no geographical or social structuresCHAPTER 1. INTRODUCTION 7
exist in the population, i.e the population is randomly mating. As with the as-
sumption of discrete and non-overlapping generations, this is a highly unrealistic
assumption to make for humans. There are multiple ways in which this assump-
tion can be violated in practice, based upon common-sense arguments such as in
human populations there are inherent social and geographical restrictions that
have shaped the development and isolation of dierent populations and ethnic
groups over history. There are, however, methods of attempting to reconstruct
populations (demes) with migration activity between them, such as the nite
islands model. Features of migration models have not been incorporated into the
PheGe-Sim program, as methods of association will have diculty in adequately
detecting and modelling these features. As such, even large scale association
studies tend to be based upon a single ethnic group or population, in attempts
to reduce the risk of inated type-I error rates that can arise when population
structure is not taken into consideration.
A further assumption of coalescent theory, that has subsequently been relaxed,
is that the region of DNA under consideration is not aected by any recombina-
tion events. Hudson (1983) developed methods to include recombination in the
coalescent history, resulting in Ancestral Recombination Graphs (ARG) (Griths
and Marjoram, 1996). Methods such as this have been implemented in ms (Hud-
son, 2002) and msHot (Hellenthal and Stephens, 2007), that simulate genetic
samples with various scenarios of recombination and recombination hostspots.
The PheGe-Sim program of Chapter 2 also allows for the inclusion of recombi-
nation events, however, it does not include extensions to variable recombination
rates and recombination hotspots. Although accounting for recombination would
be potentially useful, it will be seen in Chapter 7 that realistic ne-scale genotype
data sets can be simulated without this feature.
1.4 Coalescent Simulation
Numerous simulators have been programmed that make use of the coalescent
theory in order to create samples of DNA sequences from a population, such as:
ms (Hudson, 2002), msHot (Hellenthal and Stephens, 2007) , CoaSim (Mailund
et al., 2005), SimCoal (Excoer et al., 2000), Genome (Liang et al., 2007) andCHAPTER 1. INTRODUCTION 8
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PheGe-Sim (Chapter 2). Table 1.1 details some of the features of these widely
used programs for generating haplotype samples.
Alternative approaches of simulating genetic data are also possible, other
than the backwards-in-time coalescent methods presented in table 1.1. Forward-
in-time simulators such as Fregene (Hoggart et al., 2007; Chadeau-Hyam et al.,
2008) are potentially more exible but are substantially more computationally
intensive for large sample sizes. Approaches of simulating data based upon per-
muting HapMap data are also used in certain situations (Spencer et al., 2009).
The simulation of data in PheGe-Sim uses a backwards-in-time coalescent ap-
proach, although is not completely standard in its approach. This is because of
resampling haplotypes at an intermediate stage, a procedure that is more com-
putationally ecient. PheGe-Sim also integrates the mechanism of causative
mutations and the history of the sample at the same time, allowing for speci-
cation of causative eects that are not independent of the history of the sample.
This can subsequently be used to inform an eect size based upon multiple mu-
tations and interactions that takes into account the history for nite-sites models
of mutations.
The programs of table 1.1 could in theory be adapted to be suitable for sim-
ulations of ne-scale genotypes and continuous phenotypes, however, they would
also have to be adapted to be suitable for integration with the methods used
for association detailed in Chapter 4. The Phege-Sim application of Chapter 2
has therefore been coded in R (R Development Core Team, 2006), specically
to simulate ne-scale genotype-phenotype data and to be integrated with the
other applications used for genotype-phenotype association studies outlined in
this thesis.
In order to be suitable for generating ne-scale genetic data, the resulting
data set must display certain distinct patterns of linkage between the SNPs. In
GWAS, using a DNA microarray will provide a map of SNPs covering the whole
genome. However, this will not usually provide the dense coverage as required for
ne-scale analysis. Figure 1.1 illustrates the linkage pattern displayed within a
real data set (Chapter 6), and this can be seen to have a dierent range and spread
of colouring than can be achieved using any of the simulators that are primarily
intended for genome-wide simulation (appendix C.1). The specic details of theCHAPTER 1. INTRODUCTION 10
Figure 1.1: Example linkage plot from the data in Chapter 6.Each SNP involved
is represented by a separate row of the plot, and therefore each square represents
the linkage (correlation) between two SNPs. Increasing linkage is indicated by
darker reds, and areas of low linkage or low sample size are indicated by white or
blue squares respectively.
necessary parameters and features of PheGe-Sim that are required for the ne-
scale genotype simulation are discussed further in Chapters 2 and 7.
1.5 Fine-scale Association Study Methods
In both frequentist and Bayesian approaches to association testing, the appro-
priate choice of method to use depends upon whether the outcome of interest is
binary or continuous in nature. If the trait of interest is continuous, the simplest
test of association in an attempt to detect if there are dierences in the phe-
notype between the genotype groupings is to use a straight-forward analysis of
variance (ANOVA) model. This approach is comparable to the proposed exible
general model of the Bayesian analysis (section 3.3), whereby each genotype class
can have a dierent mean, but there is a common variance within each genotype
class. If the data is categorical, as opposed to continuous, logistic regression or
a standard 2 test can be used to test for dierences in proportions of cases and
controls, between the three genotype classes. The method suggested by BaldingCHAPTER 1. INTRODUCTION 11
(a) Additive Regression (b) Armitage Trend test
Figure 1.2: Illustrations of additive models for both continuous data (a), and the
binary method of the Armitage Trend Test (b).
(2006) provides a Bayesian option for categorical analysis, and a modied version
of this is detailed in section 3.1.
If it is assumed that the eects of alleles at a SNP are to act in an additive
manner on a continuous outcome of interest, then a standard regression can be
used as shown in equation 1.1 and gure 1.2(a):
y =  + x + "; (1.1)
where y is the phenotype response,  is the intercept of the regression equation,
 is the slope parameter of the regression equation, x is the genotype class (0
for AA, 1 for AB and 2 for BB) and " is the residual error that is Normally
distributed with mean zero and variance 2.
The Armitage trend test (Armitage, 1955) is a comparable method for detect-
ing additivity in binary data, where the outcome of interest is the proportion of
cases in each of the three genotype classes. The test can be implemented through
use of the R function prop.trend.test. An illustration of the approach is given in
gure 1.2(b), and the corresponding 2 test statistic is calculated by equation
1.2:

2
G =
N [N(r1 + 2r2)   R(n1 + 2n2)]
2
(N   R)R[N(n1 + 4n2)   (n1 + 2n2)2]
 
2
1; (1.2)CHAPTER 1. INTRODUCTION 12
where, N = Total sum of cases and controls, R = number of cases, r1 = count
of the case heterozygote alleles, r2 = count of the case homozygote alleles, n1 =
number of AB cases and controls, n2 = number of BB cases and controls; with
2
G  2
1 if there is no trend.
The additive model can be unsatisfactory in that, for a single SNP test, there
will only be three possible groupings of genotype and therefore only three pos-
sible points from which the coecients of a regression line are to be calculated.
A further possible issue with this approach is that, used in isolation, tests for
additivity can have low power for detecting non-additive dierences between the
genotypes such as may occur for dominant models, or models with three inde-
pendent genotype means. In an extreme (albeit unlikely) situation, a regression
approach for detecting additive eects would have no power to detect a true asso-
ciation if the heterozygote genotype grouping (AB) had a substantially dierent
mean phenotype measurement compared to two similar homozygote phenotype
means. Both general and additive tests should also be carried out to detect any
dierences between the genotypes, although care must be taken to ensure that
issues of multiple testing involving non-independent tests are appropriately con-
sidered. Similarly, consideration must be given to the multiple testing issues in
the calculation of p-values for dominant or recessive models, which are essentially
the same as the calculation of p-values for the general model but constrained to
only two genotype classes. Additive (section 3.4) and dominant/recessive (sec-
tion 3.5) models can be tted in the Bayesian setting for continuous data, along
with Bayes factors for combinations of two or more SNPs (sections 3.6, 3.7 and
3.8). All possible one and two SNP models can be compared in the Bayesian
framework, and although still to some extent subjective, there is explicit ac-
knowledgement of the role of prior beliefs about the proposed models that will
often nonetheless be inherently present in the frequentist approach. In addition,
if desired, a Bayes factor can also be calculated by producing a weighted average
of dierent models, with the weights being specied according to prior beliefs
about the dierent models.CHAPTER 1. INTRODUCTION 13
1.5.1 Haplotypes
In candidate-gene studies, or ne scale studies within several linked genes, there
is potential to use haplotypes as opposed to SNPs in eorts to nd causative
mutations, as haplotypes are essentially the units of inheritance passed from one
generation to the next. There are various advantages and disadvantages to a
haplotype-based approach compared to assessing the aect of each SNP individ-
ually, an area which is explored in detail by both Clark (2004) and Schaid (2004).
An immediate problem is that haplotypes are generally not observed, and have
to be inferred to the correct alignment (phase) using the available genotype data
with a program such as PHASE (Stephens et al., 2001) or fastPHASE (Scheet
and Stephens, 2006) which implement a Bayesian approach to phase estimation.
Although these programs are accurate in areas of low recombination rate and
high SNP density (Scheet and Stephens, 2006; Marchini et al., 2006), phasing
will inevitably introduce an additional source of error that would not be present
in single SNP analysis. In strongly recombinant areas of the genome, there will be
errors in phasing haplotypes due to uncertainty in determining the correct order-
ing of sequences, although in these situations it can be easier to identify potential
individual causative variants. Figure 1.1 shows an example where there is a clear
recombination hotspot that separates the SNPs into two haplotype blocks, and if
this structure is ignored, then this can lead to a far greater number of haplotypes
than if the phase is inferred for each block separately. Further details about this
particular data set are given in Chapter 6.
It is, however, thought that there may be some advantages in using haplo-
types as opposed to assessing each SNP individually. This is due to the SNPs in a
block of DNA being correlated with each other, and so there may be interactions
between SNPs that are best captured when considered as one single haplotype.
The linkage between SNPs will also invalidate some of the correction methods for
multiple testing in single SNP analysis, as the assumption of independent tests
will not be valid. Methods that test the strength of association between each of
the observable haplotypes and a phenotype of interest have been developed, to
act in an analogous way to the single SNP methods that have been used. Such
methods will however lack any ability in determining which of the SNPs on aCHAPTER 1. INTRODUCTION 14
haplotype is crucial in determining a change in phenotypic score. The use of
haplotype-based methods is therefore potentially only useful when there are mul-
tiple causative SNPs upon a single haplotype, each of which could be individually
of small eect and thus missed in a single SNP-based analysis. Haplotype-based
analysis can subsequently be modied to take into account a proposed tree struc-
ture relating the haplotypes, and this method could be better placed to identify
groups of related haplotypes that are all associated with a change in phenotype
measurement. This method will also have the added advantage, in that the SNPs
that dierentiate associated groups of haplotypes can be ascertained.
1.5.2 Phylogenetic methods and Treescanning
The structure of linkage present in small regions of chromosomes can be used
to an advantage in detecting causative associations through the use of phyloge-
netic models. There can also be advantages in the interpretation of any found
associations due to haplotypes forming a basic unit of inheritance (Drosophila
12 Genomes Consortium , 2007), although obtaining haplotypes for human pop-
ulations can present diculties (Durrant and Morris, 2005). Single SNP tests
that ignore the correlations in alleles at dierent SNPs caused by shared ancestry
would be expected to be less powerful than methods that explicitly model those
correlations, for example by inferring aspects of the ancestral tree or graph that
relates the haplotypes. Such approaches potentially allow signals coming from
multiple correlated SNPs, occurring close to each other in the ancestry, to bolster
one another.
Taking account of the ancestral relationship of haplotypes can increase the
power of association studies (Eskin, 2008; Roeder et al., 2006), and numerous
methods have been proposed that aim to take advantage of the linkage. One
such method is that proposed by Durrant et al. (2004) in which a sliding window
approach is taken to dene haplotype blocks that are then related via a clado-
gram, which is subsequently used to create tests for association with a phenotype.
Minichiello and Durbin (2006) take a related approach that estimates Ancestral
Recombination Graphs (ARGs) as opposed to cladograms to relate haplotypes.
Z ollner and Pritchard (2005) proposed a method that relies on an underlyingCHAPTER 1. INTRODUCTION 15
Figure 1.3: Example of the use of Tree-Scanning; reproduced from the Treescan
Documentation (Templeton et al., 2005). Part IV shows two groups of haplotypes,
represented by `A' and `B', that have been determined to have signicantly dif-
ferent phenotype means. In a second round of tests, illustrated by parts IV.1 to
IV.4, further groups of haplotypes are considered in an eort to determine if there
are additional signicantly dierent phenotype groups, conditional on retaining
the dierences found between groups `A' and `B'.CHAPTER 1. INTRODUCTION 16
coalescent approach to relate individuals, in an attempt to increase the ability
to nd causal variants by observing non-random clustering of haplotypes. This
approach can though be computationally expensive, a feature that Kimmel et al.
(2008) aim to overcome using their method that relies on no recombination events
and a nite sites model across each region being considered.
One of the phylogenetic methods that is assessed in this thesis through the
use of simulated data, is the Treescan method (Templeton et al., 2005). This
method is a development of the nested clade analysis method, also developed by
Templeton and colleagues in a series of articles (Templeton et al., 1987, 1988,
1992). The nested clade analysis method involves deriving a network of related
haplotypes, and then sequentially assessing for various groupings of haplotypes as
to whether there is any evidence of a dierence in phenotype scores between the
clades (groups) using F-statistics. Treescan uses a similar method to the nested
clade analysis, however a key dierence is that Treescan allows for the use of
diploid as opposed to haploid populations and is thus suitable for use on human
populations.
In situations of no recombination and innite sites mutation, the Treescan
method will produce identical results to the single SNP analysis. There will how-
ever be an advantage of the Treescan approach in circumstances where a causative
mutation may only result in a change in phenotype score on a particular lineage,
and thus only on one haplotype carrying the causative form of the mutation.
In this situation grouping together individuals with the same DNA base as in a
single SNP analysis would lead to a reduction of power, as there would be no
separation of causative and non-causative mutations that can be achieved in the
Treescan analysis.
The rst stage of a Treescan analysis is the construction of a haplotype tree,
by pruning a network of haplotypes if there is ambiguity in the branching struc-
ture, the specic details of which are described in section 4.2. The tree is then
partitioned sequentially at every branch, and an ANOVA carried out to compare
the phenotypes of the three resulting groups; namely AA, BB or AB from the top
image in gure 1.3. The p-values that result from the ANOVA must be corrected
in some way, to compensate for multiple testing and for the correlation betweenCHAPTER 1. INTRODUCTION 17
the dierent tests. Treescan obtains corrected p-values using a permutation ap-
proach, whereby the phenotype scores of the sample are randomly allocated to
each of the three groups, whilst preserving the initial number of samples in each.
A p-value is then obtained by taking the proportion of the F-statistics from the
ANOVA's for each of the permuted data sets, that exceeds the original F-statistic
relating to the grouping of clades. Monotonicity is then enforced through succes-
sive maximization of the p-values, to ensure that a higher F-statistic results in a
lower permuted p-value.
Due to the correlation that exists between closely spaced SNPs on a haplotype,
the Treescan method may detect branches with a low p-value due to a `spill-over'
eect from a branch that is truly associated with the phenotype. To compensate
for this eect, Treescan performs a second stage of splitting the tree, conditional
on a branch that is found signicant in the rst round of tests. Figure 1.3
illustrates the second round of partitions that are assessed, after initially nding
the groupings A and B as signicantly dierent, as adjudged by having a corrected
p-value of less than 0.05. All splits that satisfy this criteria from the rst round
are then xed, and a second stage of splitting conditional to this is implemented.
A decision can then be formed as to whether a haplotype is strongly associated
with the phenotype, by assessing the tables of rst and second stage results (see
section 4.4).
The methods discussed so far are all in the frequentist setting and rely on the
use of p-values, which are corrected for instances of multiple testing. Although
there are valid criticisms that can be made regarding the frequentist approach
and its use of multiple-testing corrections, it is still useful for the context of
association studies. A SNP that has been found to be strongly associated with
a phenotype of interest by the use of p-values will also have a strong chance of
being found through the use of a properly calibrated Bayesian analysis. The use of
Bayes factors is though particularly appropriate for data in a genetic association
context, for the following key reasons:
1. In ne-scale association studies, there is a large number of hypothesis to
be tested as there are at least as many tests to be performed as there are
SNPs that have been typed in a study. This leads to issues in appropriatelyCHAPTER 1. INTRODUCTION 18
correcting for multiple testing, a situation that is even more crucial for
GWAS, where the number of tests can run into the millions.
2. It is possible to end up with rare groupings of genotypes that have large p-
values which are in fact a result of chance, due to there being low power to
detect such dierences. Appropriate reporting and analysis of such SNPs
should take this into account. However, this situation is automatically
accounted for in the Bayes factors through the use of the priors, but can
often be neglected when assessing p-values. There are no known methods to
correcting reliably for this issue in the frequentist setting, and any sensible
approach will necessarily be introducing some form of subjective opinion as
to what sample size and power are suitable criteria to determine signicance.
3. Multiple dierent models, such as additivity, dominance or recessive eects,
can be applied to the same SNP or combinations of SNPs. The weight of
evidence for all the possible models should be calculated and compared,
to ensure full exploration of a data set, as is the situation in the Bayes
factors context. In a frequentist approach, consideration should be given to
multiple testing issues for the non-independent tests of the dierent models.
4. In ne-scale studies in particular, SNPs may be highly correlated, and there
are no suitable methods of correcting p-value cut-os for such data. The
linkage that occurs in data will also be a feature of the Bayesian analysis,
however as noted in the previous comment, the Bayesian approach can fully
explore all combinations of models and SNPs that are deemed appropriate
without fear of multiple testing issues, which are replaced by a priori models
of eect sizes and the number of causative SNPs.
5. There are no steadfast rules about what can be considered as `signicance'
in reporting of a found association, and a criticism of the Bayes factor
method in that there is subjective use of priors can equally be applied to
the interpretation and reporting of results from p-values. The strength of
an association of a SNP with a trait will depend on many factors, and the
weight of evidence that is found for each possible model should be reported.
This is possible in a Bayesian approach, where the evidence can be presentedCHAPTER 1. INTRODUCTION 19
in such a way that can convey the uncertainty in whether true associations
are present.
The following sections detail the approaches that could be applicable in the
calculation of Bayes factors, in addition to introducing the possibility of the
exactly computed Bayes factors that are used in the PheGe-Find application of
Chapter 4.
1.6 Bayesian Methods
The theory of Bayes factors was rst developed by Jereys (1939), as a way
of quantifying the evidence in favour of competing models or hypotheses. The
methodology behind Bayes factors was re-introduced with the review paper of
Kass and Raftery (1995).
The Bayes factor for two competing models H0 and H1, are part of the fol-
lowing relationship:
Posterior Odds = Prior Odds  Bayes Factor: (1.3)
That is,
p(H1jy)
p(H0jy)
=
p(H1)
p(H0)

p(yjH1)
p(yjH0)
; (1.4)
where y symbolizes the data, and the calculation of the marginal likelihoods
p(yjH1) and p(yjH0) that form the Bayes factor, requires calculation of the fol-
lowing integrals:
p(yjH0) =
Z
p(0jH0)p(yj0;H0)d0; (1.5)
and
p(yjH1) =
Z
p(1jH1)p(yj1;H1)d1; (1.6)
where i are the parameters of model Hi, i = 0;1.
The primary consideration in the use of Bayes factors is in evaluating the
integrals of equations 1.5 and 1.6. The posterior distributions for a Bayesian
analysis should be proper, i.e. integrate to 1, thus also ensuring that appropriate
comparisons between competing hypothesis can be made. To satisfy this criteriaCHAPTER 1. INTRODUCTION 20
careful consideration must be made when deciding on the prior distributions that
are chosen, particularly if using non-conjugate priors.
The use of Bayes factors as a method of ranking associations has been in-
creasing in popularity in the context of genetic studies. However, the relation-
ship between p-values and Bayes factors is not straightforward as the interpre-
tation depends strongly on the sample size and minor allele frequency of each
test being considered (Wakeeld, 2009). Methods providing a compromise on
the frequentist and Bayesian approaches have also been proposed such as treat-
ing Bayes factors as a test statistic and obtaining p-values by permutation, or
by calculation of a posterior probability of association (Stephens and Balding,
2009; Servin and Stephens, 2007). The Wellcome Trust Case Control Consor-
tium (2007) used Bayes factors for case-control studies with conjugate priors
developed in the SNPtest program (Marchini et al., 2007), and the Bayes factors
used have been useful in dealing with the uncertainty caused by imputed geno-
types. As GWAS studies of continuous phenotypes are increasingly being tested,
the Bayes factors have to be adapted to be suitable for this context, resulting in
increased diculty in the choice and specication of suitable priors.
In some instances the integral can be calculated analytically, if suitable prior
distributions are chosen. The advantages of this approach is accuracy in the
answer, and in reduced computation time in comparison to numerical methods of
evaluating the integral. In order to use the analytic approach, conjugate priors
provide the most straightforward approach, to ensure that the posterior is of the
same form as the prior. In the examples in Chapter 3, a conjugate Normal Inverse
Chi-squared distribution (Gelman et al., 2004) is used for the prior for the mean
and variance.
If the integrals cannot be performed analytically, there are various alternative
methods that can be used. Laplace' method can be employed in order to estimate
Bayes factors. An un-normalized posterior density is obtained, and then this
distribution is approximated with a Normal distribution by matching of the mean
and variance. The normalizing constant of the posterior distribution, that is
required for the calculation of the Bayes factors, is then approximated by the
normalizing constant of the matched Normal distribution. The Laplace approach
is also potentially useful for calculation of the Bayes factors for multiple testsCHAPTER 1. INTRODUCTION 21
of association, as the normalizing constant can be found relatively quickly and
easily.
Depending on the chosen prior and likelihood distributions the calculation of
the integrals for the competing models can be intractable, and the results have
to be approximated through methods such as Markov-Chain Monte Carlo and
importance sampling. Although a Monte Carlo approach can be useful in many
situations where the evaluation of the integrals is impossible analytically, for the
high dimensional SNP data the problems in high run time and in automating
the assessment of convergence make the use of these approaches less appealing in
this context.
As with all Bayesian analysis suitable parameters for the prior distribution
must be chosen, the choice of which is both a positive and a negative feature
of Bayesian analysis. In choosing a prior, information that is previously known
about a data set can be included in the analysis which can increase the power
of a study. However, if unsuitable priors have been chosen then incorrect or
misleading conclusions can be inferred. The various issues with selection of prior
parameters are documented further by Gelman et al. (2004). Further discussions
relating to the appropriate choice of prior parameters for the exactly computed
Bayes factors used in this thesis, are given separately for each of the data specic
Chapters (5, 6 and 7). BimBam (Servin and Stephens, 2007) is an application
that also uses exactly computed Bayes factors, but uses a dierent approach for
the prior distributions (section 4.4.1).
The exact analytic approach that has been chosen to calculate the integrals
in equations 1.5 and 1.6, requires the use of conjugate priors, so that the pos-
terior distribution of model parameters can be obtained easily, and integrated
in a relatively straightforward manner. Using exact evaluation of the integrals
will result in the most accurate answer if the assumptions underlying the chosen
distributions are valid, and will also be the quickest method to implement. This
approach is though restricted to the exponential family of models, as they have
suitable conjugate prior distributions. For the purposes of most continuous phe-
notype traits they will approximately follow, or can be transformed to represent,
a Normal distribution and so the exact analytic computed Bayes factors can be
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Table 1.2: Interpreting the strength of associations using Bayes factors, repre-
sented by B.
2logeB B Evidence against H0
0 to 2 1 to 3 Minimal
2 to 6 3 to 20 Positive
6 to 10 20 to 150 Strong
>10 >150 Very Strong
The relationship between p-values and Bayes factors is not straightforward,
and as much care must be taken in their interpretation as with their formula-
tion. In frequentist studies a signicance level of 0.05 or 0.01 is used, and this is
corrected in some way to take into account multiple testing. In a Bayes factor
approach, there is a less rigid specication of a value that is required for `signi-
cance', however, table 1.2 presents a reproduction of approximate guidelines for
interpretation as specied by Kass and Raftery (1995).
The posterior odds that are obtained from the Bayes factors will be heav-
ily dependent on the choice of the prior odds of association for the test under
consideration, and this choice will depend on the situation being considered. For
example, in a GWAS it is unlikely that any one particular SNP will have an eect
on a trait of interest, however, for a candidate gene study it would be reasonable
to expect that there already exists some justication that there is an association
within the region being considered. A crucial element in the use of Bayes factors
is that this choice of prior odds is made by some careful reasoning, and is not
tailored to simply accommodate strong results being articially found. The up-
side of choosing prior odds is that, unlike in the use of p-values, a Bayes factor
may be inuenced less by small changes in the observable data.
1.7 Example Data Sets
Simulations of the coalescent will provide some impressions about the likely ef-
fectiveness of the methods that are assessed. However, they are also tested on
real data sets as there will inevitably be features of genetic data that are notCHAPTER 1. INTRODUCTION 23
replicated in the simulated data. Two data sets were available upon which to
test the methods used for association. The rst of these data sets in Chapter
5 is that which was initially analyzed using the Nested Clade Analysis method
(Templeton et al., 1988), and subsequently in the Treescan (Templeton et al.,
2005) approach to provide comparisons between the two procedures. This data
set is relatively small and involves homozygous inbred Drosophila melanogaster
fruit ies, as opposed to human data which would involve heterozygous geno-
type groupings. The analysis of this data set will however provide useful initial
indications as to the similarities and dierences of the methods assessed in this
thesis.
Data has also been made available from the PAMELA (Padmanabhan et al.,
2010) study relating to phenotype and genotype measurements of an Italian pop-
ulation that has not previously been analyzed using Treescan or Bayesian ap-
proaches. The available data set involves 70 SNPs relating to a gene that is
targeted by anti-hypertensive treatments, and so is a plausible candidate gene
for association with the measurements of heart rates and blood pressures that
have been recorded.
Both of the data sets have been analyzed using the interactive PheGe-Find ap-
plication, developed in Chapter 4, which has been created to allow for phenotype-
genotype data sets to be simply and quickly analyzed.
1.8 Overview of the Thesis
  Chapter 2 introduces the coalescent data simulation features that PheGe-
Sim uses in order to simulate data for fair comparison of the association
methods presented elsewhere in the thesis.
  Chapter 3 provides further details behind the methods used in the PheGe-
Find application, in particular detailing the formulations of the Bayes fac-
tors used throughout the thesis.
  Chapter 4 contains information on the features and methods that are present
in the PheGe-Find and PheGe-Sim applications.CHAPTER 1. INTRODUCTION 24
  Chapter 5 uses the methods of Chapter 3 on the Drosophila melanogaster
data set.
  Chapter 6 uses the methods of Chapter 3 on a data set involving heart rate
and blood pressure measurements.
  Chapter 7 uses the methods to simulate data as presented in Chapter 2, in
order to test the eectiveness of the various association study approaches
given in Chapters 5 and 6.
  Chapter 8 provides a summary, some conclusions, and potential further
work.
1.9 Aims of the Thesis
  To simulate data that can reasonably represent data sets arising in a ne-
scale genetic association study.
  To investigate the advantages and disadvantages of various approaches that
can be used in ne-scale genetic association studies, through the use of simu-
lated data sets. In particular, to compare the eectiveness of methods based
upon Treescan to those that test each SNP individually; and to assess the
potential benets of using a Bayes factor approach compared to standard
frequentist p-values.
  To provide applications that can be used to implement the association study
methods for real data sets.
  To use the applications on real data sets to detect any associations present,
and to illustrate any deciencies of the methods that are not apparent with
simulated data.Chapter 2
PheGe-Sim
The PheGe-Sim application (gure 2.1) has been written in the R program-
ming language (version 2.4.1)1 in order to simulate data from the coalescent
process, and if specied, to apply the various association study methods to de-
tect causative loci. PheGe-Sim has been written as a function contained within
the Rpanel (Bowman et al., 2007) environment, which creates a windows-based
application that can be used to easily specify the many possible input variables.
For the variables that can be numerical, or take on a range of categorical values,
the simulator will check that the input is of the correct type and that it is consis-
tent with the other selected variable options. If an inappropriate input is entered
an error message such as that in gure 2.2 will be produced, suggesting what
inputs should be changed to allow the program to run. The following section
details the possible input variables, and the options that are permissible to be
entered for each.
1PheGe-Sim was initially programmed in R 2.4.1 and Rpanel (1.0-4) , but the code will also
run in the newest version of both R (2.10.1) and Rpanel (1.0-5). There are however minor
dierences with the versions, as R 2.4.1 will run with the textentry boxes as they appear,
whereas R 2.10.1 requires a carriage return after changing any of the values for the change to
be recognized.
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Figure 2.1: PheGe-Sim simulator screen shot.
2.1 Input Options
 Number of simulations : f1,2,...g = Run and summarize results
(section A.4) for the chosen number of simulations.
 Nt : f5,6,...g = Number of terminal nodes of Ancestral Recombination
Graph (ARG) used to simulate genotypes (section 2.2).
 Beta.par : [0;1) = The population size expansion parameter , where
 = 2Nb is the scaled expansion rate, N is the eective population size,
and b is the expansion rate per generation.
 Theta : [1, 1) = Mutation rate per 4N generations.
 Sample size : f50, 51, 52, ...g = The number of individuals with
genotypes and phenotypes that are to be sampled from the population.
 Newick options: fT,Fg = Save dierent variations of Newick format les
(Felsenstein et al., 2010) of coalescent trees resulting from the simulated
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Figure 2.2: Example of error message from PheGe-Sim.
 Number of Defective loci : f1,2,...g = Specify how many mutations
are selected to be causative in the simulations.
 Risk per mutation : ( 1;1) = Specify the average increase in phe-
notypic measurement for each copy of a causative mutation. This is for the
heterozygote mean of an additive model, the value of dominant or recessive
models is therefore twice the specied value (section 2.6).
 Interaction Eects : ( 1;1) = Specify any two-way interactions
between causative mutations, if it has been chosen to have more than one
defective locus. Alternatively, if it is chosen to have only one defective loci,
the single value entered for an interaction eect will represent an `excess
additive' form of mutation (section 2.6).
 SDev per mutation : (0, 1) = Specify a common standard deviation
for each genotype grouping.
 Fasta : fT,Fg = Save the genotypes in the Fasta format (section A.1).
 Phylip : fT,Fg = Save the genotypes in the Phylip format (section A.2).
 PED : fT,Fg = Save the genotypes in a PED le format (section A.3).
Will also run the Haploview (Barrett et al., 2005) application to provide a
linkage plot of the simulated data set.
 Save Treeplot : fT,Fg = Save the true coalescent plots and ARG used
to simulate data (section A.11).
 Innite Sites : fT,Fg = Use an innite sites model for the mutations,
or a nite-sites model if unselected (section 2.4.1).CHAPTER 2. PHEGE-SIM 28
 All Causative : fT,Fg = Select whether or not a causative mutation is
causative in all positions that it occurs on the ARG (2.4.1).
 Gen options : fT,Fg = Use Maximum Likelihood, Fitch algorithm or the
Parsimony method in the reconstruction of a haplotype tree (sections 4.2
and 4.3).
 Run Treescan : fT,Fg = Runs the Treescan application and interprets
the results from the output (sections 1.5.2 and B.2).
 Bonferroni Test : fT,Fg = Implements a test of association with the
Bonferroni correction on each SNP and interprets the results (section 4.4).
 Single SNP test : fT,Fg = Runs a single SNP method that corrects
p-values in an analogous way to Treescan (section 4.4).
 Bay Factor Tree : fT,Fg = Use the Bayes factors method on haplotype
groupings given by the Treescan method (section 1.5.2).
 Bay Factor SNP : fT,Fg = Runs a single SNP method using Bayes
factors to test for associations (Chapter 3 and section 4.4).
 Haplo options : fT,Fg = Runs the appropriate method using haplotypes
instead of SNPs to test for associations (section 4.4).
 Gamma options : (0, 1) = The shape and scale parameter of the
Gamma distribution of the nite sites model (section 2.4.1).
 Recombination rate : [0,2] = Specify the recombination rate for the
ARG per 4N generations.
 BimBam SNP : fT,Fg = Runs the single SNP BimBam (Servin and
Stephens, 2007) method (section 4.4.1).
 BimBam TSC : fT,Fg = Runs the Treescan method using the Bayes
factors of BimBam (sections 1.5.2 and 4.4.1).
 Mutation Type : fA,D,Rg = Species whether the simulated causative
variants act in an Additive, Dominant, or Recessive manner. A non-additiveCHAPTER 2. PHEGE-SIM 29
model for one causative site can be obtained using an additive model with
an interaction (section 2.6).
 Simulate all num : = Upon selection will start execution of the simula-
tions, or will notify of any errors in the specied entries.
2.2 Simulate ARG matrix
Input:
Recombination rate - 
Number of (terminal) nodes - n
Population expansion parameter - 
The rst stage in simulating the coalescent process consists of generating a
vector representing the sequence of coalescent and recombination events that
occur, going back in time from the present. A time is simulated until either
a coalescent or recombination event occurs, based upon the number of nodes
that are currently remaining (k) and the recombination parameter (). The
waiting time to a coalescent event is modeled with an exponential distribution
with parameter 1
2k(k   1) and the time till a recombination event is modelled
with an exponential distribution with parameter 1
2k; therefore the waiting time
till an event of either type is modelled as an exponential with the sum of these
rates:
Exponential

k(k   1)
2
+

2
k

: (2.1)
The type of event occurring is then chosen according a Bernoulli distribution
with probabilities given according to the values from each of the two indepen-
dent coalescent and recombination distributions. If the simulated event is of a
coalescence between two nodes, then the two nodes that coalesce are randomly
chosen from the available nodes at that stage in the simulation, as illustrated in
gure 2.3 where nodes 1 and 2 are chosen resulting in the creation of node 6. The
number of nodes present is reduced by one, i.e., k ! k   1, and so in gure 2.3
after the rst coalescent event only the set of nodes f4,3,6,5g remains.CHAPTER 2. PHEGE-SIM 30
Figure 2.3: Sequence of coalescent(C) and recombination(R) events and times.
The set of ft1,t2,t3,t4,t5,t6g represents the sum of the waiting times at each
event.
The next time till an event occurs is then generated, and if this event happens
to be a recombination event then the result is to increase the number of nodes
remaining by one, i.e., k ! k + 1. The lineage on which recombination occurs is
chosen randomly from those that are present at that stage in the simulation, so
in gure 2.3 node 3 has been chosen thus resulting in the creation of branches 7
and 8. The position of the recombination event is chosen according to a Uniform
distribution covering the section of DNA. The process of sampling coalescent and
recombination events is then continued until all nodes have coalesced to a common
ancestor, so that k = 1, which in this example occurs at node 12, the most recent
common ancestor of this sample. Careful selection of () must be made to ensure
that the most recent common ancestor is reached within a `reasonable' amount
of time, and is therefore restricted to an upper limit of two 4N recombination
units.
As the sequence of coalescent and recombination events is occurring, the evo-
lutionary time between events is stored. This results in the branch lengths of a
particular lineage being simply calculated from the dierences in event times on
that lineage. In order to model the potential eect of a non-constant population
size (Hein et al., 2005), the branch lengths can be adjusted for exponentiallyCHAPTER 2. PHEGE-SIM 31
increasing population size using:
tk =
1

log(1 + t

k); (2.2)
where tk represents the adjusted branch lengths,  is the scaled growth rate, and
t
k are the branch lengths from a coalescent process with no population growth.
Output of:
ARG branch lengths - branch.length.ARG
ARG node labels - ARG.matrix
Sequence of coalescent and recombination events - ARG.matrix
2.3 Plotting the ARG
Inputs:
ARG branch lengths - branch.length.ARG
ARG node labels - ARG.matrix
Sequence of coalescent and recombination events - ARG.matrix
The ARG that has been generated in the previous section can be plotted,
with the aim being to produce the clearest plot possible by reducing the number
of lines that cross over as a result of recombination events. Although not of
primary concern to any of the results of the simulations, the methods involved
in determining the relationship between dierent lineages for the plot are closely
related to the format of the methods used to allocate the list of branches for each
terminal node. This information is then used once mutations have been added
to the branches in section 2.4 to determine the sequence of bases of each of the
sample haplotypes.
Figure 2.4 and table 2.1 represent the rst three stages involved in plotting
the ARG that was illustrated in gure 2.3, and demonstrates the algorithm that
can be generalized for plotting any ARG. At the initial stage of the plotting
algorithm, none of the terminal nodes are xed in position on the x-axis. A
coalescent event then occurs which xes nodes 1 and 2 in position adjacent toCHAPTER 2. PHEGE-SIM 32
(a) (b) (c)
Figure 2.4: First three stages involved in plotting the example ARG of gure 2.3.
each other, as illustrated in gure 2.4(a).
The second event that occurs, as shown in gure 2.4(b), is a recombination
on the lineage of node 3. A recombination event does not alter the ordering of
terminal nodes, but the spacing of the terminal nodes is adjusted so as to maintain
a clear appearance of the plot (2.4(c)). Information regarding the ancestry of the
terminal node 3 is retained, with it being either connected to lineage 7 for sites
to the left of the recombination breakpoint, or connected to lineage 8 for sites to
the right of the recombination position.
The next event that occurs is a coalescent event involving two nodes that
have been involved in events from earlier on in the plotting process. In this
case, the nodes that are joining together are the node labelled 6 resulting from
the rst coalescent event, and the node labelled 8 that is the result of the rst
Table 2.1: First three stages involved in plotting the example ARG of gure 2.3.
The `Fixed' row refers to terminal nodes that have been xed in a sequence, and
the `Current Nodes' row illustrates the nodes that are remaining at each stage of
the plotting.
Stage in gure 2.4 - a b c
Fixed 1 2 1 2 1 2
Current Nodes 1 2 3 4 5 3 4 5 6 4 5 6 7 8 3 4 5 6CHAPTER 2. PHEGE-SIM 33
(a) (b) (c)
Figure 2.5: Second stages involved in plotting the ARG of gure 2.3.
recombination event. The plotting algorithm attempts to minimize the number of
instances of lines crossing over to maintain the clearest plot, and so the sequence
of terminal nodes in gure 2.5(b) is chosen in preference to that of gure 2.5(a).
The fourth event in this example is that of a coalescence between nodes 4 and
7. The algorithm again checks for crossing over of branches, and subsequently
chooses the sequence of terminal nodes that minimizes the number of instances
of this happening. For this coalescent event, that results in the terminal node
sequence being that as shown in 2.6(a) as opposed to that of gure 2.5(c).
The penultimate event occurring in gure 2.6(b) is of a coalescence between
nodes 9 and 10, resulting in the creation of node 11. As the sequence of terminal
nodes have already been xed for both nodes 9 and 10, the nodes are joined
together irrespective of whether there are any branches crossing over. This can
lead to the base of a plot being well structured but with the top of a plot being
cluttered because of many branches crossing over: as a greedy algorithm is being
used that decides upon the best conguration based only on the current level
Table 2.2: Second stages involved in plotting the ARG of gure 2.3.
Stage in gure 2.5 a b c
Fixed 1 2 3 1 2 3 3 1 2 4
Current Nodes 4 5 7 9 4 5 7 9 9 10 5CHAPTER 2. PHEGE-SIM 34
(a) (b) (c)
Figure 2.6: Final three stages involved in plotting the ARG of gure 2.3.
in the process. This situation is however unlikely to occur in practice unless a
relatively large recombination rate is chosen in comparison to the rate of coales-
cence. Possible improvements could be made to the algorithm to improve the
appearance of plots in situations such as this, although the algorithm works suc-
cessfully in its current form for its primary function of determining the sequence
of branches for each terminal node.
The nal event for this example, as illustrated in gure 2.6(c), is of the coa-
lescence of nodes 11 and 5. In this instance there is no preference for an ordering
of f4,3,1,2,5g or f5,4,3,1,2g, as neither alternative will result in branches crossing
over each other on the plot. The sequence of terminal nodes is therefore chosen
randomly from the two possibilities.
The resultant plot can then be saved to an appropriate le if the Save Treeplot
option is selected on the Rpanel simulator. The information regarding the se-
quences of internal nodes for each side of the recombination breakpoint are saved
Table 2.3: Final three stages involved in plotting the ARG of gure 2.3.
Stage in gure 2.6 a b c
Fixed 1 2 3 4 4 3 1 2 4 3 1 2 5
Current Nodes 9 10 5 11 5 12CHAPTER 2. PHEGE-SIM 35
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(b)
Figure 2.7: Matrices of terminal nodes (TN) for the left (a) and right (b) of the
recombination breakpoint.
in a series of matrices for each of the Terminal Nodes (TN). Continuing the ex-
ample ARG used previously, the saved matrices would take the form of that in
gure 2.7 for the left and right hand sides of the recombination event.
Outputs of:
Sequence of internal nodes - lineage.nodes.matrix
ARG plot - Saved to le
2.4 Assign Mutations onto the ARG
Inputs:
Branch Lengths - branch.length.ARG
Mutation Rate - 
Number of defective Loci - defect.loci
Sequence of internal nodes - lineage.nodes.matrix
The ARG that has been created can now have the mutations that aect the
observed genotypes superimposed on it. This is possible due to the coalescent
theory allowing the evolutionary and mutation history to be separable from each
other, if the eects of mutations are assumed to be selectively neutral. Each
branch is treated independently, and the number of mutations that occur on
a branch is chosen according to a Poi(t) distribution, where t represents the
branch length and  represents the mutation rate. Continuing the example of theCHAPTER 2. PHEGE-SIM 36
Figure 2.8: ARG with overlaid mutations, with red lines indicating mutations
occurring on sites to the left of the recombination breakpoint, and blue mutations
representing mutations that occur to the right of the site at which recombination
occurs.
ARG used in sections 2.2 and 2.3, the plot of an ARG overlaid with mutations
is shown in gure 2.8.
In order to allocate the positions of sites that mutate at each SNP on the
ARG, the randomly selected locations at which recombination events occur must
also be taken into consideration. For each mutation that occurs on the ARG,
the position of the site that the mutation represents is chosen according to the
regions that are possible on the branch under consideration. For example, in
gure 2.9(a) only sites to the left of the recombination breakpoint are possible
on branch 7, whereas the complete set of sites can mutate on branch 11 as this
occurs in the coalescent trees of both regions. This procedure ensures that all
mutations correspond to a change in the base at a selected site, except in cases of
trapped ancestral material, where branches of the ARG are not possible in any
of the coalescent trees and so do not contribute to the sample.
Each recombination event will result in a separate coalescent tree describing
a dierent region of a sequence of DNA bases. To ensure that a model of in-
nite sites is possible, the number of sites in a region must be at least as large as
the number of mutations that are sampled to occur for that region. An initial
sequence length of 500 is used as this is assumed to be at a level far above that
of the number of SNPs in a ne-scale study. If a larger number of mutations areCHAPTER 2. PHEGE-SIM 37
(a) Left hand side of recombina-
tion event
(b) Right hand side of recombina-
tion event
Figure 2.9: Mutations allocated to coalescent trees.
sampled than there are possible sites in a region, the region is simply extended in
size to accommodate the number of mutations. The recombination breakpoints
are then adjusted according to the new size of the regions. This procedure is pos-
sible as the distances between recombination breakpoints and SNPs are assumed
to be irrelevant in practice. Dealing with the recombination breakpoints in this
manner also prevents large numbers of simulations from being discarded for not
allowing the possibility of the specied number of mutations to occur within a
region.
The information regarding the terminal node sequences are determined for
each coalescent region separately, and the terminal node sequence for the entire
range of the ARG is obtained by simply joining these regions together. Figure 2.10
illustrates matrices that could result from the coalescent trees, with mutations
as in gures 2.9(a) and 2.9(b). Information from the stored matrices can also
be shown graphically (gures 2.10(d), 2.10(e) and 2.10(f)), using `lineplots' that
illustrate the relative locations of mutations for each terminal node.
2.4.1 Finite Sites
Additional Input:
Innite sites option - innite.sitesCHAPTER 2. PHEGE-SIM 38
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(c) ALL
(d) LHS (e) RHS (f) ALL
Figure 2.10: phy.matrix for both left (a) and right (b) hand sides of the recom-
bination event. This results in the matrix phy.matrix.ARG (c) which covers the
full ARG. The recombination event in the region can be determined by the obser-
vation that there exists 4 haplotype congurations (AT, GT, GG, AG) between
the third snp of (a) and the third snp of (b). Figures (d) to (f) illustrate the `line
plots' corresponding to (a) to (c).
The simulator allows the possibility of either a nite or innite-sites model of
mutation to be implemented, since recurrent mutation may have a strong eect.
Figure 2.11(a) illustrates the model of innite sites whereby each mutation is
constrained to occur only once on the ARG. A nite-sites model corresponding
to the same number of mutations on the tree, but where site number 74 has
mutated in two positions is illustrated in gure 2.11(b). In this case the eect of
the mutation on branch 10 is reversed by the mutation on branch 3, but is still
observable on branch 4. The program allows for the possibility of a mutation
to be completely removed by reverse mutations, however, a site that is allocated
to cause a change in phenotype measurement in section 2.6 must occur in two
forms. Although unlikely, the program also guards against all the sites aected by
mutations existing in only one form by discarding simulations where this occurs.CHAPTER 2. PHEGE-SIM 39
(a) Innite Sites (b) Finite Sites
Figure 2.11: Illustration of innite and nite-sites models.
If the program consistently fails to complete due to the set of initial parameter
choices, the program will terminate and inform the user that a dierent set of
parameter values should be chosen.
It is ensured that there are only two bases present at each SNP, irrespective
of how many mutations at that position occur on the ARG, with the causative
form of the mutation always chosen to be the base that a mutation changes to
away from the ancestral base.
2.4.2 Gamma Model of Finite Sites
Additional Inputs:
Shape parameter of Gamma distribution -  
Scale parameter of Gamma distribution -  
Ancestral Recombination Graph - ARG.matrix
Recombination breakpoints - break.points
The rst stage of the nite sites model is to replicate the generation of muta-
tions according to the procedure of innite sites as previously described in section
2.4.1. For each SNP that is sampled, the number of times that it occurs on the
ARG is randomly chosen based on a Gamma distribution with shape parameter
  and scale parameter  . A Gamma distribution has been chosen as it is plau-
sible that there are a few sites that mutate many times, whereas at the majorityCHAPTER 2. PHEGE-SIM 40
(a) Gamma distributed rates, with
shape parameter of 1 and scale parame-
ter of 1
(b) Gamma distributed rates, with
shape parameter of 6 and scale parame-
ter of 0.5
Figure 2.12: An example from the discrete Gamma distribution for nite sites.
of locations there will only be a small number of mutations. To ensure that only
positive integers are selected, the sampled value from the Gamma distribution is
rounded up to the nearest integer value which results in discrete groups of the
sampled mutations, as illustrated in gure 2.12. Although the y axis scales are
dierent for both 2.12(a) and 2.12(b), it should be noted that in both cases the
total number of mutations involved is the same. It can also be the case that if
certain values of   and   are chosen, the data can begin to resemble the innite
sites model.
As this is a procedure involving random sampling it can, and indeed will, be
the case that the total number of mutations sampled to occur according to the
nite sites method exceeds the number of mutations that actually occur under
the innite sites model in section 2.4. In order to deal with this situation, various
corrections are applied to the sampling of the number of mutations, so that the
correct mutation rate is retained and in order to obtain as close to the desired
nite sites distribution as possible. The steps taken are shown in the ow chart in
supplementary section A.10. In practice in the majority of situations, the steps
taken have minimal impact on the specied nite sites distribution.
The sites involved of each chosen mutation are then randomly `thrown' ontoCHAPTER 2. PHEGE-SIM 41
the coalescent plot of the region involved, and subsequently the ARG, as shown
in gure 2.11(b).
Outputs of:
Ancestral Recombination graph with site positions - ARG.matrix
2.5 Collapsing the ARG
Inputs:
ARG branch lengths - branch.length.ARG
ARG node labels - ARG.matrix
The ARG, and therefore the matrix phy.matrix.ARG, that have been created
have to now be collapsed to a data structure containing only branches on which
mutations occur. The reasoning for this is that in an association study, using the
available data, an analyst would not be able to reconstruct ancestral events that
have no discernible eects on an individuals genotype. The only features that
would be observable are the unique haplotypes of a sample of individual's and
their corresponding phenotypes. It would therefore be inappropriate to retain any
information from the construction of the data other than the unique haplotypes
and phenotypes of a simulated population, before analysis using the methods
detailed in the following chapter.
There are four situations that can occur in determining whether a branch
should be collapsed, applied separately to each of the coalescent regions of the
ARG. Three are given in gure 2.13, where each plot represents a section of the
ARG with potential congurations of mutations. The fourth condition is that of
a branch where no mutations occur at all, and as such the entire section would
be removed until there occurred further back in the tree a mutation structure
similar to one of the other three congurations.
The removal of branches from gure 2.13 results in the sections of trees being
reduced to that shown in gure 2.14. This procedure is applied to all branches
involved in each non-recombining region and, with the example data set used
throughout this chapter, would result in trees relating haplotypes given in gureCHAPTER 2. PHEGE-SIM 42
(a) (b) (c)
Figure 2.13: Examples of the initial conguration of branches from the ARG
that can subsequently be collapsed due to some branches having no occurrences
of observable mutations, with the horizontal lines representing such mutations.
2.15.
The collapsed ARG is then used in order to generate the potential haplotypes
that can reasonably be sampled within the simulation, as any unobserved internal
nodes will be discounted. The information regarding the number of terminal
nodes on the un-collapsed tree carrying each of the collapsed trees nodes is also
used in determining the relative probabilities of selecting an individual haplotype
for the sample.
To create a sample `individual' from a population, two haplotypes are ran-
domly selected, based on the assumptions discussed in section 1.3. Information
regarding the sample from a population is retained in the matrix c.p.details, which
is subsequently used in assigning phenotype scores for each sampled individual.
(a) (b) (c)
Figure 2.14: Examples of the new structures that result after collapsing branches
of the forms in gure 2.13.CHAPTER 2. PHEGE-SIM 43
(a) Left of split collapsed (b) Right of split collapsed
Figure 2.15: Collapsed coalescent haplotype trees for the example data, for both
the left and right hand side of the recombination breakpoint.
Outputs:
Sampled individuals' haplotypes - c.p.details
Collapsed matrix of haplotypes - phy.matrix.ARG
2.6 Assigning phenotype scores
Inputs:
Collapsed matrix of haplotypes - phy.matrix.ARG
Number of causative mutations - defect.loci
Causative eect per mutation - mut.par.rsk
Standard deviation of phenotype scores - sids.par.rsk
Types of mutation(s) - mut.type
Interaction eects between mutations - interact.eect
In PheGe-Sim, phenotype scores are assigned to an individual based upon a
range of parameters. The rst of these is the choice of the number of causative
mutations (defect.loci) that will increase the mean phenotype of aected individ-
uals by eect sizes given by the parameter mut.par.rsk. If more than one mutation
is chosen as causative, there is the potential to specify that the mean eect size
of each mutation is dierent to obtain dierent patterns of phenotype measure-
ments. The phenotype of each sampled individual is chosen according to a normal
distribution, with the mean parameter xed according to the causative mutations
that are present in that individual, whether any interactions are present, and the
specied mutation types. The standard deviation parameter is chosen to be the
same value for each distribution, and is specied by the sids.par.rsk parameter.CHAPTER 2. PHEGE-SIM 44
(a) Recessive (b) Dominant
(c) Additive (d) Excess Additive
Figure 2.16: Models of phenotype measurements.
For each mutation that is chosen to be causative, the haplotypes that are
aected by the mutation are determined by following the structure of the coa-
lescent tree away from the root. If a model of nite sites is chosen, it may be
that a causative mutation is cancelled out in some of the haplotypes that would
otherwise have been aected. It is however ensured that at least one haplotype
will carry the causative form of the mutation. When using a nite-sites model
a choice can also be made with the All Causative parameter as to whether a
mutation is causative in all positions at which it occurs on a tree, or that it is
only causative on one specic branch of the ARG.
Another inuencing factor on the phenotype scores is the choice of whether
a mutation is to act in an additive, dominant or recessive manner. In the simu-
lations, a recessive model requires the causative mutation to be present in bothCHAPTER 2. PHEGE-SIM 45
Figure 2.17: Example of the possible groups resulting from two causative SNPs
and their interaction. The two copies present for each individual are shown, with
`1' being the causative form for both of the two SNPs.
haplotypes of an individual to cause an increase in phenotype, whereas a dom-
inant model requires at least one copy to cause the relevant increase in score.
These denitions are chosen as the simulations work on the arbitrary assumption
that mutations cause an increase in scores as opposed to a decrease in scores.
The program will however operate under either condition.
If only one causative SNP is selected the interaction eects option can be
used to specify a model of the mutant homozygous group, containing the causative
form of the mutation, having an extra eect compared to the heterozygous group-
ing. For recessive models this will have no relevance and will only act as an
addition of phenotype measurement to the already specied mutation eect size.
However, in the case of a specied additive mutation the interaction will allow
for specication of models with non-perfect additivity, the type of model being
dependent on whether the interaction has a positive or negative value. A positive
interaction eect can specify an `excess additive' model as shown in gure 2.16(d),
whereby the eect of having two copies of the causative mutation is stronger than
an additive presence of only one causative mutation (gure 2.16(c)). If on the
other hand the interaction is chosen to have a negative eect, the additive modelCHAPTER 2. PHEGE-SIM 46
will begin to resemble the phenotype pattern of the dominant model. If the in-
teraction is chosen to be larger than the original eect size, this can result in the
situation whereby the mean of the heterozygous grouping is higher than either
of the two homozygous groups.
If two or more mutations are chosen to be causative, then the program allows
for the eect of two-way interactions (i.e., epistasis) to exist if the causative forms
of both mutations are present. Interaction eects of up to the number of two-
way combinations involving the number of causative mutations can be specied,
with the allocation of eects to each being randomly chosen amongst the possible
combinations.
Outputs:
Sampled phenotypes for each individual - c.p.details
2.7 Output Files
PheGe-Sim creates various les and folders as determined by the choice of in-
put parameters, features previously described in section 2.1 and throughout this
chapter. In particular, for each of the association methods and tree construction
approaches, a folder will be created to contain the appropriate summary les of
that method.
In addition to the output les of the programs that are collected into relevant
folders, two output les are also created that collate together the details and
results of all the simulations. The sim results le summarizes information about
the eectiveness of each method that is being considered in terms of nding the
true causative mutations. An example of sim results is given in section A.4, where
it can be seen that for each simulation and method comparisons are made between
the true causative mutations and any mutations that have been `found' by the
method. The left hand side of table 2.4 illustrates the criteria used for assessing
the eectiveness of each method in nding causative SNPs for the simulations
when the true causative mutations are known.
In addition to assessing whether causative SNPs have been found correctly
using the Treescan method, it is also tested as to whether Treescan correctlyCHAPTER 2. PHEGE-SIM 47
Table 2.4: Determining the criteria of found SNPs or branches.
Criteria SNP Branch
Found
As determined by the Frequentist (gure 4.6) or Bayesian
(gure 4.7) approach that is taken
Correct Find
A SNP that has been found
corresponds to the true
causative SNP.
A found haplotype/branch
contains the causative form of
a true causative SNP.
False +
(Type I error)
A found SNP is not any of the
true causative SNPs.
A found haplotype contains
no SNPs in their causative
form.
False  
(Type II error)
A true causative SNP has not
been found.
NA
Linked +
A SNP has been found that is
in perfect linkage with a true
causative SNP.
NA
nds branches containing the true causative SNP(s). The rationale for this is
that the tree construction method can suggest multiple site changes on the same
branch, and will therefore have to declare all of these SNPs as being `found' if
that branch is signicantly associated with the phenotype. This can result in a
high False Discovery Rate that is largely due to errors in the tree construction
method, and not necessarily errors in the Treescan method itself. The `branch'
correction method can therefore be used as a potentially fairer comparison in
terms of the False Discovery Rates. However, the downside of this approach is
that there is insucient knowledge to ascertain specically which of the SNPs
upon a haplotype are indeed causative. This approach is similar to the methods
employed when using the simple haplotype methods of association.
At the end of the sim results le, a summary of the performance of each
association method in nding true causative mutations over all the simulations is
also displayed. The False Discovery Rate (FDR), that can be used as an indicator
of what proportion of the mutations that are declared as signicantly associatedCHAPTER 2. PHEGE-SIM 48
Table 2.5: Summary of output les and folders of PheGe-Sim. Items preceded
with y are common to PheGe-Sim and PheGe-Find, and are described in Chapter
4.
Location Description
Sim Out Directory containing output folders
Folders
PHYLIP PHYLIP format les of the unique genotypes
FASTA FASTA format les of the unique genotypes
yBayes Factor TSC Treescan version of Bayes factors
yBayes Factor SNP Single SNP (and haplotype) Bayes factor les
yFitch Files Files involved in the Fitch tree construction from
PHYLIP
yMax L Files Files involved in the Maximum Likelihood construction
from PHYLIP
yPars Files Files involved in the Maximum Parsimony Tree con-
struction from PHYLIP
Treeplot Files Plots of the ARG, coalescent and line plots.
yTreescan Input Files Input Treescan les for all the tree construction ap-
proaches
yTreescan Out Files Treescan Output les for all the tree construction ap-
proaches
StdNewick Out Files Newick output les for the true coalescent regions
Int.Newick Files Newick output les, with labeled internal nodes, for the
true coalescent regions
Observable Trees Collapsed haplotype trees of each coalescent region
ySingSNP Out Files Results les of the Single SNP (and haplotype) analysis
based on Treescan
yPED Files PED les and Haploview Linkage plots
Wkspc Folder R workspace of the key variables that have been saved
in the simulation
yBonf Files Results les of the Bonferroni SNP (and haplotype)
analysis
yBIMBAM Output Files from BimBam relating to single SNP anal-
ysis
yBIMBAM.TSC Output Files from BimBam relating to Treescan based
analysis
Files
Sim Results.txt Text le summarizing results of the association ap-
proaches
details.txt Text le summarizing various features of the parameters
involved in the simulationsCHAPTER 2. PHEGE-SIM 49
are indeed truly associated with the phenotype, is also displayed in the sim results
le. The denition of the false discovery rate is:
FDR =
Sum of False Positives
Sum of False Positives + Sum of correctly found SNPs
: (2.3)
The second le specic to PheGe-Sim is the details le, an example of which
is given in section A.5. This le contains information about the causative sites
for each simulation, and the haplotypes that are aected as a result of carrying
the causative form of the mutation. A brief summary of the input parameters
that have been chosen for that simulation is also given at the end of the details
le. A brief summary of all the output les from the PheGe-Sim application is
given in table 2.5.Chapter 3
Association Methods
The exactly computed Bayes factors that are used in the PheGe-Sim application
are discussed in the following sections, for the dierent models of mutation eects:
Additive, Dominance, Recessive and a General model. Section 3.1 introduces
the use of the exactly computed analytic Bayes factors in a similar manner to
that suggested by Balding (2006), for use in case-control studies. Sections 3.2
- 3.5 subsequently introduce the Bayes factors that have been developed and
implemented here for use with continuous phenotype measurements, in the case
of assessing only one SNP (or branch) with the outcome. The concepts that have
been applied for the single SNP/branch tests are then extended in sections 3.6
to 3.8, in order to accommodate the testing of multiple SNPs in combination.
3.1 Binary Data
In the supplementary information of `Bayesian approaches to single-SNP asso-
ciation' (Balding, 2006), a Bayes factor approach was used as a method to nd
causative SNPs in a case-control setting. The Bayes factors are used to test
for evidence of an association comparing the null model of no association (M0),
against the alternative (M1) that there are dierences in the proportions of cases
and controls across the heterozygote and the two homozygote genotype classes.
The likelihood for the data (D) is specied in terms of the probability, , of an
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individual involved in the study being a case, in a binomial form:
P(Dj) =

nA + nU
nA


nA(1   )
nU; (3.1)
where nA is the number of cases and nU is the number of controls. This applies
independently in the three genotypes, with a common  under M0, and three
dierent s under M1.
The approach taken by Balding is to use a Uniform prior for  in (0,1), for
illustrative purposes and to ensure a proper posterior distribution. Alternatively
a Beta prior distribution can be used and, as it is conjugate to the likelihood, this
will also ensure that a proper Beta posterior distribution is obtained. One reason
for using the Beta in favour of the Uniform prior is that the resultant Bayes factor
may be less sensitive to small sample sizes of cases or controls at any one SNP,
depending on the choice of hyperparameters. Thus the prior is taken as:
p() =
 ( + )
 () ()

 1(1   )
 1; (3.2)
for the single  in M0, and as a product of three such terms under M1.
The Beta prior of equation 3.2 is a generalization of the Uniform prior, which
can be obtained by setting both  and  equal to one. Initial impressions using
the data in Chapter 6 suggest that setting  and  to approximately ve will
be eective in dampening down the stochastic eects when there is only a small
sample size available for the test under consideration. However, this can be quite
an informative prior for a low sample size and tests with lower values of  and 
may also be appropriate depending on the specic context of the outcome being
considered.
The posterior distribution using the Beta prior can be calculated analytically,
as follows:
p(jD) / 
nA(1   )
nU
 1(1   )
 1
= 
nA+ 1(1   )
nU+ 1
i.e. jD  Be( + nA;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which applies to the global  of M0. Integrating out the parameter  to obtain
the marginal likelihood for the null model, M0, will result in:
P(DjM0) =
Z 1
0
p(Dj)p()d = cB( + nA; + nU); (3.4)
where c is a constant. In a similar manner, assuming the groups are indepen-
dent, the marginal likelihood for an alternative model, M1, allowing for dierent
probabilities of being aected within each genotype class is:
P(DjM1) = cB(nA0 + ;nU0 + )
 B(nA1 + ;nU1 + )
 B(nA2 + ;nU2 + ); (3.5)
where the subscripts 0, 1 and 2 refer to the three genotype groups, and c is the
same constant as in (3.4). Therefore, the Bayes factor for the alternative model
compared to the null model in the case of binary data reduces to (3.5) divided
by (3.4). The posterior odds of the alternative model can then be obtained by
multiplying the Bayes factor by a suitable choice of prior odds.
3.2 Null Model
This section describes a null model for the case of continuous phenotype data,
where the null model involves a single parameter for describing the means of each
of the three genotype classes in the rst round of tests. Subjects are assumed to
be independent, and the null model assumes a normal likelihood for the data, for
the phenotype of the ith subject:
yi  N
 
; 
2
: (3.6)
Conjugate priors for the mean  and the within group variance 2 are assumed:
j
2  N

0 ;
2
0

; (3.7)CHAPTER 3. ASSOCIATION METHODS 53

2  Inv-
2  
0 ; 
2
0

; (3.8)
where 0, 0, 0 and 2
0 are hyperparameters.
The full joint distribution is obtained by multiplying the likelihood for the n
data points (the total number of subjects in all 3 genotype groups), by the prior
densities for  and :
p(y ; ; 
2) = c(
2)
  n
2exp

 
(n   1)s2 + n(    y)2
22

 (
2)
 (
0
2 +1)exp

 
02
0
22

 
 1exp

 
0(   0)2
22

; (3.9)
where c is a constant that does not involve  and , and takes the form:
c =
p
0 p
2
(
0
2 )
0
2
 (
0
2 )
(
2
0)
0
2 (2)
  n
2: (3.10)
The resulting posterior distribution for  and 2 is a N-Inv2(n;
2
n
n;n;2
n) dis-
tribution (Gelman et al., 2004), due to the priors being conjugate, the form of
which is:
p(;
2jy) / 
 1(
2)
 (
n
2 +1)exp

 
1
22[n
2
n + n(n   )
2]

; (3.11)
where
n =
00 + n y
0 + n
;
n = 0 + n;
n = 0 + n;

2
n =
02
0 +
Pn
i=1(yi    y)2 +
0n
0+n( y   0)2
n
: (3.12)
To obtain the marginal likelihood for the null model, the unknown parametersCHAPTER 3. ASSOCIATION METHODS 54
 and 2 can be integrated out of the full density (3.9). This yields:
p(y) =
Z 1
0
Z 1
 1
p(y j; 
2)p(;
2)dd
2
= c
Z Z

 1(
2)
 (
n
2 +1) exp

 
1
22 [n
2
n + n(   n)
2]

dd
2
= c
Z

 1(
2)
 (
n
2 +1) exp

 
1
22 [n
2
n]


Z
exp

 
1
22 [n(   n)
2]

d

d
2
= c
Z
(
2)
 (
n
2 +1) exp

 
1
22 [n
2
n]
 p
2
p
n
d
2: (3.13)
The resulting marginal likelihood for the data under the null model is therefore:
p(yjH0) =
p
0 p
n
(
0
2 )
0
2
 (
0
2 )
(
2
0)
0
2 (2)
  n
2  (n
2 )
(n
2 )
n
2 (2
n)
n
2
: (3.14)
3.3 Alternative Model
The alternative model allows for each of the three groups to have separate means,
but a common variance for each group is assumed. Similar to the null model
scenario, the mean of each group is chosen to be normally distributed a priori,with
the within-group variance distributed according to an Inv-2 distribution. The
likelihoods are again taken to be normal. That is,
A j
2  N

1;
2
0

; yAi  N(A;
2);
B j
2  N

2;
2
0

; yBi  N(B;
2);
C j
2  N

3;
2
0

; yCi  N(C;
2);

2  Inv-
2  
0 ; 
2
0

; (3.15)
with all y's independent (conditional on their group membership), and 1, 2,
3, 0, 0 and 2
0 are hyperparameters.CHAPTER 3. ASSOCIATION METHODS 55
The full joint distribution p(A ;B ;C ;2 ;y) can be found by multiplying
the priors for the means and variance, by the likelihood of the data:
p(A ;B ;C ;
2 ;y) = p(A j
2)p(y jA ; 
2)p(B j
2)p(y jB ; 
2)
 p(C j
2)p(y jC ; 
2)p(
2): (3.16)
Hence the full distribution is:
p(A; B; C; 
2; y) = c2 exp

 
1
22 [0
2
0]

 exp

 
1
22
h
0(A   1)
2 + 0(B   2)
2 + 0(C   3)
2
i
 exp

 
1
22
h nA X
i=1
(yi    yA)
2 + nA( yA   A)
2
+
nB X
i=1
(yi    yB)
2 + nB( yB   B)
2
+
nC X
i=1
(yi    yC)
2 + nC( yC   C)
2
i

 1
 1
 1(
2)
 
nA
2 (
2)
 
nB
2 (
2)
 
nC
2 (
2)
 (
0
2 +1); (3.17)
where c2 is a constant that does not depend on A, B, C or 2 and takes the
form:
c2 =
p
0 p
2
p
0 p
2
p
0 p
2
(
0
2 )
0
2
 
 
0
2
 (
2
0)
0
2 (2)
 
nA
2 (2)
 
nB
2 (2)
 
nC
2 : (3.18)
However, since nA + nB + nC = n, equation 3.18 can be simplied as:
c2 =
p
0 p
2
3 (
0
2 )
0
2
 
 
0
2
 (
2
0)
0
2 (2)
  n
2: (3.19)
Bringing together the arguments of the exponentials in 3.17, and multiplying out
the squares, results in:
 
1
22
h
0
2
0 + (nA   1)s
2
1 + 0
2
A   20A1 + 0
2
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+ nA y
2
A   2nA yAA + nA
2
A
+ (nB   1)s
2
2 + 0
2
B   20B2 + 0
2
2
+ nB y
2
B   2nB yBB + nB
2
B
+ (nC   1)s
2
3 + 0
2
C   20C3 + 0
2
3
+ nC y
2
C   2nC yCC + nC
2
C
i
: (3.20)
Collecting together the terms in A and completing the square yields:
 
1
22
"
(0 + nA)

A  
10 + nA yA
0 + nA
2
 
(10 + nA yA)2
0 + nA
#
: (3.21)
Similar terms for B and C can be obtained. In a similar manner, the terms
that involve the prior means 1, 2 and 3 can be treated separately from each
other. For example, the terms involving 1 can be collected together with the
term nA y2
A and a square completed, to yield:
1
22
"
(10 + nA yA)
2
0 + nA
  0
2
0   nA y
2
A
#
=  
1
22
nA0( yA   1)2
0 + nA
: (3.22)
Bringing all this together results in:
p(A;B;C;
2;y) = c2 
( 5 nA nB nC 0)
 exp
 
 
1
22
"
0
2
0 + (nA   1)s
2
1 + (nB   1)s
2
2 + (nC   1)s
2
3
+
nA0( yA   1)2
0 + nA
+
nB0( yB   2)2
0 + nB
+
nC0( yC   3)2
0 + nC
+ (0 + nA)

A  
10 + nA yA
0 + nA
2
+ (0 + nB)

B  
20 + nB yB
0 + nB
2
+ (0 + nC)

C  
30 + nC yC
0 + nC
2 #!
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If we dene:
NA =
10 + nA yA
nA + 0
; NA = 0 + nA;
NB =
20 + nB yB
nB + 0
; NB = 0 + nB;
NC =
30 + nC yC
nC + 0
; NC = 0 + nC;
n
2
n = 0
2
0 + (nA   1)s
2
1 + (nB   1)s
2
2 + (nC   1)s
2
3
+
nA0( yA   1)2
0 + nA
+
nB0( yB   2)2
0 + nB
+
nC0( yC   3)2
0 + nC
;
then the full joint distribution can be written as:
p(A;B;C;
2;y) =c2 
( 5 nA nB nC 0)
 exp

 
1
22
h
n
2
n + NA(A   NA)
2 + NB(B   NB)
2
+ NC(C   NC)
2
i
: (3.24)
Exploiting the normality of this expression in A, B and C, and the inverse
chi-squared form in 2, integration of (3.24) with respect to A, B, C and 2
gives the following marginal likelihood:
p(yjHalt) =
p
0 p
2
3 (
0
2 )
0
2
 (
0
2 )
(
2
0)
0
2 (2)
  n
2

p
2
p
NA
p
2
p
NB
p
2
p
NC
 (n
2 )
(n
2 )
n
2 (2
n)
n
2
: (3.25)
Therefore the Bayes factor representing the evidence in favour of the alternative
model (3.25) compared to the null model (3.14) is:
p
0 p
2
3 (
0
2 )
0
2
 (
0
2 ) (2
0)
0
2 (2)  n
2
p
2 p
NA
p
2 p
NB
p
2 p
NC
 ( n
2 )
( n
2 )
n
2 
n
alt
p
0 p
2
(
0
2 )
0
2
 (
0
2 ) (2
0)
0
2 (2)  n
2
p
2 p
N
 ( n
2 )
( n
2 )
n
2 
n
null
; (3.26)
where alt and null are the n for the alternative and null models respectively.CHAPTER 3. ASSOCIATION METHODS 58
Hence,
p(yjHalt)
p(yjHnull)
=

0 p
NA
p
NB
p
NC
1

n
alt
,
1
p
N
1

n
null

: (3.27)
3.4 Simple Additive Model
An additive model, for the one split or SNP being considered, can be considered
in addition to the general model that allows exibility in having separate means
for each group. The following priors are assigned for the unknown means of the
homozygous genotype classes:
A j
2 N

1;
2
0

;
B j
2 N

2;
2
0

; (3.28)
and the corresponding likelihoods for an individual from the three possible groups
are:
yA N
 
A;
2
;
yAB N
 
1
2(A + B);
2
;
yB N
 
B;
2
; (3.29)
where the heterozygote mean is half-way between the homozygote means. Thus
the full joint distribution is:
p(y; A; B; 
2) = c3 exp

 
1
22 [0
2
0]

 exp

 
1
22

0(A   1)
2 + 0(B   2)
2
 exp
 
 
1
22
 nA X
i=1
(yi    yA)
2 + nA( yA   A)
2
+
nAB X
i=1
(yi    yAB)
2 + nAB
 
 yAB   1
2(A + B)
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+
nB X
i=1
(yi    yB)
2 + nB( yB   B)
2
!
 
 1
 1(
2)
  n
2(
2)
 (
0
2 +1); (3.30)
where n represents the total sample size and c3 is a constant that does not depend
on A, B, C or 2, taking the form:
c3 =
p
0 p
2
2 (
0
2 )
0
2
 
 
0
2
 (
2
0)
0
2 (2)
  n
2: (3.31)
Multiplying out the arguments to the exponentials leads to:
l   2
2lnp =  2
2lnc3   2
2ln
 

 n 0 4
+ 0
2
0
+
 
0 + nA + 1
4nAB


2
A + 2
 
1
4nAB

AB +
 
0 + nB + 1
4nAB


2
B
  2
 
01 + nA yA + 1
2nAB yAB

A   2
 
02 + nB yB + 1
2nAB yAB

B
+
nA X
i=1
(yi    yA)
2 + 0
2
1 + nA y
2
A +
nAB X
i=1
(yi    yAB)
2 + nAB y
2
AB
+
nB X
i=1
(yi    yB)
2 + 0
2
2 + nB y
2
B: (3.32)
This is a quadratic form in A and B, which implies that the density is
bivariate normal in these parameters, the mean of which is identical to the mode.
The mean can therefore be found by identifying the minimum of  22lnp. First
the partial derivative, @l
@A, is obtained:
@l
@A
= 2A
 
0 + nA + 1
4nAB

+2B
 
1
4nAB

 201 2nA yA nAB yAB: (3.33)
Equating this to zero at (^ A; ^ B) gives :
2^ A
 
0 + nA + 1
4nAB

= 201 + 2nA yA + nAB yAB   2^ B
 
1
4nAB

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Solving for ^ A:
^ A =
01 + nA yA + 1
2nAB yAB   1
4^ BnAB
0 + nA + 1
4nAB
: (3.35)
Similarly, the partial derivative , @l
@B, set to zero results in the following estimate
for B:
^ B =
02 + nB yB + 1
2nAB yAB   1
4^ AnAB
0 + nB + 1
4nAB
: (3.36)
Solving these two simultaneous equations for ^ A and ^ B gives the estimator ^ A
of A:
^ A =
(0 + nB + 1
4nAB)(01 + nA yA + 1
2nAB yAB)   1
4nAB(02 + nB yB + 1
2nAB yAB)
(0 + nA + 1
4nAB)(0 + nB + 1
4nAB)   1
16n2
AB
:
(3.37)
Similarly the estimator ^ B of B is:
^ B =
(0 + nA + 1
4nAB)(02 + nB yB + 1
2nAB yAB)   1
4nAB(01 + nA yA + 1
2nAB yAB)
(0 + nA + 1
4nAB)(0 + nB + 1
4nAB)   1
16n2
AB
:
(3.38)
The standard form of a bivariate normal distribution is:
f(A;B) =
1
2
p
det(Q)
exp

 
1
2
(A   ^ A;B   ^ B)Q
 1(A   ^ A;B   ^ B)
T

;
(3.39)
where Q is the positive semi-denite and symmetric covariance matrix . There-
fore, comparing (3.32) to (3.39), the elements of Q
 1 can be identied:
Q
 1 =
1
2
 
0 + nA + 1
4nAB
1
4nAB
1
4nAB 0 + nB + 1
4nAB
!
: (3.40)
The remaining terms in (3.32) are  22lnc3,  22ln( n 0 4) and:
n
2
n  0
2
0 +
nA X
i=1
(yi    yA)
2 +
nAB X
i=1
(yi    yAB)
2 +
nB X
i=1
(yi    yB)
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+ k0
2
1 + nA y
2
A + k0
2
2 + nB y
2
B + nAB y
2
AB
  (0 + nA + 1
4nAB)^ 
2
A   (0 + nB + 1
4nAB)^ 
2
B
  1
2nAB^ A^ B; (3.41)
where n is given by
n = 0 + nA + nAB + nB
= 0 + n: (3.42)
Integration of (3.32) with respect to A, B and 2, exploiting the bivariate
normal form in A and B, yields:
p(y jHadd) =
0
2
 
0
2
 0
2
 
 
0
2

 

2
0
 0
2 (2)
  n
2

2
q 
0 + nA + 1
4nAB
 
0 + nB + 1
4nAB

  1
16n2
AB

 
 
n
2

 
n
2
 n
2 
n
add
: (3.43)
Therefore the Bayes factor for comparing the additive model to the null model
is:
p(yjHadd)
p(yjHnull)
=
0
@
p
0 q 
0 + nA + 1
4nAB
 
0 + nB + 1
4nAB

  1
16n2
AB
1
(add)n
1
A


1
p
n
1
(null)n

: (3.44)
3.5 Dominant and Recessive Models
In the rst round of association testing, dominant and recessive models can be
tested using the Bayes factors. The specication of both forms of models is es-
sentially the same as that for a general model, but where the phenotypes of the
heterozygote grouping (AB) are allocated to either of the homozygote groupingsCHAPTER 3. ASSOCIATION METHODS 62
(AA or BB). Table 3.1 illustrates the denitions of dominant and recessive muta-
tions that are used, where AA.AB represents the combined phenotypes of groups
AA and AB, and similarly BB.AB represents the combined phenotypes of groups
BB and AB. As a dominant model for one allele is the same as a recessive model
for the other allele, it has been chosen to refer to a model as dominant or recessive
according to the group containing a higher phenotype mean.
Table 3.1: Dominant and recessive allocation.
Criterion 1 Criterion 2 Conclusion
BF(AA.AB) > BF(BB.AB) BB:AB > AA:AB Recessive in B
BF(AA.AB)  BF(BB.AB) BB:AB > AA:AB Dominant in B
BF(AA.AB) > BF(BB.AB) BB:AB  AA:AB Dominant in A
BF(AA.AB)  BF(BB.AB) BB:AB  AA:AB Recessive in A
If group A is being considered, the marginal likelihood resulting from the re-
cessive model is simply as in equation 3.45. This marginal likelihood is equivalent
to that for the dominant model of group B. That is,
p(y jHrecA) =
p
0 p
2
2 (
0
2 )
0
2
 (
0
2 )
(
2
0)
0
2 (2)
  n
2
p
2
p
NAA
p
2
p
NAB:BB
 (n
2 )
(n
2 )
n
2 n
recA
:
(3.45)
This is derived by a very similar argument to that which led to expression (3.25),
with the dierence being that two of the genotypes can be grouped together as
they are phenotypically indistinguishable in a dominant or a recessive model. In
an analogous manner, the marginal likelihood resulting for the dominant model
in A (or the recessive model for group B), can be found:
p(y jHdomA) =
p
0 p
2
2 (
0
2 )
0
2
 (
0
2 )
(
2
0)
0
2 (2)
  n
2
p
2
p
NAA:AB
p
2
p
NBB
 (n
2 )
(n
2 )
n
2 
n
domA
:
(3.46)
Information regarding the dominant or additive nature of the 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stored, and used if required in the more complex second-round splits of section
3.8.
3.6 Alternative Model II
As the Bayes factors for dierent branches are correlated, some branches will
be declared as signicant as a result of being close to a branch that carries a
true causative mutation. The same is also true if the SNPs are to be assessed
individually, ignoring the tree structure in the analysis. In order to compensate
for this, a further model can be proposed that can assess whether a branch is
declared signicant, conditional on the split in data determined from another
branch.
The most basic model that could represent this conditional stage would be to
have a model with six groups representing the six combinations that could arise.
A Bayes factor can then be determined to assess the evidence in favour of the
six-group model, compared to that of the previous alternative of three groups.
The marginal likelihood of this model can be calculated in an analogous way to
that of the three group model, and this is implemented for all non-empty groups
that are present at a stage of splitting:
p(y jHAB1B2) =
p
0 p
2
6 (
0
2 )
0
2
 (
0
2 )
(
2
0)
0
2 (2)
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2

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p
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p
2
p
NAB1
p
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p
NAB2
p
2
p
NB1B1
p
2
p
NB2B2
p
2
p
NB1B2

 (n
2 )
(n
2 )
n
2 
n
AB1B2
; (3.47)
where class B has been split into B1 and B2 at the second round (see gure 1.3).
This will result in a Bayes factor comparing the six-group model to that of theCHAPTER 3. ASSOCIATION METHODS 64
three-group model, which simplies down to:
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In a similar manner, the comparison can be made between the additive or the
dominant/recessive model, according to which model performed best in the rst
round of tests.
3.7 Complex Additive Model
A model for second or further stage splits can be calculated, if all the splits in-
volved are determined from the rst round as having acted in an additive manner.
There is an option of either introducing a new mean for the cross-term at the
second-stage split, or assuming that the eect of the cross-term is an additive
eect of both groups. The second interpretation will be discussed here, as the
approach of adding a new mean for the cross-term will be dealt with in section 3.8.
In a similar approach to that used for the simple additive model of section 3.4,
each homozygous grouping can be given a Normal prior for the unknown mean.
The likelihood for the heterozygous groupings consisting of the cross terms of
those groups involved. Solving the system of equations for a second-stage split
will result in the following estimators of the means for the three possible groupings
involved.
^ A =
01 + nA yA + 1
2nAB yAB + 1
2nAC yAC   1
4nAB^ B   1
4nAC^ C
0 + nA + 1
4nAB + 1
4nAC
;
^ B =
01 + nB yB + 1
2nAB yAB + 1
2nBC yBC   1
4nAB^ A   1
4nBC^ C
0 + nB + 1
4nAB + 1
4nBC
;
^ C =
01 + nC yC + 1
2nAC yAC + 1
2nBC yBC   1
4nAC^ B   1
4nBC^ A
0 + nC + 1
4nAC + 1
4nBC
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An example of a second round of testing has been given , however but the
pattern can be easily extended for further levels of splits as required. These
simultaneous equations can be solved for ^ A, ^ B and ^ C using matrix algebra,
by nding the solution for X of the equation AX = b, where X = (^ A; ^ B; ^ C)T.
This can be done through the use of the solve function in R, where the relevant
matrices required for a two-split model are of the form:
b =
0
B B
B B B B B
@
01+nA yA+ 1
2nAB yAB+ 1
2nAC yAC
0+nA+ 1
4nAB+ 1
4nAC
02+nB yB+ 1
2nAB yAB+ 1
2nBC yBC
0+nB+ 1
4nAB+ 1
4nBC
03+nC yC+ 1
2nAC yAC+ 1
2nBC yBC
0+nC+ 1
4nAC+ 1
4nBC
1
C C
C C C C C
A
(3.50)
and
A =
0
B B B B
B B
@
0  
nAB
0+nA+ 1
4nAB+ 1
4nAC  
nAC
0+nA+ 1
4nAB+ 1
4nAC
 
nAB
0+nB+ 1
4nAB+ 1
4nBC 0  
nBC
0+nB+ 1
4nAB+ 1
4nBC
 
nAC
0+nC+ 1
4nAC+ 1
4nBC  
nBC
0+nC+ 1
4nAC+ 1
4nBC 0
1
C C C C
C C
A
: (3.51)
To obtain a Bayes factor for the complex additive model, the marginal likeli-
hood can be obtained by integrating out the parameters in an analogous way to
the simple additive model, and compared to the highest marginal likelihood of
the models involved in the previous round of comparisons.
3.8 Complex Mixture Model
This section details how at second or higher-order splits, an alternative likelihood
is calculated for groupings that have been found to be mixtures of additive, dom-
inant, and recessive in the rst round of tests. This ensures that fair comparisons
are made between each level of splits, by taking into account all the information
present in the data.
In order to retain information about the mutation mechanisms involved fromCHAPTER 3. ASSOCIATION METHODS 66
(a) First round split(1) (b) First round split (2) (c) Second round split
(d) Dominant splits (e) A additive with C; B dominant over C
Figure 3.1: Signicant splits (red) that have been found in the rst round of the
procedure (a,b) and the resultant `strong' (red) and `weak' (blue) groupings to
be dened in the second round of tests (c). Figures (d) and (e) represent the
second-stage groupings of phenotypes, according to two possible combinations of
rst round mutation models.
the rst round of splits, a method has been developed that relies upon a concept
of `strong' and `weak' groupings of SNPs or haplotypes. In order for a grouping
to be considered `strong', there must be a signicant eect for that group with
regards to an increase in a phenotype measurement, as determined by a p-value
of less than 0.05 or a Bayes Factor of greater than 150. Equivalently, a grouping
is considered `weak' if it is a group that contains the lowest phenotype mean from
the initial split considered.
Figure 3.1(c) illustrates the rst possible combination of strong and weak
splits, as determined from a rst round of tests (gures 3.1(a) and 3.1(b)). In
this instance, both the split at branches 1-6 and 2-6 have been determined to
be associated with the phenotype, with the `strong' eect being apparent in both
the A and B groups of haplotypes. This situation could arise if there is a baseline
(wild-type) group where there is no apparent dierence in phenotype scores, but
on two separate branches a mutation occurs that results in an increased pheno-
type measurement. The illustrations in 3.1(d) and 3.1(e) shows the groupings of
haplotypes that would be obtained for two possible combinations of additive andCHAPTER 3. ASSOCIATION METHODS 67
(a) First round split (1) (b) First round split (2) (c) Second round split
(d) Dominant splits (e) C additive with A; B dominant over A
Figure 3.2: Signicant splits (red) that have been found in the rst round of the
procedure (a,b) and the resultant `strong' (red) and `weak' (blue) groupings to
be dened in the second round of tests (c). Figures (d) and (e) represent the
second-stage groupings of phenotypes, according to two possible combinations of
rst round mutation models.
dominant mutations.
A further combination of strong and weak groupings is given in gure 3.2.
This scenario could arise due to two causative mutations occurring on the same
lineage, having been derived from a wild-type group. The concept of weak and
strong groupings can once again be used to determine the clustering of groups.
However, in this case the sub-tree involving nodes f3,4,5,6,7,8g has been declared
as strong in one scenario, and weak in the other. The groupings that result from
such conditions are given for two scenarios of additive and dominant mutations
in gures 3.2(d) and 3.2(e).
The nal combination of strong and weak classes can be shown in gure 3.3.
This situation is the reverse of the rst scenario, in that here both haplotypes
1 and 2 are declared as strong in one of the rst round splits, but weak in the
other. This situation would be likely to appear if mutations result in a decrease, as
opposed to an increase, of some phenotypic score. As with the previous examples,
the groupings that could result for selected scenarios can be illustrated for second-
round mutations following the pattern of 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(a) First round split (1) (b) First round split (2) (c) Second round split
(d) Dominant splits (e) C additive with A; C dominant over B
Figure 3.3: Signicant splits (red) that have been found in the rst round of the
procedure (a,b) and the resultant `strong' (red) and `weak' (blue) groupings to
be dened in the second round of tests (c). Figures (d) and (e) represent the
second-stage groupings of phenotypes, according to two possible combinations of
rst round mutation models.
Figure 3.4: Second stage SNP groups, with homoplasy being present.
For single SNP methods, the number of groupings can be dierent in compar-
ison to the Treescan approach at the second stage of splitting due to the presence
of homoplasy. For example, if there were the choice of bases fA,Tg at the rst
SNP, and at the second site there existed the sites fC,Gg, then the nine possible
combinations of SNPs are as given in gure 3.4. It should be noted that the
method assumes that there are only two possible bases at each site, as is the
case for all the simulated and real data available. The approach could however
be extended to accommodate sites with three or four observable bases, although
this situation is less likely to occur in real data sets.CHAPTER 3. ASSOCIATION METHODS 69
However, if for the same two SNPs homoplasy was not present, then a situ-
ation analogous to that of the tree-based methods can be implemented whereby
only six possible combinations of bases could occur, as shown in table 3.5.
Figure 3.5: Second stage SNP groups, with homoplasy not being present.
3.9 Covariates
Although not included in the PheGe-Find application, covariates can also be
straightforwardly added to the Bayes factor methods. This could then be useful
for including non-genetic components into the Bayes factors, so that the genetic
and environmental eects can be assessed together. The simplest case of adding
one covariate to a single genetic group is briey introduced.
The mean phenotype value is written as A +Ax, where A is the intercept,
x is the covariate and A is the slope parameter. Both A and A are assigned
independent normal priors:
A j
2 N

1;
2
0

;
A j
2 N

1;
2
0

: (3.52)
In this situation a common variance has been chosen for simplicity, with the
prior again being chosen as an inverse-chi-squared distribution. However, models
for unequal variances can also be introduced if required. It is also natural to set
1 as zero in this context, as this would correspond to the prior belief that there
is no covariate eect. The likelihood for a single observation is given by:
yA N
 
A + (Ax);
2
: (3.53)CHAPTER 3. ASSOCIATION METHODS 70
Assuming independence of the observations, the full joint distribution can
be obtained in a similar manner as to the previous models that have been dis-
cussed. The marginal likelihood of the covariate model can be obtained, and a
Bayes factor calculated for comparing this to an appropriate model not involv-
ing the covariate. Further details of the `Bayesian regression' approach, and the
accompanying issues of model selection, can be found in Gelman et al. (2004).Chapter 4
PheGe-Find
PheGe-Find is a program that has been written in R version 2.4.1 with the aim
being to implement various methods that can be applied for ne-scale association
studies. As with PheGe-Sim the program is contained within the Rpanel (Bow-
man et al., 2007) environment to allow for easy specication of the various input
options. Figure 4.1 illustrates a screen shot of the application with the various
input options that are possible.
PheGe-Find allows for the input of les containing the genotypes and phe-
notypes required for the association testing. These will be checked against each
other to ensure that they match, and the program will subsequently run using
only individuals with both genotype and phenotype measurements.
The methods of association implemented in PheGe-Find are the same as those
used upon simulated data in the PheGe-Sim application of Chapter 2. This is as
a result of the requirement that the detection of causative SNPs must be treated
independently from the simulation. As such none of the information relating
to the simulations can be used, aside from the genotypes and corresponding
phenotypes in the sample. The following section details the input options that
are specic to the use of real data in PheGe-Find. The input options for the
methods of association having previously been discussed in section 2.1.
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Figure 4.1: PheGe-Find screen shot.
4.1 Input Options
 fastphase: (String)) = The location of the output le from fastPHASE
(Scheet and Stephens, 2006) with the phased haplotypes of the genotype
data. PED, or BIMBAM format, les can also be used.
 Output dir : (String) = Location of the directory where output les
and plots are to be produced.
 Input dir : (String) = The location of the folder containing the external
applications that are required, namely Treescan, PHYLIP, BimBam andCHAPTER 4. PHEGE-FIND 73
Haploview.
 Phenotype : (String) = Location of the le with Phenotype scores
(section A.8).
 Site Positions : (String) = (Optional) Location of the le with SNP
locations (section A.9).
 mu 0: ( 1;1), [D] = 0 hyperparameter for the Bayes factor approach
(chapter 3).
 kappa 0 : (0;1) = 0 hyperparameter for the Bayes factor approach
(chapter 3).
 nu 0 : (4;1) = 0 hyperparameter for the Bayes factor approach (chapter
3).
 sigma2 0 : (0;1), [D] = 2
0 hyperparameter for the Bayes factor ap-
proach (chapter 3).
 Range options : (0;1) = The range of values of the hyperparameters
to be assessed in the sensitivity analysis plots (section 7.2.5).
4.2 Reconstruction of a Tree Based upon the
Sequences
Inputs:
Sequences of SNPs in Phylip format
Although the methods involved in reconstructing phylogenetic trees are not of
primary importance in this thesis as the trees are primarily considered nuisance
parameters for the use of Treescan, the results of the Treescan-based methods
could potentially be dependent on the method of tree construction used. There
are numerous phylogenetic programs, applying a variety of methods, that could
be used for reconstruction of a phylogeny: such as PAUP* (Swoord, 2003), TCSCHAPTER 4. PHEGE-FIND 74
(Clement et al., 2000) and PHYLIP (Felsenstein, 2005). The original Treescan
paper (Templeton et al., 2005) advocates the use of TCS, however this program
does not lend itself to the simulations since the output is a graphic, and is also
restricted in that only the Parsimony method of tree construction is possible.
In order to assess multiple methods of tree construction, and to be suitable for
automating in simulations, it was decided to use the PHYLIP package of meth-
ods. This package allows for the phylogeny to be reconstructed using any of
three commonly used methods: Maximum Parsimony, Maximum Likelihood and
a distance-based method using the Fitch-Margoliash algorithm (Fitch and Mar-
goliash, 1967).
Bayesian methods of reconstructing haplotype trees could also be imple-
mented, such as those advocated by the application MrBayes (Huelsenbeck and
Ronquist, 2001). However, there is a disadvantage with the Bayesian approach,
in terms of the long run time required for the convergence and sampling of an
MCMC chain used to approximate posterior densities of alternate trees, which
makes it less suitable for the simulations of Chapter 7. The increased diculties
of interpreting MCMC output automatically, to assess whether convergence to
the posterior distribution has been obtained, is a further issue that makes this
approach less suitable for simulations and any form of automated use that could
be integrated into PheGe-Sim. The implementation of a Bayesian MCMC ap-
proach is though a feature that could plausibly obtain small improvements in the
results of the Treescan-based methods, although there would still be uncertainty
caused by recombination and the same mutation occurring on dierent lineages
(homoplasy), that would be dicult to resolve in any method of tree construction.
The resulting output les from the chosen PHYLIP application are then ma-
nipulated in R in order to get the information in a suitable form for the use in
Treescan and the Bayes factor version of Treescan. The aim in manipulating
the Newick (Felsenstein et al., 2010) format of trees returned by the PHYLIP
programs is to process the bifurcating trees to multifurcating trees, where each
branch involved corresponds to at least one mutation (the PHYLIP methods
returning branches unsupported by any mutation).
Details of the tree construction methods used are given in the following sec-
tions, with the approaches being chosen able to run within a reasonable timeCHAPTER 4. PHEGE-FIND 75
data sets of up to 2000 individuals. More in depth discussion of the methods
involved can however be found in Felsenstein (1988) and Chapter 16 of Balding
et al. (2001). In order to visualize the trees, the Newick code that is produced
can be viewed using the Treeview program (Page, 1996).
4.2.1 Parsimony Tree Construction
Uses the following application from the Phylip Package:
dnapars
The application dnapars of the PHYLIP package is used to implement the
method of maximum parsimony, whereby a tree is chosen that requires the lowest
number of mutations to describe the observable haplotypes. The method does
not however guarantee to nd the globally shortest tree. In situations where there
are multiple congurations of tree structure and mutations that are equally t in
describing the data, for simplicity it is chosen to only analyze a single best tree.
Details of the specic choices of inputs to dnapars are shown in gure B.1(a).
The parsimony method is generally fast to implement for reasonably sized
data sets and, if there is no recombination and an innite sites model is to be
assumed, will always reconstruct the true underlying tree. The accuracy of the
method can however begin to deteriorate if the assumption of innite sites is not
valid, as the true tree may no longer be consistent with the tree containing the
least number of mutations.
The output from dnapars details the estimated branch distances between
nodes, and also reconstructs unknown ancestral sequences. For the ancestral
sequences, it is however required to add arbitrary node labels to the tree as given
by the dnapars application. The methods of section 4.3 can then be applied
in order to reduce the stated output tree to a format that is compatible with
Treescan, whereby branches that are estimated to be of zero length are removed.
Outputs:
Parsimony output le saved to folderCHAPTER 4. PHEGE-FIND 76
4.2.2 Maximum-Likelihood Tree Construction
Uses the following application from the Phylip Package:
dnaml
The maximum likelihood method of reconstructing an unknown phylogenetic
tree is applied through the use of the dnaml application of the PHYLIP package.
Further details of the methods used are detailed in Felsenstein and Churchill
(1996). The key aim of the method is to maximize the likelihood with respect
to three multi-dimensional parameters: the topology of the tree , the branch
lengths  and a vector of evolutionary parameters . Assuming independent
evolution at dierent positions in the nucleotide sequence, the likelihood can be
written as follows:
f (Xj;;) =
c Y
i=1
f (xij;;); (4.1)
where X is the full sequence data, and xi is the data at the i'th SNP (i = 1;:::;c).
The dnaml program allows for the specication of various parameter choices,
with the specic choices that have been made illustrated in gure B.1(d). As
with the maximum parsimony method, the program can return reconstructed
hypothetical sequences for internal nodes and these can subsequently be used to
determine whether it is required to retain any unobserved internal nodes, which
the R code will arbitrarily label. Branches that are estimated to have a non-
signicant length are removed according to the methods in section 4.3.
Outputs:
Maximum Likelihood output le saved to folder
4.2.3 Fitch-Margoliash Distance Tree Construction
Uses the following applications from the Phylip Package:
dnadist
tch
A pairwise distance matrix between sampled haplotypes is computed using theCHAPTER 4. PHEGE-FIND 77
PHYLIP application dnadist. The distances are calculated under the assumption
of a Jukes-Cantor (Jukes and Cantor, 1969) model of evolution, a Markov model
which assumes that there is an equal probability of changing from the current base
to any of the other three bases. More complicated models are though possible,
which could take advantage of there being dierent rates of mutations between
dierent types of bases. Equation 4.2 illustrates the formula used for calculating
a pairwise distance, where d is the estimated distance, and p is the proportion of
sites with dierent nucleotides:
d =  3
4 loge
 
1   4
3 p

: (4.2)
The distance matrix is then used as an input for the tch program, which con-
structs a tree using the weighted least squares method of the Fitch-Margoliash
(Fitch and Margoliash, 1967) algorithm which aims to minimize the sum of
squares:
SS =
X
i
X
j
(Dij   dij)2
D2
ij
(4.3)
where D is the observed distance between species i and j, and d is the expected
distance.
The output of the program details where branches have been estimated to have
zero length although, unlike the maximum likelihood and parsimony methods,
the tch application does not indicate the reconstruction of unobserved internal
nodes. So, after the branches of estimated zero length have been collapsed,
the Fitch algorithm (Fitch, 1971) is used to reconstruct the likely sequences of
the non-terminal nodes. An example of a tree output from the Fitch program is
shown in gure 4.2. This can be represented in Newick format, where an arbitrary
root is taken and nodes are then grouped together inside brackets, until all the
nodes present are collected together inside one expression. For this example, the
corresponding Newick code with arbitrary branch lengths of one, is:
(1:1,2:1,(3:1,(5:1,4:1):1):1); (4.4)
where no internal nodes labels have been assigned.CHAPTER 4. PHEGE-FIND 78
(a) First `sweep' of the Fitch algorithm (b) Second `sweep' of the Fitch algo-
rithm
Figure 4.2: Fitch algorithm, where unresolved sites are in red, and subsequently
resolved sites are coloured blue. Terminal nodes are xed, as these are observed,
and are coloured black.
All internal nodes are then added to the Newick code, and the bases at each
site of these nodes are determined by application of the Fitch algorithm. Figure
4.2 represents the process for a single site, where the root has been chosen to be
the node labelled 7. The bases present at each of the internal nodes, 6,7 and 8, are
determined by the intersection of the sets of possible bases at nodes immediately
below it in the tree and the resulting base is illustrated below in gure 4.2. Node
8 however cannot be resolved, and so the algorithm then proceeds in reverse, as
in gure 4.2(b), which therefore assigns the state to be an `A'. This process is
repeated for all the SNPs of the terminal nodes, and ensures that the minimum
number of base changes occurs for the constructed tree, while reconstructing the
internal nodes. Branches are then removed according to the procedures of section
4.3, if the sequences at the nodes at both ends of the branch are identical. In the
example this results in the nal Newick form:
(1:1,2:1,6:0,(3:1,7:0,(5:1,4:1,8:0):1):1); (4.5)
Outputs:
Fitch output le Saved to Fitch folderCHAPTER 4. PHEGE-FIND 79
(a) (b)
Figure 4.3: Initial (a) and reconstructed tree (b), when the branch in red is
estimated as carrying no mutations.
4.3 Removal of Branches
Inputs:
Parsimony output le and estimated Parsimony tree
Maximum Likelihood output le and estimated Maximum Likelihood tree
Fitch output le and estimated Fitch tree
The following conditions are applied for each of the tree construction methods
to evaluate whether a branch is required or not, as it may be that an interior node
is predicted to have the same sequence as a terminal node. Each tree is rened
so that there is at least one mutation on every branch on the tree, as otherwise
multiple branches will result in the same test statistic value. It should also be
noted that for the purposes of Treescan it is only relevant whether a branch
length could be equal to zero or not as indicated by the presence or absence of a
mutation, and the actual distances involved are of no importance.
There is no known format for giving a coded representation of an ARG,
however the Newick format can be used for illustrating a haplotype tree with
multifurcating branches. The Newick code returned from each of the PHYLIP
programs can subsequently be altered by counting the number of internal and
external nodes present within each set of brackets. It is ensured that within each
set of brackets there is one node that is labelled as being internal, and that no
adjacent nodes are equal to each other as indicated by having the same real or
reconstructed sequence.CHAPTER 4. PHEGE-FIND 80
Figure 4.3(a) relates to the situation whereby the internal node 8 is the same
as the terminal node 4. In this situation, the node labelled 8 is removed and
node 4 is relabelled as an internal node. This is illustrated in gure 4.3(b),and
the corresponding transformation of the Newick form is:
(1:1,2:1,6:0,(3:1,7:0,(5:1,4:1,8:0):1):1); ! (1:1,2:1,6:0,(3:1,7:0,(5:1,4:0):1):1);:
(4.6)
The second criterion to be assessed relating to whether to remove node labels
is if the initial tree structure is as indicated in gure 4.4(a), where the internal
node 8 is dierent from both of the terminal nodes 4 and 5, but is the same as
the internal node 7. If this combination arises, the eect is to remove node 8
and this results in a multifurcation at the internal node 7, an illustrated in gure
4.4(b). The corresponding transformation of the Newick code is:
(1:1,2:1,6:0,(3:1,7:0,(5:1,4:1,8:0):1):1); ! (1:1,2:1,6:0,(3:1,7:0,5:1,4:1):1);: (4.7)
A further criterion to be considered is given in gure 4.5(a). This details a
situation whereby the internal node 8 is equal to one of the terminal nodes, in
this case 4, and also to the internal node 7. This results in node 8 being removed,
and node 7 being replaced with node 4, leading to the tree in gure 4.5(b) and a
Newick code as shown in equation 4.8.
(1:1,2:1,6:0,(3:1,7:0,(5:1,4:1,8:0):1):1); ! (1:1,2:1,6:0,(3:1,5:1,4:0):1);: (4.8)
(a) (b)
Figure 4.4: Initial (a) and reconstructed tree (b), when the branch in red is
estimated as carrying no mutations.CHAPTER 4. PHEGE-FIND 81
(a) (b)
Figure 4.5: Initial (a) and reconstructed tree (b), when the branches in red are
estimated as carrying no mutations.
The nal possible consideration is where the internal node 8 is not equal to any
of the nodes that it is connected to. In this situation, the tree remains unchanged
as none of the branches can be collapsed. Each section of the haplotype tree is
assessed in turn using these criteria, working from the terminal nodes towards
the chosen root, as determined by the tree construction method. The resultant
haplotype tree that remains will be a multifurcating network of observable nodes
and hypothesized ancestral sequences, as is required for the Treescan-based meth-
ods. Information relating to the haplotypes of the nodes remaining in the tree is
retained, so that the SNPs that relate to each branch can be identied.
Outputs:
Collapsed Fitch tree - pentax.pars.tch
Collapsed Parsimony tree - pentax.pars.pars
Collapsed Maximum Likelihood tree - pentax.pars.ml
4.4 Methods of Association
Inputs:
Observable haplotype sequences of SNPs
Number of permutations for p-value calculation - num.perm
There are numerous association methods that have been programmed for use
in both the PheGe-Sim and PheGe-Find programs, and these are illustrated in
table 4.1. The approach used for the standard Treescan method has previouslyCHAPTER 4. PHEGE-FIND 82
Table 4.1: Methods used in the association studies of PheGe-Find and PheGe-
Sim.
Method Frame
Extra
Tests
Correction Comment
Tscan
Standard
Bayesian
Bimbam
Pars
Fitch
Max Lik
Snp
Branch
Treescan based methods are pro-
grammed to run under all combina-
tions of frame, extra tests and cor-
rection (resulting in a total of 18 dif-
ferent interpretations).
Single
SNP
Standard
Bayesian
Bimbam
Bonferroni
Snp
Single SNP methods can only assess
SNPs individually, or in combina-
tion with one or two others, before
the number of combinations becomes
prohibitive.
Single
Hap
Standard
Bayesian
(Bimbam)
Bonferroni
Branch
Haplotype methods have no ability
to detect which SNPs upon a haplo-
type confer an increased association,
unlike the Treescan based methods.
been described in section 1.5.2, and this is modied for the creation of the stan-
dard single SNP and standard single haplotype procedures. The ow chart of
gure 4.6 shows the steps taken in determining whether any signicant groupings
have been found.
As each individual will contain two copies of a gene, there are three possible
combinations of bases that are possible, assuming that only two variants are
observable at each location. The combination of bases that an individual has is
determined for each site, and the phenotype score from that individual is then
assigned to the appropriate base grouping.
At this stage, the Bonferroni method and the single SNP version of Treescan
both calculate an F statistic from an ANOVA comparing the distributions of
1Only applies once for each causative SNP to ensure that there are fair comparisons between
simulations and to avoid declaring more correctly found haplotypes than there are causative
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Figure 4.6: Flow chart of the decisions involved in frequentist methods. These are
chosen so as to mirror the steps taken in the Treescan procedure (gure 1.3), with
both rst and second round tests of association being used. A SNP is declared as
`found' if it is found in the rst round of tests, and all the other tables of second
stage splits.CHAPTER 4. PHEGE-FIND 84
phenotypes in the three genotype classes. The Bonferroni method then simply
adjusts the signicance level  from the ANOVA using the standard Bonferroni
correction for multiple testing, namely the equation adj = 1   
n, where n rep-
resents the total number of tests performed. Sites are subsequently adjudged to
be signicantly associated with a change in phenotype if the p-value is less than
the adjusted signicance level.
The Single SNP method adjusts the F-statistic by the use of the Boerwinkle-
Singh (Boerwinkle and Sing, 1986) corrected estimator, so as to remain consistent
with the methodology used in the Treescan program. This correction involves
adjusting the observed phenotype variance, by the number of genotype classes
present in that comparison:
s
2
G =
k X
i=1
ni( Yi    Y )2
n
 
k   1
n
k X
i=1
ni X
j=1
(Yij    Yi)2
n   k
; (4.9)
where n is the total sample size, k is the number of genotypic classes with obser-
vations,  Y is the sample grand mean, ni is the number of individuals in the ith
genotypic class, and Yij is the phenotype of the jth individual with genotype i.
The nal adjusted p-values from the single SNP method are then obtained
by the permutation and correction methods detailed in the Treescan approach
(section 1.5.2). As with the Treescan method, a SNP is adjudged to be signi-
cantly associated with the phenotype if it is found as signicant in the rst table
of splits, and in all second round tables conditional on the other found SNPs (see
gure 4.6).
The method of using Bayes factors for assessing the dierences of phenotypes
between the genotypes at each SNP will be discussed in detail in Chapter 3. In
contrast to the frequentist approaches, the Bayes factor versions computes all
second-round comparisons, as it may be that a combination of splits that are not
found signicant in the rst round may have a signicant eect when considered
together. If second-round splits are also found as signicant, then third-order
splits are considered using only the combinations of SNPs that are found as
signicant in the previous round.
The set of all combinations in third and higher-order splits is not considered,
as the number of comparisons increases dramatically for higher-order splits. ForCHAPTER 4. PHEGE-FIND 85
Figure 4.7: Flow chart of the decisions involved in Bayesian methods. The ap-
proach aims to test all rst round associations, and then testing subsets of the
splits that appear to be associated from the previous rounds of tests. At each
round of splits all the relevant tests of association are used, and the maximum
value is taken for use in determining if a SNP/split is declared to be found.CHAPTER 4. PHEGE-FIND 86
example, for n SNPs a third round comparison would involve
 n
3

comparisons,
and therefore a typical data set of 70 SNPs, such as the blood pressure data set
analyzed in Chapter 6, would involve 54;740 comparisons at the third-level of
splitting. This would increase the computation time considerably, and is unlikely
to discover any SNPs that have not been indicated as signicant to some extent
in the rst or second-round splits.
In order for a SNP or branch to be declared as signicant in a Bayes factor
approach, it has been decided that a Bayes factor of > 150 is required to obtain
`very strong' evidence against H0, according to the categories of table 1.2 (Kass
and Raftery, 1995). No choices are made for the prior odds of association, which
would vary in practice depending on the strength of prior knowledge available.
However, the choice of a region to use for a ne-scale study would in itself indicate
that there is a suggestion, from a GWAS or from previous studies, that a variant in
the region is to some extent associated with the phenotype. Figure 4.7 illustrates
the steps used in calculation of the Bayes factors. It can be seen that for the rst
round of tests, a SNP or branch is to be designated as found if a Bayes factor is
obtained that is signicantly larger than the overall null model. At the second
and subsequent level of splits, the Bayes factor is calculated according to the
comparison between the marginal likelihood of the current level, and the highest
marginal likelihood of the previous round of tests.
4.4.1 BimBam
BimBam (Bayesian IMputation Based Association Mapping, Servin and Stephens
(2007)) is a method that implements exactly computed Bayes factors for use
in phenotype-genotype association studies. Conceptually similar to the Bayes
factors used in PheGe-Find, there are however some dierences in the approaches
that can have implications for the outcome and interpretation of the resulting
Bayes factors.
As with PheGe-Find (Chapter 3), BimBam uses conjugate priors for dening
the prior mean () and the reciprocal of the variance () of the phenotype data,CHAPTER 4. PHEGE-FIND 87
that is assumed to be Normally distributed. These priors are of the form:
  


2
;

2

; (4.10)
j N

0;
2



; (4.11)
where ,  and 2
 are hyperparameters to be specied.
BimBam subsequently takes the limiting form of this distribution, that is
letting ; ! 0 and 2
 ! 1. Although this results in an improper prior
distribution, the posterior can be shown to be proper, with Bayes factors which
are reported as tending towards sensible limits. As a result of this, BimBam
requires the specication of two other hyperparameters, a and d, specifying
respectively a standard deviation of an eect size, and a measure of how close
the eect of a mutation is to being additive. A further prior choice is made
regarding a distribution concerning the number of SNPs that are likely to be
dened as causative, denoted by the distribution p(l), where l represents the
number of specied SNPs.
An advantage of the approach taken by BIMBAM is that the prior mean
and variance are not required to be specied, thus avoiding uncertainty about
what represents suitable information to assign these values. However, the lack
of specication can also be a negative feature, as if there are data available from
another source then this will not be able to be incorporated into the Bayes factors
of Bimbam. In real data sets there is likely to be some prior knowledge about
what range of values is expected for a given phenotype, and basing the prior
mean and variance on the sample of data is not always appropriate.
A further dierence between the methods used in BIMBAM and those used
in this thesis is that BIMBAM requires specication of the distribution of SNPs
that are to be determined as causative. The prior used puts equal weight on
any choice of up to four causative SNPs, as it is stated that the alternative of
calculating each Bayes factor in comparison to a null model will lead to implicit
prior assumptions about the relative plausibility of each multiple SNP model.
However, the view taken in this thesis is that there is decreasing plausibility of
larger numbers of SNPs being associated with a phenotype, and that the eect ofCHAPTER 4. PHEGE-FIND 88
multiple SNPs should provide signicant improvement on a simpler model with
only a single variant. This is possibly most relevant in the context of this thesis,
that is ne-scale studies as opposed to GWAS, as due to strong linkage between
variants there will be multiple correlated SNPs associated with a phenotype as
a result of one true signal. In this setting, it is preferable that strong evidence
is required to suggest that the apparent eects of multiple variants is not simply
the linked eects to the actual causative variant. An improvement suggested but
not implemented by the BIMBAM approach is to use a prior with decreasing
probability for larger numbers of causative SNPs. This is a possibility that needs
further work but that could potentially be useful for the situation of assessing
multiple linked SNPs.
As with the approach taken in this thesis, BIMBAM does not focus on the
specication of the prior odds of an association. The choice of the prior odds will
be context specic and, irrespective of the method that is chosen in calculation
of the Bayes factors, should be chosen with care dependent on prior knowledge
about the regions and variants being assessed.
4.5 PheGe-Find Output
In addition to the output les created for each of the methods of association
and tree construction that have been described previously, PheGe-Find also con-
structs three plots relating to the data. However, PheGe-Find does not create
the sim results and details les that were created in PheGe-Sim, as in real data
sets there will be no knowledge as to what are the `true' causative mutations.
4.5.1 Linkage Plots
PheGe-Sim creates a PED le of the genotypes involved in a data set, which
is then used as an input for the Haploview (Barrett et al., 2005) application.
Haploview is automatically run through its command line options (section B.4),
and will produce a linkage plot of the genotypes involved. The statistics used to
illustrate the linkage between each pair of SNPs are D0 and the LOD (Log Odds)CHAPTER 4. PHEGE-FIND 89
score. D0 is dened by:
D
0 =
(
D
min(p1q2;p2q1) if D  0;
D
 min(p1q1;p2q2) if D < 0;
(4.12)
with perfect linkage corresponding to a D0 = 1, no linkage corresponds to D0 = 0,
and where:
D = p11p22   p12p21 = p1q1; (4.13)
where the pij values are the proportions of each entry from the following:
SNP 2
allele 1 allele 2
SNP 1
allele 1 p11 p12 q1
allele 2 p21 p22 q1
p1 p2
The LOD score is calculated according to the following equation (Ott, 1999):
LOD = log10
maxrP(datajr)
P(datajr = 1
2)
(4.14)
where r corresponds to the recombination fraction. The computation of this in
Haploview relies upon a two-marker EM algorithm for estimating the maximum
likelihood values required. Information regarding the D0 and LOD scores are then
visually summarized in Haploview according to the classications of table 4.2.
Table 4.2: Key to colour combinations of linkage plots, reproduced from the help
les of Haploview (Barrett et al., 2005).
D0 < 1 D0 = 1
LOD < 2 white blue
LOD  2 shades of pink/red bright redCHAPTER 4. PHEGE-FIND 90
4.5.2 Manhattan Plots of Results
PheGe-Sim produces `Manhattan' plots summarizing the results of the single SNP
and Treescan analysis, for both the frequentist and Bayesian settings. Results
are displayed according to the maximum  log10 p-value (i.e. the minimum p-
value), or Bayes factor that has been observed in all the tests of association under
consideration, to ensure that the scales of each of the plots are comparable. The
logarithm of the p-values is taken to ensure that the results are strictly positive
on a scale of zero to innity. Treescan results are displayed as the association
levels for each of the SNPs as opposed to branches, and as such there is liable
to be multiple `hits' for each SNP under consideration. If a valid Site Positions
le has been specied, the results will be displayed according to the specied
locations of each SNP. If this information is not provided, the plot will use a
default spacing of one unit between each of the SNPs of the study.
4.5.3 Sensitivity Analysis
As with most Bayesian analysis, the Bayes factors that are to be developed in
Chapter 3 and have been used for the association studies, require the specication
of hyperparameters in the prior distribution. Having to make choices of prior dis-
tributions can be both a positive and negative feature of any analysis. However,
it would be hoped that any conclusions from a data set would not be substan-
tially altered by small changes in prior specications. PheGe-Sim produces two
plots that can provide visual summaries of the sensitivity to these prior choices;
one of these corresponding to the prior for the mean of the data, and the other
corresponding to the prior on the within-group variance.
The normal-inverse-chi-squared distribution used for the specication of the
prior distribution (equation 3.11) consists of dependent normal and inverse-chi-
squared distributions. The normal distribution describes the mean of the data,
whereas the inverse-chi-squared distribution describes the variance.
The mean of the prior distribution for the phenotype mean, can be specied
by the 0 parameter. As a default choice for this value, the mean of the sampled
data can be used, however, 0 can ideally also be chosen according to the mean
of a suitably similar data set to the one being assessed.CHAPTER 4. PHEGE-FIND 91
The choice of 0 relates to the information on , with 0 number of observa-
tions of mean 0 and variance 2. Choosing a large value of 0 would imply that
there is a large degree of certainty about the mean of the data; and conversely
choosing 0 as zero would imply that there is no knowledge of the potential mean
of the data set. A default value of 20 is chosen, which appears to be reasonable
in conveying a sucient amount of condence in the prior mean of the data. The
eect of 0 on the Bayes factors is relatively minimal for reasonably sized data
sets (Chapter 6), but for small data sets it can have a stronger impact and lower
values may be more appropriate (Chapter 5). The mean and variance of the
inverse-chi-squared distribution for the within-group variance, are respectively:
E[
2] =
02
0
0   2
(4.15)
and
Var[
2] =
204
0
(0   2)2(0   4)
: (4.16)
It can be seen that the hyperparameters of 0 and 2
0 are entangled, as they
both appear in the formulations of the mean and the variance of the variance
distribution. It should be noted that the mean is only dened if 0 > 2, and
likewise the variance is only dened if 0 > 4.
Analogous to the choice of 0, the information on 2 is equivalent to the
choice of the number of observations, 0, with variance 2
0. Distributions where
0 is less than 4, resulting in prior distributions with innite variance, cause the
Bayes factors to be unstable and unreasonably high. An increase in 0 above 4
results in a steady increase in the Bayes factor, assuming that the prior mean is
reasonably close to the mean of the sample data. It has therefore been chosen
that the default value of 0 shall be 20, and the choice of 2
0 shall be chosen as the
sample variance. If there is therefore a reason for increased condence in prior
knowledge of the variance then 0 can be increased to reect this, and the prior
variance will become concentrated around 2
0.
Using the sample mean and variance as default choices of priors can result
in the data articially being used twice, and therefore may result in a misplaced
condence in a lack of uncertainty relating to the estimates. As a starting pointCHAPTER 4. PHEGE-FIND 92
they can though be useful as the calculation of meaningful Bayes factors requires
the prior values to be reasonably consistent with the sample, as otherwise the
reported Bayes factors will be uniformly small. However, the use of previously
reported information relating to inform the hyperparameter choices should be
used whenever possible to avoid an overcondence in the interpretation of results.Chapter 5
Drosophila melanogaster Data
5.1 Background of Data
Drosophila melanogaster is a breed of fruit y that has been extensively studied
in genetics since the beginning of the twentieth century, and studies by Thomas
Morgan of the phenotype characteristics of the y formed the basis of many
aspects of modern genetics. The use of D. melanogaster in genetic studies sub-
sequently became popular due to the relative ease with which the ies could be
maintained, and due to the short life cycle and high breeding rate of the ies.
Further understanding of genetics led to the discovery that the DNA of the D.
melanogaster fruit y contains four chromosomes, three autosomes and an X-Y
pair. The chromosome number is substantially smaller than that of mice and
humans and so the fruit-y was one of the rst organism to have its DNA fully
mapped, with the information currently being contained online in the FlyBase
database (FlyBase, 2010).
Although the chromosome number is substantially lower than that of humans,
there are some genes that are present in the y that are directly related to an
equivalent human gene. One such gene is ADH, that is located on chromosome
2L of D. melanogaster and on chromosome 4q of human DNA. This gene is
responsible for the production of alcohol dehydrogenase, an enzyme involved in
the breakdown of alcohol, that in the y is present as a result of its diet consisting
of rotting fruit. As humans also contain the ADH gene, numerous studies have
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Figure 5.1: Reconstructed haplotype tree using the parsimony method.
been conducted using D. melanogaster in an attempt to gain an insight into
potential risk factors of alcoholism. One such study was conducted by Aquadro
et al. (1986), to gain an understanding of the relationship between dierent strains
of the y and the ADH gene as measured by the activity levels of the alcohol
dehydrogenase enzyme.
Aquadro et al. (1986) constructed a phylogenetic tree using parsimony meth-
ods to describe the relationship between the various strains of D. melanogaster
based on the ADH sequence data, and also found that there was an association
between a variant at one of the sites in the ADH gene and alcohol dehydrogenase
enzyme activity, when assessing each SNPs relationship with the phenotype indi-
vidually. Templeton et al. (1987) subsequently suggested using the reconstructed
tree implicitly in attempts to nd associations, and this resulted in the nested-
clade analysis (NCA) method. The fruit ies involved in the Aquadro study
were bred to be homozygous for the ADH region. However, this is impossible
for human studies, and so Treescan was developed which takes into account theCHAPTER 5. DROSOPHILA MELANOGASTER DATA 95
potentially heterozygous nature of most naturally occurring DNA. The Aquadro
data set was reanalyzed by Treescan to provide a valid comparison with the NCA
method, and in a similar way is being reanalyzed here to provide valid compar-
isons between the Bayes factors and frequentist-based methods.
The data available from D. melanogaster diers from the usual data sets
required for Treescan-based analysis in a variety of ways. The rst dierence is
that the D. melanogaster have been back-crossed so as to be homozygous, and so,
unlike for most human data sets, it is not possible to test for any additive, general
or recessive eects. As the ies are homozygous, there is also no requirement to
phase the data set. A second dierence is that insertions and deletions (indels)
are present in the genotypes of the fruit ies, and these have been treated in
a similar way to the treatment of SNPs by simply coding whether the indel is
present or absent in a particular haplotype. There may be complex dierences
in the biological mechanisms that result in SNPs or indels that are not being
accounted for in this approach. However, recoding in such a manner does not
change the analysis methods and therefore allows for valid comparisons with the
approach employed by Treescan (Templeton et al., 2005).
Figure 5.1 shows the haplotype tree relating the 48 D. melanogaster present
in the study, that has been reconstructed using the parsimony method as de-
tailed in Chapter 4. This corresponds exactly to the tree that was obtained by
Aquadro et al. (1986) and subsequently by Templeton et al. (2005), and infers
the same unobserved internal sequences that have been automatically labelled by
the PheGe-Sim application. Although of small size, the data can be shown to be
roughly normally distributed, as is required for some of the following analysis.
5.2 Linkage Plot
Figure 5.2 illustrates the linkage between the SNPs that are present in the D.
melanogaster data set. There does not appear to be any clear pattern from
the plot, although this is largely due to the relatively small data set in terms
of sample size (48) and the small number of variants (22). In particular, the
large number of blue squares illustrate regions where D0 = 1 and LOD < 2
and are generally a result of low sample size and therefore low power to detectCHAPTER 5. DROSOPHILA MELANOGASTER DATA 96
Figure 5.2: Linkage plot for D. melanogaster data. The plot is predominately
blue due to evidence of linkage, but there being only a relatively small sample
size. See table 4.2 for the details of the colouring used in the plot.
linkage. It should be noted that there are small dierences between the estimates
given by Haploview and those given in Aquadro et al. (1986), due to Haploview
using Hedrick's (1987) estimator of D0, whereas Aquadro uses Lewontin's (1964)
estimate of linkage disequilibrium.
5.3 Estimating Recombination Rates
& Hotspots
The interval program of the LDHat (McVean et al., 2002) package is a program
that estimates recombination rates based upon imputed phased haplotypes. Al-
though a newer version of the program has been written (rhomap), the interval
program was used so that results in Chapter 6 can be comparable with the current
estimates given in HapMap for human data. The application uses a composite
likelihood estimation of the recombination rate, as calculation of the likelihood
of the full data set is intractable. This method was rst implemented by Hudson
(2001) but adapted to include the possibility of a nite-sites model of mutation
in the LDHat package. The inclusion of the possibility of a nite sites model
is particularly relevant, as recurrent mutation and recombination can plausiblyCHAPTER 5. DROSOPHILA MELANOGASTER DATA 97
Figure 5.3: Recombination estimates directly from D. melanogaster data.
result in identical sequences of DNA.
The composite likelihood scheme involves four key stages, the rst of which
is to estimate the population mutation rate per site. All possible two-locus com-
binations of sites are then compared, and the likelihood of each comparison is
calculated. The overall population recombination rate for the data set is then
estimated by combining the pairwise comparisons. Further details of the scheme
are given in the methods section of the paper by McVean et al. (2002).
Due to the small number of variants and small sample size of the number of
ies under consideration, it is unlikely that clear estimates of recombination could
be estimated using this data set. This proves to be the case as illustrated in gure
5.3, with recombination estimates suggesting some evidence of recombination, but
with a large degree of uncertainty due to the small sample size. For the analysis
in the following sections it is assumed that the data can be treated as if from one
region of low recombination, because of the low sample size and relative simplicity
of the reconstructed haplotype tree of gure 5.1.CHAPTER 5. DROSOPHILA MELANOGASTER DATA 98
(a)
(b)
Figure 5.4: D. melanogaster results, for the frequentist (a) and Bayesian (b)
versions of the single SNP method. Site locations are approximate, based upon
information in Aquadro et al. (1986).
5.4 Single SNP-based Analysis
Figure 5.4(a) illustrates the results from the single SNP method, with the un-
corrected p-values from ANOVA tests being displayed. Initially it seems that
there are three variants that are strongly associated with the phenotype, labelled
SNP-1,SNP-12 and SNP-2, with p-values extremely low for such a small sample
size (table 5.1). A Bonferroni correction for multiple testing would require that
the p-values are lower than 2:272  10 3 for the 22 variants considered, and as
such all three would be considered to be associated with the ADH phenotype. A
further two SNPs (labelled SNP-10 and SNP-13) are associated with p-values of
less than 0.05, which are not small enough to pass the Bonferroni-corrected level
of signicance. The linkage plot of gure 5.2 shows that the three variants with
strong associations are also in strong linkage with each other, and so it may be
that not all three are indeed causative. According to the procedure used by the
single SNP method (gure 4.6), only SNP-1 would be declared to be signicantly
associated with the phenotype as none of the other SNPs considered account for
any signicant signal in addition to this SNP.
The results from the rst round of association using Bayes factors are shownCHAPTER 5. DROSOPHILA MELANOGASTER DATA 99
Table 5.1: Selected single SNP (top), Treescan (middle), and Haplotype (bottom)
results of analysis of D. melanogaster data. Note as homozygous bred there are
no heterozygous measurements
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SNP-1 16 25 7.8 3.5 2446.0 4:8  10 16 0.00
SNP-12 18 23 7.5 3.4 1302.4 2:2  10 13 0.00
SNP-2 19 22 7.2 3.5 277.1 5:7  10 10 0.00
SNP-10 8 33 7.7 4.6 1.8 2:6  10 4 0.00
SNP-13 8 33 3.2 5.7 0.7 5:9  10 3 0.00
SNP-1 16 25 7.8 3.5 2446.0 4:8  10 16 0.00
SNP-12 17 24 7.6 3.5 1323.9 1:0  10 13 0.00
SNP-2 19 22 7.2 3.5 277.1 5:7  10 10 0.00
SNP-10 8 33 7.7 4.6 1.8 2:6  10 4 0.00
SNP-13 6 35 3.3 5.5 0.4 2:6  10 4 0.00
HAP-23 2 39 8.6 5.0 0.3 0.034 0.21
HAP-2 5 36 3.2 5.5 0.4 0.036 0.21
in gure 5.4(b). The chosen hyperparameters are the defaults of PheGe-Sim,
namely: 0 = 5:204;0 = 20;2
0 = 5:383;0 = 20. The values of 0 and 0 are
relatively high for this setting due to the small sample size, and therefore may
strongly aect the resultant Bayes factors, particularly as the mean and variance
have been set at the true levels of the sample. The Bayes factors do indeed
uctuate to a reasonable extent depending on the combination of all four of the
hyperparameters, however, remain reassuringly high at the same variants largely
irrespective of the specic values that are chosen.
The pattern of association is similar to that for the frequentist approach,
although variants SNP-10 and SNP-13 have comparatively lower association in
the Bayesian setting1. The procedure used for Bayesian methods in determining
the number of SNPs associated with the phenotype (gure 4.7) would determine
that only variant SNP-1 is found to be associated, as at the second level of
1Note, however, unlike the p-values, the Bayes factors are not on the log scale.CHAPTER 5. DROSOPHILA MELANOGASTER DATA 100
(a)
(b)
Figure 5.5: D. melanogaster results, for the frequentist (a) and Bayesian (b)
versions of Treescan. Site locations are approximate, based upon information in
Aquadro et al. (1986).
tests the addition of extra variants does not signicantly improve the marginal
likelihood of the alternative model.
5.5 Treescan & Haplotype Analysis
Treescan-based analysis can be performed upon the D. melanogaster data and re-
sults are shown using the standard approach in gure 5.5(a), and for the Bayesian
alternative in gure 5.5(b), and are summarized in table 5.1. Unlike for most hu-
man data sets, there is no uncertainty in the haplotype reconstruction as the
haplotype have been explicitly observed due to the ies being bred to be ho-
mozygous. The patterns of association for both Bayesian and frequentist ap-
proaches are strikingly similar to those of the comparable single-SNP analysis,
due to there being only eight mutations occurring in more than one position on
the reconstructed maximum parsimony haplotype tree. The Manhattan plots
of gure 5.5 do however illustrate one of the potential problems with the use
of Treescan, namely that SNPs can result in being declared as both associated
and un-associated with the phenotype at dierent locations on the haplotypeCHAPTER 5. DROSOPHILA MELANOGASTER DATA 101
(a) D. melanogaster sensitivity to the 0
and 0 hyperparameters (SNP 1)
(b) D. melanogaster sensitivity to the 0
and 0 hyperparameters (SNP 6)
Figure 5.6: D. melanogaster sensitivity to hyperparameters.
tree. This is particularly true in this example, whereby the haplotype tree re-
construction has resulted in there being two instances SNP-12 occurring (table
5.1). Based upon this, it is not possible to determine whether a mutation is
indeed responsible for a change in phenotype measurement, and it can only be
declared as to the association of the specic haplotype with the phenotype. If it
is indeed SNPs or other variants as opposed to haplotypes that are the driving
force responsible for a phenotype, then the Treescan method fails to be useful in
comparison with the single SNP approaches for this particular data set.
Testing the associations of haplotypes with the phenotype when ignoring the
tree structure is also possible using the PheGe-Sim application, and the two
haplotypes with strongest associations are presented in table 5.1. It is apparent
that haplotype-based analysis for this particular data set is ineectual, as a result
of there being only 25 unique haplotypes for the 41 ies involved and therefore
there is extremely low power to detect any dierences that could exist. This
is apparent in both the Bayesian and Frequentist settings, assuming that the
p-value is corrected for multiple testing in an appropriate manner.CHAPTER 5. DROSOPHILA MELANOGASTER DATA 102
(a) D. melanogaster sensitivity to the 0
and 2
0 hyperparameters (SNP 1)
(b) D. melanogaster sensitivity to the 0
and 2
0 hyperparameters (SNP 6)
Figure 5.7: D. melanogaster sensitivity to hyperparameters.
5.6 Sensitivity Analysis
The Bayes factors that have been presented are equivalent to the posterior odds
of association as they have not been adjusted by prior odds, and the sensitivity
of these Bayes factors to hyperparmeter choices can be explored. Figure 5.6(a)
represents the sensitivity of SNP-1 to the hyperparameters of the overall mean.
It can be seen that the Bayes factors that are obtained are highly sensitive to
the choice of both the 0 and 0 hyperparameters. The Bayes factors for this
example are extremely sensitive to the prior choices mainly because of the small
sample sizes involved, and so the choice of prior values in this situation can have
an unreasonably high impact on the resultant Bayes factors.
Figure 5.6(b) illustrates the sensitivity to the Bayes factors of SNP-6, a vari-
ant that appears to have little or no association with the ADH enzyme activity.
In this situation, unlike that for SNP-1, the choice of the mean related hyperpa-
rameters has only a marginal eect on the Bayes factors and that, irrespective of
the values that are chosen, the Bayes factors remain small. The plots of gure
5.6 are reassuring in that with reasonable choices of prior values apparent true
associations can be found, but irrespective of prior choices variants that show
little association in the sample data will not be mistakenly interpreted as being
in association with the phenotype.CHAPTER 5. DROSOPHILA MELANOGASTER DATA 103
Careful consideration must also be made for the hyperparameters 0 and 2
0,
that are used for describing the prior variance. In order to produce reasonable
Bayes factors the choice of 0 should be as low as possible, as a higher value
represents increased condence in the prior distribution of the within-group vari-
ance. Figure 5.7(a) represents the sensitivity of the Bayes factors to the variance
hyperparameters for a SNP that appears to be associated with the phenotype.
It can be seen that the plot appears to consist of curved segments, with it being
suggested that an increase in Bayes factor would be obtained by using a lower
variance of the within-group variance. This is a result of the within-group vari-
ance being substantially lower than the between-group variance, which has been
used to x the 2
0 hyperparameter of this test. This is in itself an indication that
there may be a true eect at this SNP, however, the Bayes factors are generally
suggestive of an eect at most combinations of 0 and 2
0. Figure 5.7(b) illustrates
the sensitivity of the Bayes factors at a SNP with little apparent association with
the phenotype, and displays a pattern that is more centred on the overall variance
of the data than was displayed for SNP-1. Irrespective of the choices made for
the prior variance, the Bayes factors remain reassuringly low at this SNP.
5.7 Conclusions
The analysis presented of the ADH data set results in similar conclusions to those
previously reported by Templeton et al. (2005) and Aquadro et al. (1986). The
three SNPs that have been found to be strongly associated with the ADH pheno-
type are found irrespective of whether a single SNP-based or Treescan approach
is used, or whether the strength of association is tested using p-values or Bayes
factors. It is also observed that the use of haplotype-based analysis is inappro-
priate for this data set, due to the small sample size that results in low power at
detecting any potential associations.
The three SNPs that have been found to be associated with the phenotype
are, however, in strong linkage with each other, and so there may be only one
true causative variant. The most likely candidate for true association is the
variant with the strongest association, namely SNP-1. There are no signicant
associations at the second round of splits in any of the forms of the analysis.CHAPTER 5. DROSOPHILA MELANOGASTER DATA 104
However, this could potentially be a result of there being a small sample size and
therefore there is low power to detect multiple SNP eects.
Detailed dierences between the Treescan and single SNP-based approaches
are dicult to ascertain for this data, as there are only a few instances of repeat
mutations on the reconstructed haplotype tree. It can be seen though that a
stronger eect of SNP-12 is found using the Treescan approach, however, gure
5.5 shows that this SNP also appears to be unassociated with the phenotype
at another location on the haplotype tree. The conclusion that can be made
regarding this situation is open to interpretation, and it can reasonably be argued
as a benet or indeed a drawback of the Treescan method that the two instances
of the mutation have been dierentiated in this way. The argument of it being
a drawback does though seem to be a more reasonable position, as a strong
association at this SNP is nonetheless found using both p-values and Bayes factors
when using a single SNP approach.
The comparison between the Treescan and single-variant approaches can also
be useful in illustrating the potential benets of a Bayes factor approach over
the standard use of p-values. SNP-12 is found to have p-values diering by 220%
between the two approaches, even though there is only a small dierence in the
allocation of phenotypes under the two scenarios. The Bayes factors, on the
other hand, are more robust to such small adjustments of the observed data,
and the Bayes factor only changes by 1.65% from 1302:4 to 1323:9. Although
the Bayes factors are indeed sensitive to the hyperparameter values used for the
prior distribution, the default choices of PheGe-Find have been demonstrated to
result in reasonable values.Chapter 6
ADRA1A Data
6.1 Background of Data
The 1A adrenergic receptor gene (ADRA1A) is located on chromosome 8 of the
human genome, and is involved in the contraction (vasodilation) and expansion
(vasoconstriction) of blood vessels. As a result of these actions, the ADRA1A
gene has been targeted in the treatment of hypertension and benign prostatic
hyperplasia (BPH) through the use of alpha-adrenergic antagonist drugs such as
Prazosin (Mancia et al., 1980). The eect of these drugs in the treatment of
hypertension is that the drug inhibits the vasoconstriction eects of adrenaline
and noradrenaline, thus reducing blood pressure.
As a consequence of the use of drugs that target the ADRA1A gene having the
eect of reducing blood pressure, it is plausible that there may be genetic variants
in the region of this gene that are positively associated with hypertension/blood
pressure. A large collaborative GWAS attempting to nd loci associated with
blood pressure (Newton-Cheh et al., 2009) explicitly examined the association of
common variants in the region of the ADRA1A gene due to the plausible associa-
tion. However, no results exceeded chance expectations. Other smaller ne-scale
studies (e.g. Gu et al. 2006) have, however, identied marginally signicant, al-
beit of small eect size, associations with variants in the ADRA1A gene with the
outcome of hypertension.
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Figure 6.1: Correlation of systolic and diastolic blood pressure readings. The hy-
pertension classications are illustrated on the plot with the following categories:
N (Green) = Normotensive, MI (Blue) = Mild Hypertensive, MO (Orange) =
Moderate Hypertensive, S (Red) = Severe Hypertensive.
The data available for analysis in this case study are the genotypes of indi-
viduals from the PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni)
study, involving a random sample from the Monza region of northern Italy. In
addition to the genotypes, continuous phenotype measurements of resting Heart
Rates (HR), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)
have been recorded. The recorded blood pressure measurements are taken as
the average of three readings over the course of an appointment with a trained
physician, in order to try and reduce the within-patient variability of these mea-
surements. Each measurement can be shown to be approximately normally dis-
tributed, as required for the analysis that follows. Further details of the PAMELA
study and the data involved can be found in both Mancia et al. (1995) and Pad-
manabhan et al. (2010).
Individuals with missing/untyped genotypes were removed from the analysis,
and individuals were also removed from analysis where a phenotype measure-
ment had not been recorded. This resulted in a sample of 1895 individuals withCHAPTER 6. ADRA1A DATA 107
(a) Correlation of diastolic BP and heart
rate
(b) Correlation of systolic BP and heart
rate
Figure 6.2: Correlation of blood pressure and heart rate measurements. The
ve individuals with valid blood pressure readings but no available heart rate
information are omitted from the plots.
genotypes and both systolic and diastolic blood pressure readings, however, only
1890 of this sample also had a valid heart rate measurement collected. Each
individual had 70 SNPs genotyped, covering 132.045 kb of the region involving
the ADRA1A gene.
Figure 6.1 illustrates the relationship between systolic and diastolic blood
pressure readings for the available subjects. It can be seen that there is a rea-
sonably strong signicant positive correlation between the two measurements
(r = 0:74, p-value < 2:210 16), and therefore using a single measurement that
takes into account both the systolic and diastolic readings in combination may
be reasonable. The colouring of the points in gure 6.1 represents a hypertension
classication that is commonly used as a measure that combines the blood pres-
sure readings into discrete categories. The classication of hypertension is given
according to the World Health Organization Guidelines (1999) and Williams et al.
(2004).
The relationships between heart rates and the blood pressure measurements
is illustrated in gures 6.2(a) and 6.2(b). The correlations between HR and SBP
(r = 0:11, p-value = 1:0  10 6) and between HR and DBP (r = 0:16, p-value
= 9:6  10 13) are both signicantly dierent from zero, albeit relatively low,
suggesting that combining these values into a single measurement may not beCHAPTER 6. ADRA1A DATA 108
Figure 6.3: Linkage plot for individuals with systolic and diastolic readings.
appropriate. It is though evident from the plots that there is one individual,
coloured red, with an unusually high heart rate measurement that could be the
result of the data being incorrectly recorded. The analysis of this chapter assumes
that the value has been incorrectly recorded, although if this assumption is not
made and the data is analyzed including this point, the same general conclusions
can be made (results not shown).
6.2 Linkage Plot
Initial phasing of the data using fastPHASE (Scheet and Stephens, 2006) results
in 1252 haplotypes being estimated to cover the 132.045 kb of available DNA for
the systolic/diastolic BP data sets, and 1276 haplotypes being estimated for the
heart rate data set. This represents an unreasonably large number of haplotypes
for the 70 SNPs of the data set, and so the data should be further explored to
determine if there is an approach that can be taken to reduce the number of
unique haplotypes.
Figure 6.3 shows a linkage plot for the systolic and diastolic blood pressure
data sets. The linkage plot produced from omitting individuals who have sys-
tolic/diastolic measurements but no reading for heart rates is extremely similar
to this plot (gure not shown). The shading of the plot is the default of the
Haploview (Barrett et al., 2005) program, with the interpretation of the colours
the same as that which was discussed previously in section 4.5.1.CHAPTER 6. ADRA1A DATA 109
Figure 6.4: Recombination estimates from HapMap, and the SNPs typed in the
study (red dots) and those in the HapMap CEU population (blue dots).
There appears to be two distinct high linkage regions shaded red, whilst link-
age between the blocks is low, as reected in the predominantly white shading.
This would indicate that there are two haplotype blocks separated by a poten-
tial recombination hotspot (Gabriel et al., 2002). The association is not however
perfect within each haplotype block, suggesting that there may be other recom-
bination events occurring at a lower rate within these regions, or that there are
sites exhibiting a degree of homoplasy. For Treescan-based methods to be appro-
priate, haplotypes should be found for areas of high linkage between SNPs since
an underlying tree model of the haplotypes is assumed, and for this reason it is
important to determine where recombination hotspots may exist.
6.3 Estimating Recombination Rates
& Hotspots
6.3.1 HapMap
The PAMELA data does not include SNPs typed for all of the 237 SNPs that have
been dened in the HapMap project (International HapMap Consortium, 2005).CHAPTER 6. ADRA1A DATA 110
Figure 6.5: Recombination estimates directly from data.
It is however hoped that most of the essential features of the ADRA1A region
can be captured by the 70 SNPs that are available in the data set. Figure 6.4
shows the pointwise recombination estimates given from the data in the HapMap
project (International HapMap Consortium, 2010), which were calculated using
the interval application from the LDHat (McVean et al., 2002) set of programs.
The 70 SNPs in the data set (red dots) seem to capture most of the main features
of the pattern of recombination, namely the three areas where there are peaks
of recombination rates. There is, however, inevitably some comparative lack of
detail, in particular there is a lack of information that could separate the two
distinct peaks between the positions at approximately 26732.950 and 26739.722
kb.
6.3.2 LDHat
The interval program is also used to obtain recombination estimates directly for
the 70 SNPs that were typed in this study. Due to the composite likelihood
method requiring products of 2-SNP likelihoods across all pairs of SNPs, there is
substantial computational time in estimating recombination rates between SNPs.CHAPTER 6. ADRA1A DATA 111
Figure 6.6: Hotspot determination by sequenceLDhot.
In order to lower the time required, various lookup tables are provided in the
LDHat package which can be used instead of calculating a table for all pairwise
comparisons when the sample size is large. fastPHASE estimated 1252 possible
haplotypes when considering the full range of data, however, the largest lookup
table available is for a sample size of 192 haplotypes. Generating a lookup table
for this number of haplotypes would require an unreasonably long period of time,
and so alternative strategies of handling the large number of haplotypes must be
considered.
It has been chosen to sample the potential haplotypes according to their
frequency of occurring in the data set so that the lookup table provided by the
program can be used. Figure 6.5 shows the recombination estimates for the
ADRA1A region using the available SNP data. It can be seen that the main
features of the region are captured by the SNPs typed in the study, with the area
of high recombination being evident.
Although the outputs from LDHat and the Haploview map strongly indi-
cates that there is a recombination hotspot existing near SNPs rs4416829 and
rs1390512 (positions 26732.950 to 26739.722 kb), the existence and location of
any hotspot can be veried using the sequenceLDhot method (Fearnhead, 2006).CHAPTER 6. ADRA1A DATA 112
sequenceLDhot explicitly determines the locations of recombination hotspots, by
using an approximate marginal likelihood method and performs likelihood ratio
tests for each possible hotspot position, details of the method of which can be
found in the paper of Fearnhead and Donnelly (2002). The results of applying
sequenceLDhot to the ADRA1A data set are shown graphically in gure 6.6,
where it can be seen that the recombination hotspot noticed previously is again
evident.
Figures 6.3-6.6 show that the position of the recombination hotspot that has
been identied covers SNPs at postions 37 and 38, and so the data is subsequently
split into two haplotype blocks of low recombination, from SNP positions 1 to 36
and from SNP 39 to 70. This results in the total number of unique haplotypes
reducing to 309 haplotypes for the systolic/diastolic data set, and 299 for the
heart rate data. A problem with the haplotype or Treescan approaches is however
illustrated, as it is not possible to include SNPs at positions 37 and 38 without
substantially increasing in the number of unique haplotypes, and thus lowering
the ability to detect any potential causative eects.
6.4 Categorized Analysis
In order to compare the analysis based upon the continuous measurements of sys-
tolic and diastolic blood pressure with the analysis performed by the WTCCC
(2007), the data is dichotomized into hypertensive and normotensive classes. The
classication of hypertension is given according to the World Health Organisa-
tion Guidelines World Health Organization (1999) and Williams et al. (2004),
whereby a subject is classied as hypertensive with either a systolic BP reading
of over 140, or a diastolic BP of over 90, or both. Figure 6.1 illustrates the hy-
pertension classications. This results in 799 people in the study being classied
as hypertensive to some degree, and 1096 being classied as normotensive.
Hypertension is widely studied and is known to be a risk factor for a wide
range of conditions, such as stroke, cardiac failure and renal conditions (Korner,
2007). Although hypertension is widely used as a categorical variable, the fact
that hypertension is actually dened by two continuous measurements could lead
to a substantial loss of information when an individual is classied as eitherCHAPTER 6. ADRA1A DATA 113
(a)
(b)
Figure 6.7: Single SNP analysis of the dichotomized hypertension data in fre-
quentist (a), and Bayesian (b), settings.
hypertensive or not. A further complication to the use of hypertension as a
categorical variable is the denition as to what constitutes hypertension, and
indeed this denition has diered slightly over time (Korner, 2007). It could be
argued that truly continuous variables should not be dichotomized (Senn, 1997),
however, a two-state classication can be useful in practice in providing guidelines
about levels of blood pressure that may be clinically signicant.
In order to analyze the data in a categorical format, dierent methods are
required compared to the analysis of continuous data. Chi-squared analysis can
be used to calculate p-values to test for an association between the hypertension
status and the genotypes at each SNP, or in a manner analogous to the Treescan
method described in section 1.5.2. A Bayes factor equivalent to each of these
methods can also be performed. Section 3.1 gave details of the Bayes factors
that can be appropriate for analyzing categorical data. For the analysis that
has been done here, a prior sample size for the Beta distribution of 5 has beenCHAPTER 6. ADRA1A DATA 114
(a)
(b)
Figure 6.8: Treescan-based analysis of the dichotomized hypertension data in fre-
quentist (a), and Bayesian (b), settings, with the recombination hotspot indicated
by dashed lines.
chosen. If the Uniform prior distribution suggested by Balding (2006) is instead
used, this can result in some marginally higher Bayes factors, in particular for
the Treescan-based analysis. This is as a result of very small groups of data being
adjudged to be dierentiated from the remaining data, whereas the the Beta prior
can dampen down such eects that may be unlikely to be true associations.
Figures 6.7 and 6.8 illustrate, respectively, the Single SNP and Treescan anal-
ysis of the data, after it has been categorized according to hypertension status.
The analysis that has been performed is for comparing the normotensive indi-
viduals to those with any degree of hypertension. Analysis can also be done
comparing the normotensive group to individuals with severe hypertension, in
order to nd any dierences between the two most extreme groups. Very similar
conclusions are reached when the data is coded in this way (results not shown).
It can be seen that irrespective of the choice of analysis, there is very littleCHAPTER 6. ADRA1A DATA 115
(a)
(b)
(c)
Figure 6.9: Standard single SNP tests for systolic (a), diastolic (b), and heart
rate (c) phenotypes.
suggestion that there are any associations between the genotypes and hyperten-
sion status. However, the dichotomizing of the data has resulted in a huge loss
of potentially useful information, and so any true associations between the geno-
type and the phenotypes may have been missed. The following sections treat the
outcomes as separate continuous measurements, and so may be more powerful at
nding any potential causative mutations.
6.5 Single SNP-based Analysis
The single SNP analysis method has the advantage over the Treescan-based anal-
ysis in that it does not require the data to be phased and does not have issues inCHAPTER 6. ADRA1A DATA 116
(a)
(b)
(c)
Figure 6.10: Bayesian single SNP tests for systolic (a), diastolic (b), and heart
rate (c) phenotypes.
determining if there are recombination hotspots within the data. However, ignor-
ing the tree structure could result in alleles being incorrectly grouped together
if there is a large degree of homoplasy. Results of the frequentist single-SNP
based approach is given in gure 6.9, and the corresponding Bayesian single-SNP
analysis is illustrated in gure 6.10.
A Bonferroni correction to the 5% signicance level applied to the 70 SNPs
observed in this data set results in a threshold of 7:1410 4. This is considerably
higher than a typical threshold used in GWAS, such as the critical level of 510 7
used in the WTCCC(2007) study. The lowest p-value that was observed in either
of the three clinical measurements in the Bonferroni analysis was 0.0028, and this
is substantially higher than the required signicance level of 7:1410 4. As such,CHAPTER 6. ADRA1A DATA 117
(a)
(b)
(c)
Figure 6.11: BimBam single SNP tests for systolic (a), diastolic (b), and heart
rate (c) phenotypes.
based upon a Bonferroni-corrected analysis, it would be concluded that none of
the SNPs have a signicant eect on any of the three clinical measurements in
this data set.
As the uncorrected p-values for the single SNP analysis are identical to the p
values obtained for the Bonferroni analysis, the lowest p-value obtained is again
0.0028 for the SNP rs11782159. This SNP results in the lowest corrected p-value,
using the permutation procedure as detailed in sections 1.5.2 and 4.4, of 0.206.
As this corrected p-value is higher than the threshold of 0:05 that is required for
a SNP to be declared signicant in this analysis, it would again be concluded
that none of the SNPs have a signicant eect on any of the clinical responses
use in this data set.CHAPTER 6. ADRA1A DATA 118
Applying the Bayes factor method to the equivalent groupings used in the
single SNP and Bonferroni-based methods, results in the 6 SNPs in table 6.1
being found that have a Bayes factor larger than 5. The Bayes factors have been
calculated based upon the default settings of the PheGe-Sim program, with the
hyperparameters being set according to the sample mean and variance of each
data set. It can be seen in table 6.1 that the size of the Bayes factor varies
considerably according to whether the additive, recessive/dominant or general
model is used. For example, for the SNP rs17055925, there would appear to be
very little eect if either the general or the recessive/dominant model is used, but
an additive model suggests that there is some slight evidence of an eect of the
SNP on the systolic blood pressure measurement. The means and size of each of
the groups is shown in table 6.1, and it can be seen that, although the dierence
is small, there does seem to be an increasing blood pressure measurement with
each copy of the B allele. In practice, however, the dierences in eect size are
likely to be too small to have any meaningful consideration in terms of the health
of an individual.
The Bayes factors of BimBam were also calculated for each SNP individually,
with the priors chosen being the default priors used by BimBam. Although
consistently lower, the pattern of results (gure 6.11) is similar to the Bayes
factors computed by PheGe-Find, with similar indications that there may be
small eects at some of the SNPs.
6.6 Treescan & Haplotype Analyses
Analyses based on the Treescan methods are carried out separately on the two
haplotype blocks of data; from SNPs rs4732845 (1) to rs11779546 (36), and from
SNPs rs4732908 (39) to rs537220 (70). A tree is constructed for each block, using
either the parsimony, tch or maximum likelihood methods. The results are given
for the parsimony method in gures 6.12 and 6.13, although the use of either
of the other two construction methods gives comparable results. If there was
no recombination and the innite-sites model assumption was true, the results
from the Treescan-based methods would be identical to the equivalent single
SNP method. However, the trees constructed show a high degree of homoplasyCHAPTER 6. ADRA1A DATA 119
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(a)
(b)
(c)
Figure 6.12: Standard Treescan results for systolic (a), diastolic (b), and heart
rate (c) phenotypes, with the recombination hotspot indicated by dashed lines.
with SNPs mutating in many positions on the tree, and this results in dierent
conclusions compared to the single SNP-based analysis. Only one of the three
SNPs found with a Bayes factor greater than 5 (or corrected p-value less than
0.05) was also found with comparable criteria in the single SNP analysis, albeit
with a stronger signal than was observed in the single SNP Bayes factor method.
The large number of repeat mutations on the reconstructed haplotype trees
make it dicult to ascertain which SNPs may indeed aect the phenotype re-
sponses. In addition, even if a SNP is adjudged to be associated with a response,
it can be dicult to determine if this is an articial feature resulting from the
tree that was constructed. The strength of associations according to haplotype-
based methods can also be assessed. However, because of the large number ofCHAPTER 6. ADRA1A DATA 121
(a)
(b)
(c)
Figure 6.13: Bayes factor Treescan results for systolic (a), diastolic (b), and heart
rate (c) phenotypes, with the recombination hotspot indicated by dashed lines.
low frequency haplotypes, there is low power to detect any dierences and as
such no strong eects are found. In the original Treescan paper, haplotypes
of frequency less than ve were removed in an attempt to decrease the risk of
falsely reconstructing haplotype trees, and therefore increase the chance of nd-
ing causative associations. Such analysis has been applied to the ADRA1A data
set, but there was also insucient evidence of any associations based upon the
resultant p-values and Bayes factors (results not shown).CHAPTER 6. ADRA1A DATA 122
(a) SNP rs4732853 (11) (b) SNP rs1048101 (23)
Figure 6.14: Sensitivity to hyperparameters of overall mean.
6.7 Sensitivity Analysis
The sensitivity of the Bayes factors to the prior hyperparameter choices should
be assessed, as it may be that the Bayes factors discussed above could be highly
dependent on these choices. The prior values that have been used in the analysis
are the default values of PheGe-Sim, however, sensible prior information from
other sources could also be used for this data set.
The parameter 0 could be chosen according to guidelines about average val-
ues for the clinical measurement in question. For the systolic blood pressure a
value of 120 mmHg would be reasonable, as this is dened as being approximately
the upper level of the optimal category of systolic blood pressure (Williams et al.,
2004; World Health Organization, 1999). The choice of this value is however sub-
ject to debate as it is also known that the blood pressure of an individual will
be related to other non-controllable factors, such as age and gender. For similar
reasons to the systolic blood pressure measurements, the prior mean for a dias-
tolic blood pressure can be chosen to be the upper value of the optimal category
of 80 mmHg. Resting heart rate measurements will also be subject to various
uncontrollable factors, although a value of 70 bpm is reasonable as this represents
the approximate average reading of a healthy adult (British Heart Foundation,
2010; American Heart Association, 2010). Analysis has been carried out usingCHAPTER 6. ADRA1A DATA 123
(a) SNP rs4732853 (11) (b) SNP rs1048101 (23)
Figure 6.15: Sensitivity to hyperparameters of within-group variance.
these hyperparameter choices in place of the default setting for 0 in PheGe-Sim,
and the patterns of association are similar for each of the SNPs being assessed.
There are, however, slight dierences in the Bayes factors, with the Bayes factors
tending to be marginally lower than when using the values set according to the
summaries of the sampled data.
The eects of the 0 and 0 hyperparameters for the mean are assessed to-
gether in gure 6.14, for two SNPs and their association with the heart rate
phenotype. It is evident that the patterns of association are similar for both a
SNP that appears to have some association with the phenotype (6.14(a)); and for
a SNP with little apparent association (6.14(b)). It can be seen that the Bayes
factors are strongly aected by the 0 parameter, and that choosing a prior value
far away from the mean of the data can result in a substantial reduction of the
Bayes factor. The hyperparameter 0 has only a relatively small inuence on the
Bayes factors, due to the large sample size of this data set.
Figure 6.15 illustrates the sensitivity of the Bayes factors to the 0 and 2
0
hyperparameters of the within-group variance 2, for the same two SNPs as used
in gure 6.14. As the prior for the mean has been centred on the sample mean,
reducing the 2
0 value indicates more condence in the location of the distribution
and therefore results in higher Bayes factors. The 0 parameter has a relatively
small eect, but increasing it will steadily increase the Bayes factors due to thisCHAPTER 6. ADRA1A DATA 124
indicating an increase in the belief about the accuracy of the prior distribution.
If, however, the prior mean of the data were to be far enough away from the true
data mean, then the Bayes factors would be increased by increasing the variance,
so that the true mean is covered by the prior distribution.Chapter 7
Results from Simulated Data
In this Chapter, the PheGe-Sim application of Chapter 2 is used to simulate
genotype-phenotype data on which the methods of association detailed in Chapter
4 can be applied. In order to choose suitable parameters for the construction of
the simulated data, the data set of Chapter 6 can be used to provide reasonable
initial estimates. The details of the realism involved in the choices of coalescent
parameters is though not of primary concern, as the most important consideration
is that the generated data sets will display similar properties to that of real data
with appropriately determined phenotypes. The estimates from the real data are
therefore adjusted in an attempt to more closely mirror the true patterns of the
resultant linkage plots.
7.1 Parameter Estimates
The choice of parameters for the simulations are intended to reect the real data
sets in Chapters 5 and 6, and as such, where possible, initial estimates are taken
from these data sets. It should however be considered that, for both the es-
timation of the mutation rate and the parameters of the gamma distribution,
estimates from the data are liable to underestimate the true values since they do
not take into account the potential homoplasy involved. The primary consider-
ation is to get a linkage plot that is similar in appearance to that of real data,
and for a similar number of segregating sites (approximately 40) to be involved
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for each variation in parameter choice.
7.1.1 Estimation of Mutation Rates
The choice of the mutation rate  for use in the simulations is dependent on
the other input parameters that can be chosen, as a change in the nite-sites
distribution (section 7.1.3) or the rate of population expansion (section 7.1.4) will
necessitate a dierent mutation rate to obtain the same number of segregating
sites on average. The simulations are intended to generate approximately the
same number of segregating sites as the real data sets, whilst also displaying
similar patterns of linkage between these sites.
In order to estimate the mutation rate for each of the real data sets, the
Watterson estimator (Watterson, 1975) can be used;
^ W =
SN Pn 1
i=1
1
i
; (7.1)
where SN represents the number of segregating sites and
Pn 1
i=1
1
i is the (n 1)th
harmonic number. This can be implemented through the use of the theta.s func-
tion of the R package ape (Paradis et al., 2004). In Chapter 6 it is found that
there is strong evidence of a recombination hotspot existing in the ADRA1A data
set. To avoid a misrepresentative mutation rate for the simulation of one haplo-
type region of low recombination, the estimate is therefore obtained separately
for each haplotype block either side of the recombination hotspot. The estimators
Table 7.1: Mutation rate estimates. Simulated data results are averages over all
the 2400 simulations.
DataSource
Number
of Sites
Number
of unique
haplotypes
Mutation
Rate
Estimate
ADRA1A LHS 36 196 6.15
ADRA1A RHS 32 113 6.04
D. melanogaster 22 41 5.14
Simulated data 37.39 59.19 8.04CHAPTER 7. RESULTS FROM SIMULATED DATA 127
for each of the real data sets are displayed in table 7.1.
The estimates of the mutation rates are however likely to be underestimates
of the true underlying mutation rates, as repeat mutations will not be accounted
for by the estimates from the Watterson's estimator since it is derived assuming
an innite sites model. This situation is demonstrated in the simulated data
sets, whereby a  of 25 has been chosen to generate, in combination with the
other parameters, representative linkage plots. Table 7.1 shows that the average
estimate of the mutation rate by ^ W is only 8.04, considerably less than the
true value of 25. The estimates from the simulated data are slightly higher than
those of the real data sets, but seem reasonable when evaluating the resultant
linkage plots. It can also be seen from table 7.1 that there are a larger number of
unique haplotypes than for the average of the simulated data. However, most of
these haplotypes are of low frequency, and so there will be low power to detect
dierences between the phenotypes at these rare haplotypes.
7.1.2 Estimation of Recombination Rate
Estimation of the recombination rate  for the simulated data can be based
directly upon estimates that are obtained using the real data sets of Chapters 5
and 6. The LDhat application by McVean et al. (2002) can be used to provide
estimates of recombination rates for the D. melanogaster and ADRA1A data
sets. A brief description of the method is given in section 5.3, and the resultant
estimates obtained are displayed in table 7.2. Estimates were not obtained for the
Table 7.2: Recombination rate estimates. The `area' is dened as the area un-
derneath the estimated recombination rate plots for each data set (Chapters 5
and 6), and the `length' is the length of the region of data being considered.
Data Source Area Length Average
Estimate
ADRA1A LHS 35.09 78.67 0.45
ADRA1A RHS 15.95 43.7 0.36
D. melanogaster 20.98 11.85 1.77CHAPTER 7. RESULTS FROM SIMULATED DATA 128
(a)  = 0 (b)  = 0:5 (c)  = 2
Figure 7.1: Simulated linkage plots for recombination rates of 0 (a), 0.5 (b) and
2 (c).)
simulated data set, as these rely on information being known about the relative
site locations of each SNP, which has not been simulated, although this could in
theory be done.
As noted in Chapter 6 and in the previous section, a recombination hotspot
between two haplotype blocks of low recombination is found to occur in the
ADRA1A data set. The simulations could be coded to mirror this eect by
allocating a single position to be the location at which a large proportion of the
recombination events occur. Although methodologically and computationally
feasible, this approach would require a high recombination rate in an attempt
to obtain the two near-independent haplotype blocks seen in the real data set.
This would result in a large increase in simulation time, since the time taken to
simulate even a single ARG substantially increases with a moderate increase in .
The eect of this is very similar to that of just pasting together two independent
simulations as shown in section C.3. It was therefore decided to focus on creating
a single haplotype block with relatively low recombination occurring uniformly
along the gene segment. A recombination rate of 0.5 has been chosen to obtain,
on average, 3.33 recombination events for each simulation, in order to obtain
linkage consistent with the real data sets.
As with the estimation of  discussed in section 7.1.1, the recombination esti-
mate can be misinterpreted in the presence of a nite-sites model of mutation, as
both features can result in the same apparent patterns of linkage. Figure 7.1 illus-
trates the linkage between sites that is obtained, using three dierent values of the
recombination parameter. As expected, it appears that there is some tendency
towards lower linkage between sites as the recombination parameter increases asCHAPTER 7. RESULTS FROM SIMULATED DATA 129
(a) Gamma Left (b) Gamma Right
Figure 7.2: Estimated Gamma distributions tted to the ADRA1A data of Chap-
ter 6; for the left (a) and right (b) of the recombination hotspot.
indicated by the increase in lighter coloured squares. The eect is however rela-
tively small, and section C.2 shows that recombination alone struggles to recreate
suciently realistic patterns of linkage.
7.1.3 Estimation of the Gamma Distribution
for Finite Sites
Approximate values of the shape () and rate () parameters of the Gamma
model for nite sites can be obtained directly from the real data sets of Chap-
ters 5 and 6. The number of repeat mutations that occur on each reconstructed
haplotype tree is counted, and the resultant distribution of the counts can be
used to estimate the required parameters of the Gamma distribution. As with
many of the other simulation parameters, the ADRA1A data set of Chapter 6
must be split into two haplotype blocks either side of the apparent recombination
hotspot. If the hotspot is ignored, the Gamma distribution becomes extremely
Table 7.3: Estimates of the parameters involved in the Gamma distribution for
nite sites. Simulated data results are averages over all the 2400 simulations.
Data Source Shape (^ ) Rate (1n^ ) Scale (^ )
ADRA1A LHS 1.609 0.187 5.353
ADRA1A RHS 4.383 0.597 1.676
D. melanogaster 8.8 6.4 0.16
Simulated data 5.636 2.028 0.530CHAPTER 7. RESULTS FROM SIMULATED DATA 130
(a) Innite sites (b) Reasonable rate of homoplasy (c) Rate of homoplasy too high
Figure 7.3: Simulated linkage plots for nite sites, as the Gamma model changes.
right skewed, with an unrealistically high number of repeat mutations being es-
timated to occur on any reconstructed haplotype tree. Figures 7.2(a) and 7.2(b)
illustrate the distribution of mutation counts for the left and right-hand side of
the recombination hotspot. Two of the SNPs from the data set are omitted,
as their inclusion into either of the haplotype blocks results in the unrealistic
situation of upwards of 50 instances of repeat mutations at a single site.
The R function tdistr by Venables and Ripley (2002) is used to obtain max-
imum likelihood estimates of the () and () parameters, and the tted distribu-
tions are shown with the solid lines on gure 7.2. A similar process was employed
for the D. melanogaster data, although there are far fewer repeat mutations and
a substantially lower sample size. The estimated parameters for the real data
sets are given in table 7.3.
It can be seen that there is some dierence between the shape and rate pa-
rameter estimates for either side of the recombination hotspot of the ADRA1A
data set. The accuracy of the method of obtaining estimates of the parameters
of the Gamma distribution through using the reconstructed haplotype trees can
be checked using the simulated data sets. For the simulated data sets, the  and
 parameters can be estimated using the same procedures as for the real data,
and the averages of these over all the simulations are displayed in table 7.3. It
can be seen that the estimates correspond closely to the values that were used
for the simulations, whereby the shape and rate parameters were specied as 5.5
and 0.5, respectively.
The usefulness of the Gamma model of nite sites can be seen when compar-
ing the linkage plots that can be obtained to those of an innite sites model, as inCHAPTER 7. RESULTS FROM SIMULATED DATA 131
(a)  = 0 (b)  = 10 (c)  = 50
Figure 7.4: Simulated coalescent trees for various rates of population expansion.
There are dierent scales on the y-axis for each of the plots, due to an increasing
level of population expansion resulting in the coalescence process completing
earlier. Changing the level of population expansion also changes the shape of
the plots, with an increasing level of expansion resulting in a smaller ratio of the
terminal and internal branch lengths.
gure 7.3. The model of innite sites shown in gure 7.3(a) shows an overabun-
dance of blue squares in comparison to that of both haplotype block regions of
the ADRA1A data set. There is also a much more block-like structure imposed
upon the linkage, and there are very few squares that are intermediate shades of
red. The other extreme (gure 7.3(c)) is where the rate is too high resulting in
far too many light red and white coloured squares, suggesting that the gamma
distribution is set too high.
7.1.4 Estimation of the Population Expansion Parameter
The  parameter relating to a theoretical exponential population expansion can-
not simply be directly estimated from real data, and is therefore determined, in
combination with the other parameters, so that the simulated data most closely
matches the real data. It is likely that there are complicated demographic events
that have occurred in human history, such as migrations between populations
and bottlenecks of population size. Other simulators of the coalescent process
can accommodate such events, however, only a simple exponential population
expansion is assumed in these simulations.CHAPTER 7. RESULTS FROM SIMULATED DATA 132
Figure 7.4 represents three realizations of the coalescent process (with no
recombination) for dierent values of the population expansion parameter. Figure
7.4(a) illustrates the extreme scenario of no population expansion occurring at
all, and it can be seen that the total length of the tree is dominated by long
ancestral branches. This results in many of the mutations occurring on these
branches and therefore there will be many mutations, particularly for an innite
sites model, that are perfectly correlated with each other (gure 7.5(a)).
The other extreme situation is that of a high rate of population expansion,
as illustrated in the coalescent plot of gure 7.4(c) and the linkage plot of gure
7.5(c). It can be seen that the scale on the y-axis is shorter than for the situation
of no population expansion, reecting the decreased time (in coalescent units)
that is taken to reach a most recent common ancestor. In addition, the terminal
branches are longer in comparison to the internal branches than is the case when
there is no population expansion. In an extreme scenario, the tree will become
more and more star-like as the population expansion parameter increases, until
all the lineages are eectively independent from each other. It can however be
seen from gure 7.5(c) that even this level of population expansion ( = 50)
results in SNPs becoming more independent from each other, as indicated by the
increasing prevalence of white coloured squares in the linkage plot. A further
consideration when increasing the value of  is that an increase in the mutation
rate, and possibly also the number of terminal nodes, will be required to obtain
approximately the same number of SNPs. For the examples in gure 7.4, table
7.4 shows dierent choices of the mutation rate , and number of terminal nodes
n, for the dierent  values.
Table 7.4: Adjustment of mutation rate and the number of terminal nodes for
dierent values of population expansion.
Figure  Mutation Rate () Terminal Nodes (n)
7.4(a) 0 10 250
7.4(b) 10 25 250
7.4(c) 50 50 500
The coalescent tree of gure 7.4(b), and the linkage plot in gure 7.5(b),CHAPTER 7. RESULTS FROM SIMULATED DATA 133
(a)  = 0 (b)  = 10 (c)  = 50
Figure 7.5: Simulated linkage plots for population expansion rates of 0 (a), 10
(b) and 50 (c).
illustrate a situation where the value of  has been set as 10. In this situation,
in combination with suitable choices for the other parameters, the linkage plot
most closely visually resembles that of the real ADRA1A data set of Chapter 6.
This can also be seen when comparing the proportions of each colour present in
the real and the simulated data sets.
7.1.5 Choice of Other Parameters
In order for the comparisons between the methods involved in nding causative
mutations to be fair, all the association methods and tree construction options
of Chapter 4 are tested on every simulated data set.
The choices as to how many causative mutations there are and their corre-
sponding eect size(s) are allowed to vary, with the eect size being given as a
percentage of the within group standard deviation, . The eect sizes chosen
represent mutations that are; 20%;40%;60% or 80% of the standard deviation.
The eect of two causative mutations is also explored, with the eect size of each
mutation being allocated to be the same. Under the nite-sites assumption, the
eect of the choice as to whether a mutation is causative in all parts of the tree
(AC), or only on a specic lineage (NAC), is also assessed. It would be expected
that Treescan-based methods would perform better than single-SNP type anal-
ysis in the NAC situation, but would perform worse if the AC assumption is
specied.
The realized number of segregating sites is a result of a complex relationship
between many of the parameter choices, including: the mutation rate, the rate
of population expansion, and the degree of homoplasy that has been specied.CHAPTER 7. RESULTS FROM SIMULATED DATA 134
Table 7.5: Summary of simulation parameters.
Variable n        num:pop
Value 250 25 10 0.5 5.5 0.5 2000
where n = Number of terminal nodes,  = Mutation rate,  = Population ex-
pansion parameter,  = Recombination rate,   = Shape parameter of Gamma
distribution,   = Scale parameter of Gamma distribution, num:pop = Simulated
population size
In addition, there is also the stochastic variation between dierent runs of the
simulation. A change in any one of these parameters will require a change in
the others to obtain the same average total number of segregating sites, and so
the calibration of all the parameter choices must be made so as to obtain an
average number of mutating sites similar to that of the real data sets. This has
been achieved with the parameter choices used in the preceding sections, as the
average number of SNPs for all the simulations that have been performed is found
to be 37.39. This is slightly higher than the corresponding number of sites of the
real ADRA1A data set, which has 36 and 32 segregating sites for the left and
right hand sides of the recombination hotspot. However, this is, in part, due to
there also being a slightly higher rate of mutation in the simulated data (section
7.1.1).
An additional parameter, n, must also be specied. This parameter controls
the number of non-unique (in terms of distinct haplotypes) terminal nodes of
the ARG, and as such its specication depends on the combination of the other
chosen parameters. The resultant linkage patterns are however reasonably con-
stant at dierent values of n, as each additional terminal node will on average
account for only a relatively small increase in the total length of the ARG, since
it typically attaches close to the tips of the existing ARG if n is suciently large
and  is comparatively small. There will therefore only be a small chance of an
increased number of mutations occurring that could aect the linkage within the
haplotypes. For the simulations that follow a value for n of 250, in combination
with the other specied variables, results in reasonable patterns of linkage.CHAPTER 7. RESULTS FROM SIMULATED DATA 135
To remain consistent with the ADRA1A data set a sample size of 2000 is
chosen for each of the simulations. Unlike the standard coalescent, whereby the
sample size is used to construct the ARG for each terminal node, the sample size
used in PheGe-Sim is used to sample the terminal nodes of the ARG according
to the frequency with which they occur. This is more ecient computationally as
less information is being retained in the construction of the ARG, in this case for
250 terminal nodes as opposed to the 2000 that the standard coalescent model
would require. The resultant linkage plots in this approach are largely unaected
compared to the standard coalescent approach, as few mutations will be predicted
to occur on the short distances of additional terminal branches.
The sample size used will have an impact on the time taken to run the simula-
tions, particularly for the permutation procedure used in the single SNP method
of association. Changes of the sample size would require alterations of the other
parameters to obtain similar patterns of linkage, primarily altering the propor-
tion of blue squares in the linkage plots that can arise through small sample sizes
of particular SNP combinations. The power of all of the methods at detecting
causative mutations will clearly increase with an increase in sample size, and
correspondingly decrease with a reduction of sample size.
Table 7.5 summarizes the choices of parameters used for the simulations that
follow. As noted throughout this chapter, dierent combinations of parameters
could reasonably be used to obtain similar patterns of linkage. However, it will
been shown that the parameters that have been chosen provide a good description
of the real data.
7.1.6 Comparisons with Real Data
Although substantial eorts have been made in order to make the simulated data
as realistic as possible, there are inevitably some dierences between the analysis
of the real and simulated data sets. The rst dierence is that the simulations
have used known haplotypes, whereas the real data required phasing of the geno-
types to obtain inferred haplotypes. The reasoning for the omission of phasing
the simulated genotypes in the simulations is that, as commented on previously in
section 1.5.1, the reconstruction of haplotypes is generally a reasonably accurateCHAPTER 7. RESULTS FROM SIMULATED DATA 136
(a) (b) (c)
Figure 7.6: Simulated linkage plots for the nal parameters chosen for the sim-
ulations (a); and the linkage plots of the LHS and RHS of the ADRA1A data
set.
procedure for tightly-linked SNPs. A more practical consideration in choosing not
to phase simulated data is that the haplotype-estimation procedure can involve
substantial computational time.
In addition to the assumption of perfectly phased haplotypes, there is also
the assumption in the simulated data that the boundaries between distinct hap-
lotype blocks have accurately been determined. In the real data set available to
this study, the recombination hotspot and block-like structure of the haplotypes
is clearly apparent, both visually in a linkage plot and through the criteria used
when applying the program SequenceLDhot (Fearnhead, 2006) in determining
hotspots. However, this will not always be the case for data sets, and in the
available data there is little indication as to how accurate the hotspot determi-
nation procedure could be. In a hypothetical situation, it can be seen that the
eect of joining together two entirely independent haplotype blocks will result in
linkage patterns similar to that of the true observed data (section C.3).
A pragmatic view is taken of the parameter choices, as the specic choice of
parameters is taken to be an issue that is not of interest in itself, but merely
useful as a mechanism for producing simulations that reects some features of
Table 7.6: Summary of colours used in linkage plots.
D0 < 0:4 0:4  D0 < 0:7 0:7  D0 < 1 D0 = 1
LOD < 2 white white white blue
LOD  2 green orange pink redCHAPTER 7. RESULTS FROM SIMULATED DATA 137
Figure 7.7: Percentages of each category of linkage for an example of ten simulated
data sets. The true proportions for the LHS and RHS of the recombination
hotspot are indicated at the LHS and RHS of the plot, respectively.
the real data. The linkage plot of gure 7.6(a) does however appear to support
the belief that features of the real data are indeed being captured, as visually at
least it appears that the simulated data set is similar in comparison to each of the
haplotype blocks of the ADRA1A data set. A summary of the proportion of each
colour present in the linkage plots can be obtained, and this can provide a further
illustration of the similarities between the real and simulated data sets. Figure
7.7 illustrates the comparison between the averages of each colour (table 7.6) for
each simulation, and the true proportion given in each haplotype block of the
ADRA1A data set. Although broadly similar, there are some dierences between
the real and simulated data: most notably, in the simulations, the proportion
of the pink group tends to be underestimated and the proportion of the orange
group is slightly overestimated.CHAPTER 7. RESULTS FROM SIMULATED DATA 138
Figure 7.8: Rpanel for illustrating simulation results.
7.2 Results of Simulations
The various association methods, and approaches in determining if a mutation
has been correctly identied, have been summarized through the use of another
interactive Rpanel, as shown in gure 7.8. The use of Rpanel in this setting
enables dierent approaches to be easily compared, and facilitates the collation
of results of simulations that have been run on multiple computers. Figure 7.9
shows the key used for plotting the results of each method, where the colouring,
line types and shape of the points have been chosen to represent the connections
between the dierent approaches.
In addition to the parameters chosen above, the results of each association
method is compared under four dierent criteria. In the plots of the results in
section 7.2, the models of causative mutations used for each of the plots is as
follows:
(a) Single `All Causative' and Additive mutation
(b) Single `All Causative' and Dominant mutation
(c) Single `Not All Causative' and Additive mutation
(d) Single `Not All Causative' and Dominant mutation
(e) Two `All Causative' and Additive mutationsCHAPTER 7. RESULTS FROM SIMULATED DATA 139
Figure 7.9: Plotting key for the results of the simulations, where the abbreviations
used are: Tsc = Treescan, Pars = Parsimony, MaxL = Maximum Likelihood,
Fitc = Fitch, Bay = Bayes factor approach, BIM = Bimbam approach, SNP =
Single SNP method, Bonf = Bonferroni Correction, HAP = Haplotype association
method, (B) = the 'branch correction' approach. Note that the found results for
both the `Treescan' and the `Treescan branch' approaches will be identical, and
thus only appear as one line in the relevant plots.CHAPTER 7. RESULTS FROM SIMULATED DATA 140
(a) (b)
(c) (d)
(e) (f)
Figure 7.10: Proportion of correctly found SNPs across the six causation models,
for the Treescan method when using the parsimony (circles), maximum likelihood
(squares) and tch (triangles) methods.CHAPTER 7. RESULTS FROM SIMULATED DATA 141
(a) (b)
(c) (d)
(e) (f)
Figure 7.11: False discovery rates for found SNPs across the six causation models,
for the Treescan method when using the parsimony (circles), maximum likelihood
(squares) and tch (triangles) methods.CHAPTER 7. RESULTS FROM SIMULATED DATA 142
(f) Two `Not All Causative'and Additive mutations
Comparisons can be made across each of the dierent models of causative
mutations. As would be expected, the ability of the methods at nding causative
mutations increases according to the size of the causative mutation, and also
increases when a mutation is allocated to be causative at all locations at which
it appears on the ARG. In general, additive models appear to be easier to detect
than the dominant models, as a result of there being fewer sampled individuals
carrying both forms of a causative mutation. It is also true that, on average,
there is slightly more diculty at detecting two causative mutations as compared
to the similar one causative mutation models.
The simulations were run on multiple computers using R version 2.9.1, along
with the PHYLIP, Treescan and BimBam applications. Each computer used for
the simulations were equipped with the Windows XP operating system, with
2.19GHz processor speed and 1GB of RAM. For each method and eect size
100 simulations were executed. The time taken for the simulations increased
according to the eect size and whether one or two causative mutations were
chosen, as this will cause more tests of two and three-way associations for both the
Bayesian and Frequentist approaches. The approximate time for single simulation
with all methods of association selected varied from about 30 minutes to 2 hours,
depending on the chosen simulation parameters.
7.2.1 Tree Construction Approaches
Figure 7.10 illustrates the results of the correctly found mutations for each of the
three construction methods applied to the original Treescan method. It can be
seen that there is very little dierence in the chance of nding the true causative
mutations between the three phylogenetic methods for each of the six causation
models that are displayed. In order for a fair comparison between the methods,
the False Discovery Rates (FDRs) of each tree construction approach must also
be taken into consideration. As with the percentages of correctly found muta-
tions, the False Discovery Rates of each tree construction method are broadly
in agreement with each other; regardless of whether the `branch' or the SNP
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(e) (f)
Figure 7.12: Proportion of correctly found SNPs across the six causation models,
for Treescan Parsimony method (solid red line with circles), Bonferroni haplotype
(dashed green line with triangles) and `single' haplotype methods (dashed purple
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(e) (f)
Figure 7.13: False discovery rates for found SNPs across the six causation models,
for Treescan Parsimony method (solid red line with circles), Bonferroni haplotype
(dashed green line with triangles) and `single' haplotype methods (dashed purple
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As expected the FDR of the branch correction method is substantially lower
than that of the single SNP approach, due to multiple mutations occurring on
branches of the reconstructed haplotype trees. There is, however, the added
consideration that, for the branch correction method, there is no information
relating to which of the SNPs that occur on a branch is indeed causative.
7.2.2 Treescan and Haplotype Comparisons
The Treescan and haplotype-based analysis can be compared in the frequentist
setting, and the results are displayed in gure 7.12. The comparison is to a
parsimony-reconstructed tree (red circles), as the previous section illustrated that
the dierence in phylogenetic approaches is small. The initial impression from
the plot is that the haplotype-based approaches are more powerful at nding
the true causative mutations for each of the simulation scenarios that have been
considered. This result is surprising in that it would be expected that the extra
information supplied by the reconstructed tree would provide more power for the
detection of causative mutations. It would however appear to be the case that
the tree-construction methods are reasonably poor at reconstructing the tree, as
a result of the recombination and homoplasy events that occur in the simulated
data. The False Discovery Rates attributable to the haplotype-based methods
are however generally higher than the comparable branch corrected Treescan
approach, apart from possibly for gures 7.13(b) and 7.13(d) representing the two
dominant models of inheritance, when it may be easier to detect dierences using
the haplotype approaches. The FDR of the non-branch-corrected SNP assessment
from Treescan is unreasonably high for all the simulations, as a result of the trees
that have been reconstructed containing multiple SNPs on each branch making it
dicult to distinguish between potential causative and non-causative mutations.
Similar comparisons between the dierent approaches can also be obtained in
the Bayesian-based association methods (results not shown). The interpretation
of the results are similar to that of the frequentist approaches, with comparable
dierences in both success and FDRs between the methods.CHAPTER 7. RESULTS FROM SIMULATED DATA 146
(a) (b)
(c) (d)
(e) (f)
Figure 7.14: Proportion of correctly found SNPs across the six causation mod-
els, for parsimony based Treescan (solid red line with circles), Bonferroni SNP
(solid green line with triangles) and single SNP methods (solid purple line with
triangles).CHAPTER 7. RESULTS FROM SIMULATED DATA 147
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Figure 7.15: False discovery rates for found SNPs across the six causation mod-
els, for parsimony based Treescan (solid red line with circles), Bonferroni SNP
(solid green line with triangles) and single SNP methods (solid purple line with
triangles).CHAPTER 7. RESULTS FROM SIMULATED DATA 148
7.2.3 Treescan and Single SNP Comparisons
Figure 7.14 illustrates comparisons that can be made between Treescan and the
single SNP correction methods in the frequentist setting. The initial impres-
sion from the plot is that the Bonferroni method is superior to all the other
approaches. However, gure 7.15 illustrates that there are exceptionally high
False Discovery Rates associated with the Bonferroni approach. Although the
Bonferroni approach is generally considered to be over-conservative in its cor-
rection levels when applied to GWAS, in the ne-scale context the reverse is
apparently true. This is due to the linkage that exists between SNPs resulting in
the `spill over' eects of closely-linked SNPs also being strongly associated with
the phenotype of interest. However, unlike the other approaches being consid-
ered there is no natural extension of the Bonferroni correction that could allow for
the consecutive assessment of both SNPs individually and in combination. The
Bonferroni method therefore correctly nds many causative SNPs, but cannot
successfully separate the eects of a causative mutation from other closely linked
non-causative SNPs.
A second feature of the illustrated results is the dierences between gures
7.14(a and b) and 7.14(c and d). The dierences are largely due to the choice
of whether a mutation is causative in all locations that it occurs in the ARG,
or whether only one lineage is aected by the occurrence of a mutation resulting
in the causative form of a SNP. This approach is in some sense intended to
reect the penetrance of a mutation, in that not all carriers of a causative form
of a mutation will necessarily have an increased phenotypic measurement. As
would be expected, the performances of each of the methods tends to be worse
in the situation of lower penetrance of the not-all-causative models. There are
though further comparisons to be made regarding the relative eectiveness of
each approach under the two simulated criteria.
In the situations of gures 7.14(a) and 7.14(b), where a mutation is causative
at all locations in an ARG, it can be seen that the single SNP-based methods
perform better than the Treescan approach in terms of nding the true causative
SNPs. It can also be seen from gures 7.15(a) and 7.15(b) that the lowest False
Discovery Rates are also obtained when using the single SNP-based approach.CHAPTER 7. RESULTS FROM SIMULATED DATA 149
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(c) (d)
(e) (f)
Figure 7.16: Proportion of correctly found SNPs across the six causation models,
for the single SNP (solid purple line with triangles), Bayes factor SNP (solid black
line with triangles) and BimBam SNP (solid blue line with triangles) methods.CHAPTER 7. RESULTS FROM SIMULATED DATA 150
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(e) (f)
Figure 7.17: False discovery rates for found SNPs across the six causation models,
for the single SNP (solid purple line with triangles), Bayes factor SNP (solid black
line with triangles) and BimBam SNP (solid blue line with triangles) methods.CHAPTER 7. RESULTS FROM SIMULATED DATA 151
In the alternative situation where a mutation is only causative at one lineage in
the ARG, it can be seen that the single SNP method performs worse than the
Treescan-based approaches. This would be expected, as the single SNP method
would be collating together individuals with causative and non-causative vari-
ants of the same mutation. Treescan would however construct a haplotype tree
that may be able to separate the same mutant allele into multiple mutations on
dierent branches. Dierences in the groupings of phenotypes may therefore be
possible to detect, and thus the Treescan approach could be more powerful at
nding causative mutations in this situation.
The dierences observed between the frequentist approaches are also observed
in the Bayesian setting, albeit with two slight dierences. The rst of these is
that of marginally higher success rate for the Bayes factor Treescan approach
as opposed to the frequentist method, however this is oset by there also being
slightly higher False Discovery Rates. This is likely in part due to the dierent
decision procedures used in the two approaches (as described previously in gures
4.6 and 4.7), as much as it is due to inherent dierences in the Frequentist and
Bayesian models.
A second dierence is that the Bayesian haplotype association method appears
to perform considerably worse than the frequentist Haplotype version. This is due
to the haplotype analyses resulting in rare groupings to be tested for association,
which can result by chance in low p-values. However, these will not be reected
in large Bayes factors since the priors on the Bayes Factors can be used to reduce
the impact of such situations.
7.2.4 Frequentist and Bayesian Comparisons
Figures 7.16 and 7.17 show the comparisons between the single SNP-based meth-
ods, for the Bayesian and frequentist settings. The results appear to be broadly
similar to each other in all of the simulation settings. There is, however, an in-
dication that the Bayes factors methods are slightly better at nding causative
mutations; particularly for lower eect sizes.
The Bayes factors of Chapter 3 and those used by BimBam are both similar
in their design, although there are some dierences in the prior specicationsCHAPTER 7. RESULTS FROM SIMULATED DATA 152
(a) Sensitivity of Bayes factors to the
hyperparameters of the overall mean
(b) Sensitivity of Bayes factors to the
hyperparameters of the within-group
variance
Figure 7.18: Sensitivity of simulations to prior choices of the Bayes factors.
that have been made in each approach. Despite this, the results obtained are
broadly similar for the success rate and for the FDR. There is some indication
that BimBam tends to perform better than the Bayes factor approach of PheGe-
Sim. However, as illustrated by gures 7.17(a) to 7.17(d) this is balanced by there
also being higher rates of False Discovery for the BimBam approach. In gures
7.17(e) and 7.17(f) there is a stronger suggestion that BimBam is preferable to
the Bayes factors of PheGe-Sim, which is as a result of the BimBam approach
being more willing to accept a model with two causative SNPs.
7.2.5 Sensitivity Analysis
Although in the PheGe-Sim program the results of the Bayes factors sensitivity
to hyperprior choices is not automatically explored, it is useful to produce the
sensitivity plots for some of the simulations where the true underlying eects are
known.
Figure 7.18(a) demonstrates the sensitivity of the Bayes factors in the simu-
lated data to the hyperparameters, for the prior of the mean for a SNP known to
be causative for the phenotype. It is apparent that the choice of 0 has a substan-
tial e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within a reasonable range about the sample mean of the data. In this situation
it appears that the prior sample size suggested by 0 has relatively little impact
on the Bayes factors, as a result of the large sample size of 2000 being for the
simulations.
For the same true causative SNP, the eect of the 0 and 2
0 hyperparameters
are shown in gure 7.18(b). Changing the 2
0 value corresponds to a reasonable
change in the Bayes factor, although the Bayes factor remains high throughout.
In a similar manner to the value of 0, the eect of 0 is relatively small due to
the large sample size that has been used.
The illustration of the sensitivity of the Bayes factors to the prior values for
the simulated data set is similar to that observed in the real data set of Chapter
6. As would be expected, a reduction of the sample size will result in there being
more eect of the priors on the Bayes factors, and this would be apparent if
chosen for the simulations, and is also shown in the small data set of chapter 5.
7.3 Conclusions
It has been shown that the simulation of data sets using PheGe-Sim can reason-
ably represent the real data set of Chapter 6. Fine adjustments could be made
to make the linkage plots of the simulated data more closely resemble that of the
ADRA1A data set. However, given that there will be uctuations between real
data sets, the simulated data would appear to be within reasonable range of the
real data. If further data sets were to become available, reasonable ranges of the
parameter values (as opposed to just point estimates) could potentially be ascer-
tained, and the accuracy of the method of simulation could be more accurately
veried.
The results of the association methods in detecting causative mutations illus-
trates that there is no method that is most appropriate for all of the six choices
of scenarios. Each method considered has advantages and disadvantages, and the
eventual choice of which could be most useful would be dependent on the prior
beliefs in the various scenarios.
Methods that rely on the construction of haplotypes are accompanied by the
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cause changes in phenotype measurement. Identication of haplotypes containing
a causative form of a mutation can be useful, however, if the causative SNP is
not identied then it would be more dicult to explain the underlying basis of
genetic conditions. However, imputation of SNPs that are not genotyped Servin
and Stephens (2007) based upon linkage with other SNPs, is a possible approach
that can be useful in identifying non-genotyped causal variants. In situations
of many low frequency haplotypes there will also be low power to detect any
potential genetic eects. Treescan analysis can allow for the identication of
the SNP upon a haplotype that causes a change in phenotype. However, in
the simulations performed it has been shown through the high FDR that this
approach can struggle to dierentiate causative and non-causative mutations that
could be predicted to occur on the same branch of a haplotype tree.
Single SNP methods may have the advantage of identifying specic causative
mutations, however there are also potential problems with their use. The method
of applying a Bonferroni correction has been shown to be awed for tightly-linked
SNPs, as it cannot dierentiate between causative SNPs and those in strong
association. It could be argued that the causative SNP will be the one with the
highest strength of association as determined by the p-value. However, there is
no appropriate method of determining if more than one SNP results in a change
of phenotype. A single SNP permutation approach can be useful in determining
causative associations, however, the use of p-values limits the exibility in testing
various models of association that can have an impact particularly at small eect
sizes. This is a real issue since most SNPs so far detected to be involved in
complex diseases appear to have relatively small eects.
The use of single SNP Bayes factors tests from Chapter 3, and also those of
BimBam, appear to be relatively successful at identifying true causative muta-
tions without also identifying large numbers of false positives. This is in part due
to two or more SNPs being tested together, and also due to it being possible to test
for multiple models of inheritance. However, for complex diseases it is plausible
that there is incomplete penetrance of causative mutations, as has been simu-
lated using the `Not All Causative' setting. In this situation, a Treescan-based
approach can be useful at separating the causative and non-causative forms of
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based methods may be slightly preferable compared to the other approaches.
However, any dierences in approaches should also be assessed using real data
sets, to assess any dierences that are not apparent in the simulated data.
7.4 Conclusions
The primary conclusion that can be made regarding the data available on the
ADRA1A gene is that there are no strong associations present in the gene with
any of the phenotype measurements of heart rate or blood pressure. This conclu-
sion is similar to that made by the WTCCC's (2007) GWAS, where the associa-
tion had been tested with the categorical outcome of hypertension. Newton-Cheh
et al. (2009) also found no signicant eects with hypertension or blood pressure
readings, commenting on the lack of association at the ADRA1A gene in partic-
ular due to the region being known to be targeted by anti-hypertensive drugs.
There are numerous reasons why no strong associations have been identied, and
the explanation that there are indeed no true associations is entirely plausible.
However, it is also known that the phenotypes, of blood pressure in particular,
are notoriously dicult to measure accurately. This is as a result of the blood
pressure and heart rate of an individual being highly variable between measure-
ments, and even though the study protocol has tried to minimize the eects of
this a moderately sized genetic eect can be masked by this variability. Further
to this, there are known environmental eects on hypertension and blood pres-
sure, such as stress, diet and exercise (Korner, 2007), such that real but small
genetic eects can eectively be lost within a sea of noise. It is also feasible that
the ADRA1A gene interacts with other genes in some way, and assessment of an
eect in each gene individually does not yield sucient information for positive
associations to be discovered.
Although no strong associations have been identied, the analysis in this
chapter can provide an insight into some of the various strengths and weaknesses
of the association methods under consideration that would not be possible using
only simulated data. Arguably the most relevant of these is the extra eort
required to construct a haplotype tree for the Treescan-based methods, with the
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prior to phasing of the haplotypes. If reasonable haplotype blocks have been
identied, then there is a further complication in the accuracy of the method
used in the construction of the haplotype tree. In this data set, irrespective of
the tree method used, there existed a large number of repeat mutations that
resulted in small and potentially unsuitable haplotype groupings. On balance,
for the PAMELA data, the potential benets of a Treescan-based approach are
outweighed by the extra eort and diculty required in running such an analysis.
In addition to the preference of using single SNP-based methods as opposed
to Treescan-based approaches, there is also some indication that the Bayes factor
approach may be more useful compared to the standard use of p-values. This is
particularly evident in the SNPs that do show some degree of association with
any of the phenotypes, in that the strength of a reported association can be
sensitive to the choice of the mutation model that has been used. A Bayes factor
approach can allow for selection over competing models, possibly by averaging
of the Bayes factors for each model, whereas in the frequentist approach this is
more dicult due to issues in dealing with adjustment of p-values as a result
of multiple testing considerations. The Bayes factors can also be useful in their
assessment of groups with small numbers of individuals, in that such associations
are unlikely to be over-interpreted, as the low power to detect associations will
be properly reected in the size of the Bayes factor. Although the use of Bayes
factors requires the explicit specication of prior information, for this data set
these can be sensibly chosen, and when this is the case, they can have a relatively
minor impact on the results.Chapter 8
Conclusions & Future Research
The objective of this thesis was to explore methods that can be used for ne-scale
phenotype-genotype association studies. This chapter will provide a summary of
the preceding chapters and the results that have been obtained, before describing
features of the thesis that could potentially be extended or improved upon.
Chapter 1 illustrates the historical context of genetic association studies, and
presents some of the specic challenges that are faced in the context of ne-scale
studies. The coalescent model is introduced as a tool that can be used for de-
veloping methods that are appropriate for both the simulation and analysis of
ne-scale genetic data sets. Methods that have been suggested for the specic
use in ne-scale studies were then introduced. In particular, haplotype-based
approaches and the Treescan method are discussed. The potential to implement
a Bayesian approach as an alternative to the commonly used frequentist method-
ology is then suggested, and possible advantages and disadvantages of such an
approach in the ne-scale genetic association context are discussed.
Chapter 2 then introduced the PheGe-Sim (Phenotype Genotype Simulation)
program that has been developed in the R language, to simulate data with some
of the specic features of ne-scale genotype-phenotype data sets. This program
extends the basic coalescent process, by allowing the possibility of recombination,
population expansion, and a nite-sites model of mutation to be modelled. It is
hoped that inclusion of such features will improve the accuracy of the simulated
data sets, when compared to the real data of Chapters 5 and 6 and ne-scale
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association study data sets in general. The procedures involved in allocating
mutations on to the Ancestral Recombination Graph are subsequently discussed,
in addition to the methods used for creating the haplotypes generated as a result
of the mutations.
The novel formulation of the Bayes factors used for PheGe-Sim and PheGe
Find is presented in Chapter 3. All the methods presented use conjugate prior
distributions to obtain exactly computed Bayes factors, which allows for fast
calculation of marginal likelihoods compared to some other possible approaches.
Methods of considering SNPs in combination with each other are also presented,
that retain information relating to the causation model involved.
The PheGe-Find (Phenotype Genotype - Find) application is introduced in
Chapter 4, in which dierent approaches that can be used for the association
studies are discussed. The methods used for association are also implemented
in the PheGe-Sim application, however, PheGe-Find is capable of reading in,
checking for inconsistencies, and analyzing real data sets from a variety of input
le formats. Methods of constructing the haplotype trees required by Treescan
are briey explored, as well as the methods of determining if causative mutations
have been correctly found when using simulated data sets.
The association methods that are under consideration for the simulated data
are also used upon the real data sets of Chapters 5 and 6. The data of Chapter 5
represents data from the ADH gene of the Drosophila melanogaster fruit y that
was initially analyzed by the Nested Clade Analysis (NCA) method, a precursor
to Treescan. As such, this data set can be used to compare the association
approaches upon data with previously detected genotype-phenotype associations.
The results from analysis of this data set are consistent with the original ndings,
with strong associations being found at three of the sites being considered. Only
one of the SNPs is considered found after corrections for correlations between the
SNPs and for multiple testing. The similarity between the results conrms that
the Bayes factors approaches are at least broadly in agreement with the standard
frequentist approaches when considering data with strong phenotype-genotype
associations.
Chapter 6 used the association methods upon a human data set concerning
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that has not previously been analyzed using either the Treescan or Bayesian-based
approaches. Some signicant associations have been found using the frequentist
approach, however, these do not pass any of the correction criteria used to address
multiple testing. The related Bayes factors also suggest that there are no overly
strong associations between the SNPs and any of the recorded phenotype mea-
surements. This data set does though illustrate some of the potential drawbacks
of the haplotype and Treescan approaches, that are not apparent when using sim-
ulated data. In particular, the additional diculties in phasing and constructing
haplotype trees were highlighted, issues that negate any benet that Treescan
may have had when using the simulated data.
Chapter 7 presents the results of a simulation study, assessing both the accu-
racy of the simulated coalescent data and the relative strengths of the association
methods that have been considered. As would be expected, the conclusions that
can be made from the simulations depends heavily on the choice of parameters
that are used. However, some general conclusions can be obtained. It is shown
that the parameters used to obtain similar patterns of linkage to the real data for
the simulations are reasonably similar to those estimated from the real data sets.
It is also shown that without having the possibility of a nite-sites model and
recombination that is contained within PheGe-Sim, it is not possible to generate
suitably realistic data sets.
The rst conclusion that can be made regarding the association approaches
on the simulated data, is that the method of using the Bonferroni-correction to
assess for signicance is unsuitable in ne-scale studies. Although the Bonfer-
roni approach can detect many causative SNPs, there is no suitable procedure
in dierentiating causative SNPs from those that are in strong linkage, and sim-
ilarly there is also no appropriate procedure for detection of multiple SNPs in
combination.
Haplotype and Treescan-based approaches are shown to be useful for detecting
SNPs that are not causative in all locations in which they occur. However, there
can also be high false discovery rates associated with these approaches under
certain scenarios. Single SNP methods seem to have a slight advantage over the
approaches using haplotypes, and the dierence is particularly clear for SNPs that
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at nding causative mutations while also being associated with low false discovery
rates. Imputation of un-genotyped SNPs can also potentially be useful to further
identify possible causative variants if they are in reasonable linkage with SNPs
that have been directly genotyped. The simulations also indicate that there may
be a slight advantage of using Bayes factors as opposed to the standard use of
p-values, however, there does not appear to be a large degree of dierence in the
ability of the single SNP permutation method and the two formulations of Bayes
factors.
There are a variety of ways in which the research that has been presented
in this thesis can be extended, and to some extents improved. The rst such
consideration is that all the models that have been presented, both Bayesian and
frequentist, have used normally distributed data. Although normality is usually
reasonable for natural data (or transformations of the data), the potential of
non-normal data sets could be further explored. As noted in section 3.9, there
is potential to include covariates into the Bayes factor procedures, and therefore
subsequently into the PheGe-Find program. This would be useful for considering
genetic and environment considerations together, however, would introduce issues
of model selection that would have to be addressed. The stepwise approach of
adding one SNP at a time has been shown to be useful for taking into account
the linkage between multiple SNPs. However, this procedure may not be as
appropriate for when there could be multiple potential covariates, and methods
such as the Lasso approach may be more suitable in such situations.
There is exibility in the construction of PheGe-Sim such that many more
models of associations could be tested, with multiple eects and interactions.
Assessment of such models may provide further insight into the potential benets
and drawbacks of the methods used, however, it is not known as to how realistic
the simulated causation models would be. If more data sets similar in size to the
data of Chapter 6 were to become available, the parameters of the simulations
could be adjusted to take account of the additional information.
A further improvement that could be made to the simulation of the coalescent
is to simulate the haplotype block structure, with regions of low recombination
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currently in use would have to be adapted to be more ecient in dealing with re-
combination events. However, as noted in section C.3, the rate of recombination
would have to be so high as to make the haplotype blocks close to being indepen-
dent. Improvements would also subsequently have to be made to the detection of
causative SNPs if a haplotype block structure was implemented, as the detection
of hotspots would also have to be automated and integrated into PheGe-Find.
Although there is some scope for improvement in aspects of the analysis that
has been presented, the methods of the PheGe-Sim and PheGe-Find applications
have been demonstrated to be useful in the context of ne-scale genetic associ-
ation studies; an area which will become ever more relevant as GWAS identify
further areas of interest, and as the SNP map of the human genome becomes ever
more detailed.Appendix A
Supplementary Figures and File
Formats
A.1 Example Fasta Output
Example of output Fasta File format:
>Sequence1
AAAGGGCGGACCTATCTTGT
TGTTCTATCCAGGCGGGAAA
>Sequence2
AAAGGGCTGACCTATCTTGT
TGTTCTATCCAGTCGGGAAA
>Sequence3
GGGAAACTGCAGTAATTTTC
CTTTTAATGACGTCAAAGGG
Sequence1: Label of sequence, preceded by > character
Sequence itself can continue over as many lines as required, until a new sequence
label is introduced.
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A.2 Example PHYLIP output
Example of output Phylip le format:
4 40
Sequence1 AAAGGGCGGACCTATCTTGT
Sequence2 AAAGGGCTGACCTATCTTGT
Sequence3 GGGAAACTGCAGTAATTTTC
TGTTCTATCCAGGCGGGAAA
TGTTCTATCCAGTCGGGAAA
CTTTTAATGACGTCAAAGGG
4: Number of Sequences
40: Number of SNPs
Sequence1: Label of sequence. Will take the rst ten characters (including spaces)
as the title of the sequence.
A.3 Example PED le format
Example of .Ped le format:
000001 000001 0 0 1 0 T A A A A A G G G A A G G T C C T C T G
000002 000002 0 0 1 0 A A A T A C G G G A G G T G C T T T T G
000003 000003 0 0 1 0 T A A A A C C G G G A G G G C T T C T G
Of the format:
000001 000001: Individual Name and Family Name (not relevant in this thesis)
0 0 1 0: Father ID, Mother ID, Sex, Aected Status
Base at SNP 1 on rst haplotype,
Base at SNP 1 on second haplotype,
Base at SNP 2 on rst haplotype,APPENDIX A. SUPPLEMENTARY FIGURES AND FILE FORMATS 164
....,
(Note can be phased or unphased haplotypes)
A.4 Example Sim Results File
Sun Apr 18 16:09:37 2010 Order: --TSC.PARS-- --BF.PARS-- --Bay.SNP--
Sim_1 True: 121 |121 |121|
Found: 55,121,148,156,175|55,121,148,156,175|121|
Corr.Find: 121 |121 |121|
False +: 55,148,156,175 |55,148,156,175 | |
False -: | | |
Linked +: | | |
Sim_2 True: 397|397|397|
Found: 397| |397|
Corr.Find: 397| |397|
False +: | | |
False -: |397| |
Linked +: | | |
Number of correctly found mutations [Tsc Pars] 2/2 (100%)
Equivalent to 1 correctly found mutations per simulation (1 per sim
true number) False positive rate of 2 (4 Total), per simulation
False Discovery Rate 0.6666667
Number of correctly found mutations [Tsc Pars BRANCH] 2/2 (100%)
Equivalent to 1 correctly found mutations per simulation (1 per sim
true number) False positive rate of 0 (0 Total), per simulation
False Discovery Rate 0
Number of correctly found mutations [Bayes Factor Pars] 1/2 (50%)
Equivalent to 0.5 correctly found mutations per simulation (1 perAPPENDIX A. SUPPLEMENTARY FIGURES AND FILE FORMATS 165
sim true number) False positive rate of 2 (4 Total), per simulation
False Discovery Rate 0.8
Number of correctly found mutations [Bay Pars BRANCH] 1/2 (50%)
Equivalent to 0.5 correctly found mutations per simulation (1 per
sim true number) False positive rate of 0 (0 Total), per simulation
False Discovery Rate 0
Number of correctly found mutations [Bayes Factor SNP] 2/2 (100%)
Equivalent to 1 correctly found mutations per simulation (1 per sim
true number) False positive rate of 0 (0 Total), per simulation
False Discovery Rate 0
Sun Apr 18 16:11:40 2010
Of the form:
Summary of the chosen methods of association, and the order in which they
appear in the tables.
For each simulation and each causative method used, summaries are given as to
whether the simulated causative mutations have been found (see table 2.4).
For each method of association used, summaries are given of the found and false
discovery rates across all of the simulated data sets.
A.5 Example Details File
Sun Apr 18 16:06:50 2010
Sim_1
Selected causative Branches
431
Individuals at risk and defective mutationsAPPENDIX A. SUPPLEMENTARY FIGURES AND FILE FORMATS 166
73 1
Observable Haplotypes
1 2 3 4 5 6 7 8 9 12 14 15 17 19 20 23 24 26 28 30 38 39 40 41
43 45 47 54 55 56 64 72 73 74 75 80 83 85 91 92 93 101 105 111
112 114 115 116 118 125 134 148 150 153 158 162 164 168 175 195
198 204 207 216 229
Caus.sites 121
-------------------------------------------------------------------------
Sun Apr 18 16:09:38 2010
Sim_2
Selected causative Branches
197 282
Individuals at risk and defective mutations
197 1
229 1
Observable Haplotypes
1 2 3 4 5 6 7 9 10 11 12 15 19 20 22 24 27 29 31 33 38 43 48 49
50 52 53 60 61 63 100 102 103 138 140 154 157 159 171 178 182
197 200 210 211 213 222 228 229 233
Caus.sites 397
-------------------------------------------------------------------------
Beta paramater = 10APPENDIX A. SUPPLEMENTARY FIGURES AND FILE FORMATS 167
Number of defective loci = 1
Interaction effects = 0
Mutation Effects = 3
Number of non distinct haplotypes = 250
Number of individuals in population = 2000
Number of Simulations executed = 2
Standard deviations of genotypes = 5
Theta 25
Recombination Rate = 0.5
Mutation Types = A
Finite Sites
AC
Gamma Shape = 5.5
Gamma Scale = 0.5
Average Number of SNPS = 33
Sun Apr 18 16:11:40 2010
Selected causative branches: The branches of the ARG upon which causative
mutations occur.
Individuals at risk and defective mutations: Details of the haplotypes aected by
each of the simulated causative mutations.
Observable Haplotypes: The unique haplotypes occurring as a result of the sim-
ulated ARG.
Caus.sites: The site(s) that have been simulated to result in a change in pheno-
type measurements
A summary is then given recapping the parameters that have been chosen for
simulating the data.
A.6 Example Single SNP output File
Tue Jun 01 15:49:43 2010
SNP# F B-W P(F) PCorr PMonAPPENDIX A. SUPPLEMENTARY FIGURES AND FILE FORMATS 168
40 10.40165 0.22373 3e-05 0 0
271 4.25547 0.07794 0.01432 0.118 0.118
97 4.81562 0.04574 0.02832 0.35 0.35
197 2.64955 0.03956 0.07093 0.398 0.398
6 1.70707 0.01697 0.18166 0.698 0.698
398 0.6702 -0.00792 0.51172 0.976 0.976
136 0.34279 -0.0158 0.70983 0.992 0.992
273 0.16387 -0.0201 0.84886 0.994 0.994
337 0.15939 -0.02021 0.85267 0.98 0.994
342 0.051 -0.02282 0.95028 0.95 0.994
SNP# F B-W P(F) PCorr PMon
271 6.21732 0.30927 1e-05 0.154 0.154
197 3.95722 0.24607 0.00027 0.806 0.806
97 6.0167 0.23861 8e-05 0.842 0.842
6 3.72457 0.22689 0.00052 0.936 0.936
273 4.33676 0.19872 0.00063 0.998 0.998
136 4.29148 0.19604 0.00069 0.994 0.998
398 3.21859 0.18508 0.00214 0.996 0.998
337 3.1661 0.18074 0.00247 0.988 0.998
342 3.11869 0.17681 0.00282 0.94 0.998
Tue Jun 01 15:50:10 2010
SNP#: SNP site position label
F: F statistic as calculated from an ANOVA
B-W: The Boerwinkle-Singh Corrected Estimator
P(F): The p-value calculated from the standard ANOVA
PCorr: The p-value calculated from the permutation correction procedure, using
the Boerwinkle-Singh estimates
PMon: The enforced Monotonic p-values from the corrected p-values, ensuringAPPENDIX A. SUPPLEMENTARY FIGURES AND FILE FORMATS 169
that a higher B-W value does not result in a lower permutation corrected p-value,
as can happen by chance.
A.7 Example Bayes factor File
Tue Jun 01 15:50:10 2010
Bayes Factor Results, under the following prior choices
mu_0 = 0 , kappa_0 = 20 , nu_0 = 20 , sigma_sqrd_0 = 20
Split Null LogL R_D LogL Add LogL Alt LogL Bay Fac Group
40 -3209.8 -3203.4 -3205.9 -3203.1 830.49 3
271 -3209.8 -3209.2 -3211.9 -3209.5 1.9027 3
197 -3209.8 -3209.5 -3210.7 -3211 1.3606 3
6 -3209.8 -3210.5 -3211.9 -3211.8 0.48385 3
273 -3209.8 -3210.8 -3211.1 -3211.5 0.35874 3
337 -3209.8 -3211 -3211.5 -3212.2 0.29501 3
136 -3209.8 -3211.1 -3211.7 -3212.5 0.28668 3
97 -3209.8 .. .. -3211.2 0.25356 2
342 -3209.8 -3211.2 -3211.7 -3212.6 0.24555 3
398 -3209.8 -3211.8 -3211.5 -3212.8 0.18347 3
Split Level = 2
Split Null LogL Mix LogL Add LogL Alt LogL Bay Fac Groups
40,271 -3203.1 -3206.9 .. -3202.5 1.7454 6
40,273 -3203.1 -3205.9 .. -3203.6 0.57764 6
40,136 -3203.1 -3211.9 .. -3205.4 0.1033 6
40,6 -3203.1 .. .. -3208.7 0.003834 8
40,337 -3203.1 .. .. -3208.9 0.003102 8
40,197 -3203.1 .. .. -3209.3 0.0020395 8
40,342 -3203.1 .. .. -3210.5 0.00058009 8APPENDIX A. SUPPLEMENTARY FIGURES AND FILE FORMATS 170
40,398 -3203.1 .. .. -3210.6 0.00053231 8
40,97 -3203.1 .. .. -3211.6 0.00020269 5
Best Model found
40
Tue Jun 01 15:50:14 2010
Date and time of start of simulation
Hyperparameter choices for the Bayes factors
Split: Branch(es) or SNP(s) under consideration
Null LogL: Null log marginal likelihood of the data set if in the rst level of splits,
or the highest marginal from the previous round of splits if in the second round
of splits or higher.
R D LogL: The Dominant or Recessive log marginal likelihood (rst round of
splits)
Mix LogL: The complex mixture marginal log Likelihood (second or higher level
of splits)
Add LogL: The additive log marginal likelihood
Alt LogL: The general alternative log marginal likelihood
Bay Fac: The Bayes factor calculated according to the highest possible log
marginal likelihood of the possible alternative models, compared to that of the
Null
Groups: The number of non-empty groups as a result of the splits
Date and time at the end of the simulation
A.8 Example Phenotype File
IID S_CLIN D_CLIN H_CLIN
640001 120 88 72
640003 118 68 66APPENDIX A. SUPPLEMENTARY FIGURES AND FILE FORMATS 171
640004 168 98 72
640005 102 78 66
640007 146 92 68
640009 118 84 60
... ... ... ...
... ... ... ...
Tab delimited le with column names corresponding to:
IID: Individual Identication Labels. Should correspond to those used in the
genotype les.
S CLIN, D CLIN, H Clin: Names for each phenotype measurement. Will be used
in labelling the output les and plots of any analysis.
A.9 Example Position File
rs4732845 26652190
rs17055869 26653565
rs17055880 26655432
rs1472346 26657311
rs7821479 26657574
rs9314327 26659872
rs4732639 26661027
... ...
... ...
Tab delimited le, with the site name followed by the base position.
A.10 Gamma Correction
The process aims to match the specied nite sites distribution as closely as
possible, without impacting on the number and positions of the mutations that
have already occurred as a result of the mutation rate and other parameters.
In order to achieve this, the options displayed in the ow chart are taken in anAPPENDIX A. SUPPLEMENTARY FIGURES AND FILE FORMATS 172
Figure A.1: Flowchart of the decisions involved in allocating nite sites using the
Gamma distribution.
attempt to ensure that sampled values are not simply discarded if they represent
a potentially valid level but do not t into the mutation structure that already
exists. In most situations where the initial parameters have been sensibly chosen,
the corrections applied will have minimal impact and the nite sites distribution
will be closely matched. In gure A.1, a `valid' value is a number that is within
the range of those previously sampled up until that stage in the algorithmAPPENDIX A. SUPPLEMENTARY FIGURES AND FILE FORMATS 173
(a) Example ARG (b) ARG Line Plot
(c) Coalescent Plot A (d) Coalescent Plot B (e) Coalescent Plot C
Figure A.2: Example output plots.
A.11 Example Output Plots
Figure A.2(a) illustrates an Ancestral Recombination Graph that has been sim-
ulated according to the parameters used for the simulations in chapter 7. In ad-
dition to the ARG, the line plot of gure A.2(b) has also been produced, which
illustrates the terminal nodes carrying each mutation. In this example, there are
two recombination events that occur, resulting in the three separate coalescent
regions illustrated in gures A.2(c), A.2(d) and A.2(e). It can be seen in gures
A.2(d) and A.2(e) that the heights of the plots are lower than that of the ARG,
indicating that the most recent common ancestor for the set of terminal nodes
has been reached at an earlier time for this coalescent region. The dierences in
coalescent structure as a result of the recombination events can also be clearly
seen across the three regions.APPENDIX A. SUPPLEMENTARY FIGURES AND FILE FORMATS 174
(a) (b)
(c) (d)
Figure A.3: Reconstructed parsimony haplotype trees for the LHS (a) and RHS
(b) of the recombination hotspot of the ADRA1A data set, and two haplotype
trees reconstructed from simulated data (c,d)
A.12 Reconstructed Haplotype Trees
Figure A.3 illustrates reconstructed haplotype trees for both real and simulated
data sets. It can be seen that the trees for the real data sets appear to have more
haplotypes than for the simulated data, particularly in gure A.3(a) for the left
of the recombination hotspot. The sample size are, however, approximately the
same for the real and simulated data, and so the increase in the number of haplo-
types implies that these haplotypes exist at lower frequencies on average. This is
indeed the case with many of the haplotypes of the real data set being estimated
to occur at low frequencies, and so there will be a corresponding low power to
detect any associations for the mutations that dene these rare haplotypes.Appendix B
Inputs to External Programs
B.1 PHYLIP Input Options
(a) dnapars (b) dnadist
(c) tch (d) dnaml
Figure B.1: Inputs for the PHYLIP program that have been used as defaults
for PheGe-Sim and PheGe-Find. Details of the options can be found at:
http://evolution.genetics.washington.edu/phylip.html
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B.2 Treescan Options
system(paste('"C:/Sim_Out/treescan.exe"',
'"C:/Sim_Out/treescansim_pars"',
"-b", "-f", "-k", "-p1000"), wait = TRUE, invisible = TRUE)
"C:/Sim Out/treescansim pars": Input Treescan le (Parsimony, Maximum
Likelihood or Fitch)
"C:/Sim Out/treescan.exe": Path of Treescan application
"-b": Forces the program to print the ANOVA tables to the log le
"-f": Results are sorted by the F statistic
"-k": Uses the Boerwinkle-Singh correction for the tests of association
"-p1000": Species 1000 permutations in order to calculate the p-values
B.3 BimBam
setwd("C:/Sim_Out")
system(paste("bimbam","-g","bimbam_tsc_geno.txt","-p",
"bimbam_pheno.PHENO",
"-pos","bimbam_pos.txt", "-o", "bimtest.out","-l 2","-sort"),
wait = TRUE, invisible = TRUE)
setwd("C:/Sim Out"): Set path of BimBam application and les.
"-g","bimbam tsc geno.txt": Specify BimBam genotype le
"-p","bimbam pheno.PHENO": Specify BimBam phenotype le
"-pos","bimbam pos.txt": Specify BimBam site locations le
"-o", "bimtest.out": Specify BimBam output folder
"-l 2": Calculates multi-SNP Bayes factors for all subsets of size 2
"-sort": Sort results according to the highest single SNP Bayes factor
B.4 Haploview
setwd("C:/Sim_Out")
Q.PED <- paste("-pedfile Sim_PED_", zorb, ".PED", sep = "")APPENDIX B. INPUTS TO EXTERNAL PROGRAMS 177
system(paste("java","-jar","Haploview.jar" , Q.PED,
"-nogui", "-png"), wait = TRUE, invisible = TRUE)
setwd("C:/Sim Out"): Set location of Haploview application and les.
Q.PED: Location of PED le for current simulation
"-nogui": Instructs Haploview not to open the Graphical User Interface
"-png": Produce the linkage plot in png le formatAppendix C
Additional Simulation Results
C.1 Linkage Plots from other Simulators
(a) ms (b) msHot
(c) Genome (d) SimCoal
Figure C.1: Examples of linkage plots from other coalescent simulators. Where
possible the parameters have been matched with those used for the parameters
for the simulations of Chapter 7.
There are numerous programs that simulate genotype data, and examples
of the resultant linkage plots are given in gure C.1. It was not possible to
generate data using the CoaSim application, as the program could not be used
on a Windows operating system, and there were unidentied problems associated
with its use under Linux.
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Figure C.1 illustrates that the simulators can generally recreate similar pat-
terns of linkage compared to that of real data. It is evident, however, that without
the use of a nite-sites model, there is an overabundance of blue and dark red
squares in the linkage plots. It appears to be the case that recombination alone
struggles to obtain sites displaying intermediate shades of red, as was displayed
in the linkage plots of the ADRA1A data set of Chapter 6 (gure 6.3).
C.2 Illustration of Linkage Plots without Finite
Sites
The apparent importance of including nite sites into the PheGe-Sim program
can be explored using the linkage plots under various scenarios where the nite
sites assumption is not used, and the other parameters are altered.
(a)  = 0 (b)  = 10 (c)  = 50
Figure C.2: Simulated linkage plots for various combinations of parameters
(innite-sites).
Figure C.2 uses an innite-sites model and no recombination, where each plot
corresponds to a dierent rate of population expansion, . As a consequence
of the reduction in height of the trees as  increases, the mutation rates must
also be increased to obtain approximately the same total number of mutations
for each situation. It can be seen that there is a block-like structure to the
situation where  = 0, in that many sites appear to be perfectly correlated to
each other as indicated by the strong presence of blue and dark red squares.
This is a result of the ancestral branches being long in comparison to the more
recent branches, and so mutations will either be perfectly associated with either
a high frequency (dark red), or low frequency (blue). As the rate of populationAPPENDIX C. ADDITIONAL SIMULATION RESULTS 180
expansion increases, more mutations will only occur on terminal nodes and so
the haplotypes will exist in lower frequency, and as a consequence there will be
an increase of blue squares in the linkage plots. Figure C.3 illustrates a similar
setting, but where a recombination rate of 2 has been chosen. It can be seen that
there is a similar pattern of the linkage plots as observed previously, and that the
increased recombination rate does not appear to substantially alter the observed
linkage plots.
(a)  = 0 (b)  = 10 (c)  = 50
Figure C.3: Simulated linkage plots for various combinations of parameters (in-
nite sites, recombination rate = 2).
C.3 Two Independent Simulations
(a) Simulated (b) Real
Figure C.4: Simulated data of two independent ARGs, and the real data that it
is intended to mimic.
Figure C.4(a) represents a simulation of haplotypes from two independent
Ancestral Recombination Graphs that have subsequently been pasted together.
It can be seen that there are a few positions where linkage is apparent in betweenAPPENDIX C. ADDITIONAL SIMULATION RESULTS 181
the two haplotype blocks, which are a result of chance. There does, however,
appear to be more instances of linkage being apparent in the real data set in
comparison to that of the simulated data, suggesting that the two haplotype
blocks may not be entirely independent from each other. Rates of recombination
in the simulations can be increased in an attempt to more closely the real data set.
However, in the current formulation of the program the run-time will dramatically
increase; and there also are memory limitations in the current formulation of the
application. There are areas in which the eciency of the PheGe-Sim application
could potentially be improved, and with this increased eciency larger regions
of genetic data containing haplotype blocks and recombination hotspots could
subsequently be simulated.
C.4 Code
The PheGe-Sim and PheGe-Find applications are available on request, along
with copies of the other applications that are required. These application run
on Windows XP, Vista and 7, although have only been extensively tested on
Windows XP. A ReadMe le accompanying the applications details the specic
procedures of running the code.Bibliography
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